EurekaMag PDF full texts Chapter 53,630

Diiorio, P.; Jurczyk, A.; Yang, C.; Racki, W.J.; Brehm, M.A.; Atkinson, M.A.; Powers, A.C.; Shultz, L.D.; Greiner, D.L.; Bortell, R. 2011: Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice. Pancreas 40(7): 1147-1149

Lei, S.; Li, H.; Xu, J.; Liu, Y.; Gao, X.; Wang, J.; Ng, K.F.J.; Lau, W.B.; Ma, X.-L.; Rodrigues, B.; Irwin, M.G.; Xia, Z. 2013: Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling. Diabetes 62(7): 2318-2328

Yao, D.; Brownlee, M. 2010: Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59(1): 249-255

Busik, J.V.; Mohr, S.; Grant, M.B. 2008: Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57(7): 1952-1965

Zhang, D.; Wan, A.; Chiu, A.P.-L.; Wang, Y.; Wang, F.; Neumaier, K.; Lal, N.; Bround, M.J.; Johnson, J.D.; Vlodavsky, I.; Rodrigues, B. 2013: Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase. Arteriosclerosis Thrombosis and Vascular Biology 33(12): 2830-2838

Huang, H.-M.; Chandramouli, V.; Ismail-Beigi, F.; Muzic, R.F. 2012: Hyperglycemia-induced stimulation of glucose transport in skeletal muscle measured by PET-[18F]6FDG and [18F]2FDG. Physiological Measurement 33(10): 1661-1673

Kim, B.; Backus, C.; Oh, S.; Feldman, E.L. 2013: Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. Journal of Alzheimer's Disease: Jad 34(3): 727-739

Turturro, F.; Von Burton, G.; Friday, E. 2007: Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(12): 3724-3730

Rajamani, U.; Essop, M.F. 2010: Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. American Journal of Physiology. Cell Physiology 299(1): C139-C147

Preiser, J-Charles.; Marik, P.Ellis. 2010: Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Critical Care Medicine 38(5): 1388; Author Reply 1388-9

Korkmaz, A.; Topal, T.; Oter, S.; Tan, D.-X.; Reiter, R.J. 2008: Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. Mini Reviews in Medicinal Chemistry 8(11): 1144-1153

Lin, C.-Y.; Lin, T.-Y.; Lee, M.-C.; Chen, S.-C.; Chang, J.-S. 2013: Hyperglycemia: GDNF-EGR1 pathway target renal epithelial cell migration and apoptosis in diabetic renal embryopathy. Plos one 8(2): E56731

Lemkes, B.A.; Hermanides, J.; Devries, J.H.; Holleman, F.; Meijers, J.C.M.; Hoekstra, J.B.L. 2010: Hyperglycemia: a prothrombotic factor?. Journal of Thrombosis and Haemostasis: Jth 8(8): 1663-1669

Elkon, B.; Cambrin, J.R.; Hirshberg, E.; Bratton, S.L. 2014: Hyperglycemia: an independent risk factor for poor outcome in children with traumatic brain injury*. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 15(7): 623-631

Harsha, S.; Aparna, A.N. 2012: Hyperglycemia: an unusual cause for hemichorea. Journal of Family Medicine and Primary Care 1(1): 74-75

Van den Heuvel, I.; Ellger, B.ör. 2009: Hyperglycemia: breaking the barriers?. Critical Care Medicine 37(3): 1160-1161

Gupta, A.K. 2010: Hyperglycemia: status epilepticus. Journal of the Association of Physicians of India 58: 264-265

Damiani, D.; Damiani, D. 2008: Hyperglycemic acute crisis in type 1 diabetes mellitus in youth. Arquivos Brasileiros de Endocrinologia e Metabologia 52(2): 367-374

Michaelson, J.; Hariharan, V.; Huang, H. 2014: Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical properties. Biophysical Journal 106(11): 2322-2329

Joshi, A.K.R.; Rajini, P.S. 2012: Hyperglycemic and stressogenic effects of monocrotophos in rats: evidence for the involvement of acetylcholinesterase inhibition. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 64(1-2): 115-120

Patibandla, P.K.; Rogers, A.J.; Giridharan, G.A.; Pallero, M.A.; Murphy-Ullrich, J.E.; Sethu, P. 2014: Hyperglycemic arterial disturbed flow niche as an in vitro model of atherosclerosis. Analytical Chemistry 86(21): 10948-10954

Kandiah, N.; Tan, K.; Lim, C.C.T.; Venketasubramanian, N. 2009: Hyperglycemic choreoathetosis: role of the putamen in pathogenesis. Movement Disorders: Official Journal of the Movement Disorder Society 24(6): 915-919

Balti, E.V.; Vandemeulebroucke, E.; Weets, I.; Van De Velde, U.; Van Dalem, A.; Demeester, S.; Verhaeghen, K.; Gillard, P.; De Block, C.; Ruige, J.; Keymeulen, B.; Pipeleers, D.G.; Decochez, K.; Gorus, F.K.; Baeten, V.; De Block, G.; De Mesmaeker, T.; Dewinter, H.; Diependaele, N.; Exterbille, S.; Glorieux, T.; Goubert, P.; Groven, C.; Haulet, T.; Ivens, A.; Kesler, D.; Lebleu, F.; Quartier, E.; Schoonjans, G.; Van Molle, M.; Vanderstraeten, S.; Walgraeve, A.; Van Gaal, L.; Braspenning, R.; Michiels, J.; Vertommen, J.; De Mesmaeker, T.; Exterbille, S.; Goubert, P.; Groven, C.; Kemels, V.; Tettelin, C.; Vanderstraeten, S.; Walgraeve, A.; Kaufman, J.M.; Hutse, A.; Rawoens, A.; Steyaert, N.; Deneve, S.; Platteau, N.; Mathieu, C.; Carpentier, M 2015: Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients. Journal of Clinical Endocrinology and Metabolism 100(2): 551-560

Sainio, A.; Jokela, T.; Tammi, M.I.; Järveläinen, H. 2010: Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis. Glycobiology 20(9): 1117-1126

Davenport, M.S.; Cohan, R.H.; Caoili, E.M.; Ellis, J.H. 2010: Hyperglycemic consequences of corticosteroid premedication in an outpatient population. AJR. American Journal of Roentgenology 194(6): W483-W488

Kitabchi, A.E.; Umpierrez, G.E.; Miles, J.M.; Fisher, J.N. 2009: Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7): 1335-1343

De Unamuno, B.; García-Casado, Z.; Bañuls, J.é; Requena, C.; Lopez-Guerrero, J.é A.; Nagore, E. 2018: CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer. Melanoma Research 28(3): 246-249

Yasuda, K.; Tanahashi, H.; Hayashi, M.; Yamakita, N. 2009: Hyperglycemic crises in adult patients with diabetes: response to Kitabchi et al. Diabetes Care 32(12): E157; Author Reply E158

Schneider, S. 2012: Hyperglycemic crisis in patients with diabetes mellitus. Medizinische Klinik Intensivmedizin und Notfallmedizin 107(6): 435-439

Edo, A.E.; Okaka, E.; Ezeani, I.U. 2014: Hyperglycemic crisis precipitated by Lassa fever in a patient with previously undiagnosed type 2 diabetes mellitus. Nigerian Journal of Clinical Practice 17(5): 658-661

Vaisy, M.; Szlufcik, K.; Maris, M.; De Bock, K.; Hesselink, M.K.C.; Eijnde, B.O.; Schrauwen, P.; Hespel, P. 2010: Hyperglycemic diet and training alter insulin sensitivity, intramyocellular lipid content but not UCP3 protein expression in rat skeletal muscles. International Journal of Molecular Medicine 25(6): 905-913

Zimmermann, B.; Donovan, T.J. 1948: Hyperglycemic effect of insulin. American Journal of Physiology 153(2): 197-204

Ganie, M.A.; Koul, S.; Razvi, H.A.; Laway, B.A.; Zargar, A.H. 2012: Hyperglycemic emergencies in Indian patients with diabetes mellitus on pilgrimage to Amarnathji yatra. Indian Journal of Endocrinology and Metabolism 16(Suppl 1): S87-S90

Goguen, J.; Gilbert, J. 2013: Hyperglycemic emergencies in adults. Canadian Journal of Diabetes 37(Suppl 1): S72-S76

Chansky, M.E.; Corbett, J.G.; Cohen, E. 2009: Hyperglycemic emergencies in athletes. Clinics in Sports Medicine 28(3): 469-478

Pleva, M.; Mirtallo, J.M.; Steinberg, S.M. 2009: Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition 24(5): 626-634

Pinto, M.E.; Manrique, H.A.; Guevara, X.; Acosta, M.; Villena, J.E.; Solís, J.é 2011: Hyperglycemic hyperosmolar state and rhino-orbital mucormycosis. Diabetes Research and Clinical Practice 91(2): E37-E39

Chen, W.-Y.; Chen, C.-C.; Hung, G.C.L. 2011: Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder. Current Drug Safety 6(3): 207-208

Rosenbloom, A.L. 2010: Hyperglycemic hyperosmolar state: an emerging pediatric problem. Journal of Pediatrics 156(2): 180-184

Tsai, S.L.; Hadjiyannakis, S.; Nakhla, M. 2012: Hyperglycemic hyperosmolar syndrome at the onset of type 2 diabetes mellitus in an adolescent male. Paediatrics and Child Health 17(1): 24-26

Kang, S.-H.; Lee, J.-Y.; Park, H.-S.; Sun, I.-O.; Choi, S.-R.; Chung, B.-H.; Choi, B.-S.; Yang, C.-W.; Kim, Y.-S.; Park, C.-W. 2011: Hyperglycemic hyperosmolar syndrome caused by steroid therapy in a patient with lupus nephritis. Journal of Korean Medical Science 26(3): 447-449

Zeitler, P.; Haqq, A.; Rosenbloom, A.; Glaser, N.; Polychronakos, C.; Quintos, J.B.; Gordon, C.; Divall, S.; Glaser, N.; Gitelman, S.; Rosenbloom, A.; Geller, D. 2011: Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. Journal of Pediatrics 158(1): 9

Bassham, B.; Estrada, C.; Abramo, T. 2012: Hyperglycemic hyperosmolar syndrome in the pediatric patient: a case report and review of the literature. Pediatric Emergency Care 28(7): 699-702

Rollins, J.L. 2013: Hyperglycemic management after solid organ transplantation. Critical Care Nursing Clinics of North America 25(1): 31-38

Yu, X.-Y.; Chen, H.-M.; Liang, J.-L.; Lin, Q.-X.; Tan, H.-H.; Fu, Y.-H.; Liu, X.-Y.; Shan, Z.-X.; Li, X.-H.; Yang, H.-Z.; Yang, M.; Li, Y.; Lin, S.-G. 2011: Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor. Plos one 6(1): E16239

Ondo, W.G. 2011: Hyperglycemic nonketotic states and other metabolic imbalances. Handbook of Clinical Neurology 100: 287-291

Sliman, S.M.; Eubank, T.D.; Kotha, S.R.; Kuppusamy, M.L.; Sherwani, S.I.; Butler, E.S.O.'C.; Kuppusamy, P.; Roy, S.; Marsh, C.B.; Stern, D.M.; Parinandi, N.L. 2010: Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Molecular and Cellular Biochemistry 333(1-2): 9-26

Frazer, C.A. 2012: Hyperglycemic state. Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 21(1): 38-39

Trunin, E.M.; Ganokhariti, I.S. 2008: Hyperglycemic syndrome at the early postoperative period. Vestnik Khirurgii Imeni I. I. Grekova 167(2): 58-60

Mohan, S.; Hegde, A.; Lyn, N.Adeline.Su.; Hui, F.; Lim, C.Cheio.Tchoyoson. 2011: Hyperglycemic unilateral choreoathetosis: hyperdensity of the contralateral basal ganglia on CT. Wiener Klinische Wochenschrift 123(7-8): 198

Hershey, D.Soltow.; Bryant, A.Leak.; Olausson, J.; Davis, E.D.; Brady, V.J.; Hammer, M. 2014: Hyperglycemic-inducing neoadjuvant agents used in treatment of solid tumors: a review of the literature. Oncology Nursing Forum 41(6): E343-E354

Fabiani Romero, F.; Bermúdez de la Vega, J.A.; González Martin, C.; Gentil González, J.; Oribe, A.; Cruz, C. 2009: Hyperglycerolemia, a pseudo-hypertriglyceridemia: a case report. Anales de Pediatria 71(1): 68-71

Cole, L.A. 2012: Hyperglycosylated hCG and pregnancy failures. Journal of Reproductive Immunology 93(2): 119-122

Cole, L.A.; Muller, C.Y. 2010: Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecologic Oncology 116(1): 3-9

Guibourdenche, J.; Handschuh, K.; Tsatsaris, V.; Gerbaud, P.; Leguy, M.C.; Muller, F.; Brion, D.E.; Fournier, T. 2010: Hyperglycosylated hCG is a marker of early human trophoblast invasion. Journal of Clinical Endocrinology and Metabolism 95(10): E240-E244

Cole, L.A. 2010: Hyperglycosylated hCG, a review. Placenta 31(8): 653-664

Cole, L.A.; Butler, S. 2012: Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: interchangeable cancer promoters. Molecular and Cellular Endocrinology 349(2): 232-238

Cole, L.A.; Butler, S.A. 2008: Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters. Journal of Reproductive Medicine 53(7): 499-512

Chuan, S.; Homer, M.; Pandian, R.; Conway, D.; Garzo, G.; Yeo, L.; Su, H.I. 2014: Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization. Fertility and Sterility 101(2): 392-398

Berndt, S.; Blacher, S.; Munaut, C.; Detilleux, J.; Perrier d'Hauterive, S.; Huhtaniemi, I.; Evain-Brion, Dèle.; Noël, Aès.; Fournier, T.; Foidart, J-Michel. 2013: Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-β receptor activation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(4): 1309-1321

Ingale, J.; Tran, K.; Kong, L.; Dey, B.; McKee, K.; Schief, W.; Kwong, P.D.; Mascola, J.R.; Wyatt, R.T. 2014: Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. Journal of Virology 88(24): 14002-14016

Palomaki, G.E.; Neveux, L.M.; Haddow, J.E.; Wyatt, P. 2007: Hyperglycosylated-hCG (h-hCG) and down syndrome screening in the first and second trimesters of pregnancy. Prenatal Diagnosis 27(9): 808-813

Zhang, Y.; Gao, H.; Guo, Y.; Joo, Y.-H.; Shreeve, J.'n.M. 2010: Hypergolic N,N-dimethylhydrazinium ionic liquids. Chemistry 16(10): 3114-3120

McCrary, P.D.; Beasley, P.A.; Cojocaru, O.Andreea.; Schneider, S.; Hawkins, T.W.; Perez, J.Paulo.L.; McMahon, B.W.; Pfeil, M.; Boatz, J.A.; Anderson, S.L.; Son, S.F.; Rogers, R.D. 2012: Hypergolic ionic liquids to mill, suspend, and ignite boron nanoparticles. Chemical Communications 48(36): 4311-4313

Gao, H.; Joo, Y.-H.; Twamley, B.; Zhou, Z.; Shreeve, J.'n.M. 2009: Hypergolic ionic liquids with the 2,2-dialkyltriazanium cation. Angewandte Chemie 48(15): 2792-2795

Odièvre, M.-H.; Labrune, P.; Odièvre, M. 2008: Hypergonadotrophic hypogonadism and congenital galactosemia. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(6): 1124-1125

Yoshida, T.; Awaya, T.; Shibata, M.; Kato, T.; Numabe, H.; Kobayashi, J.; Komatsu, K.; Heike, T. 2014: Hypergonadotropic hypogonadism and hypersegmented neutrophils in a patient with ataxia-telangiectasia-like disorder: potential diagnostic clues?. American Journal of Medical Genetics. Part a 164a (7): 1830-1834

Tzschach, A.; Ramel, C.; Kron, A.; Seipel, B.; Wüster, C.; Cordes, U.; Liehr, T.; Hoeltzenbein, M.; Menzel, C.; Ropers, H.-H.; Ullmann, R.; Kalscheuer, V.; Decker, J.; Steinberger, D. 2009: Hypergonadotropic hypogonadism in a patient with inv ins (2;4). International Journal of Andrology 32(3): 226-230

Kwon, D-Young.; Park, M.Ho. 2009: Hypergonadotropic hypogonadism in spinocerebellar ataxia type 2: a case report. Journal of Sexual Medicine 6(6): 1779-1782

Tembhare, P.R.; Subramanian, P.G.; Sehgal, K.; Yajamanam, B.; Kumar, A.; Gujral, S. 2009: Hypergranular precursor B-cell acute lymphoblastic leukemia in a 16-year-old boy. Indian Journal of Pathology and Microbiology 52(3): 421-423

St-Cyr, D. 2012: Hypergranulation: a wound healing obstacle. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 9(6): 50-53

Vuolo, J. 2010: Hypergranulation: exploring possible management options. British Journal of Nursing 19(6): S4 S6-8

Breuer, F.; Dall, A.; Kubitzke, M. 2012: Hypergraph coloring complexes. Discrete Mathematics 312(16): 2407-2420

Zlatić, V.; Ghoshal, G.; Caldarelli, G. 2009: Hypergraph topological quantities for tagged social networks. Physical Review. e Statistical Nonlinear and Soft Matter Physics 80(3 Part 2): 036118

Silva, J.; Willett, R. 2009: Hypergraph-based anomaly detection of high-dimensional co-occurrences. IEEE Transactions on Pattern Analysis and Machine Intelligence 31(3): 563-569

Kim, H.; Park, J.-H. 2014: Hypergraph-based recognition memory model for lifelong experience. Computational Intelligence and Neuroscience 2014: 354703

Kalamangalam, G.P. 2009: Hypergraphia in temporal lobe epilepsy. Annals of Indian Academy of Neurology 12(3): 193-194

Klamt, S.; Haus, U.-U.; Theis, F. 2009: Hypergraphs and cellular networks. Plos Computational Biology 5(5): E1000385

Thongrattanasiri, S.; Podolskiy, V.A. 2009: Hypergratings: nanophotonics in planar anisotropic metamaterials. Optics Letters 34(7): 890-892

Rubenstein, D.A.; Yin, W. 2014: Hypergravity and hypobaric hypoxic conditions promote endothelial cell and platelet activation. High Altitude Medicine and Biology 15(3): 396-405

Gerzer, R. 2009: Hypergravity and microgravity influence haemostasis. Thrombosis and Haemostasis 101(5): 799

Kimoto, M.; Zeredo, J.L.; Toda, K. 2012: Hypergravity conditioning on ileal movements in rats. Aviation Space and Environmental Medicine 83(5): 483-487

Casey, T.; Zakrzewska, E.I.; Maple, R.L.; Lintault, L.; Wade, C.E.; Baer, L.A.; Ronca, A.E.; Plaut, K. 2012: Hypergravity disruption of homeorhetic adaptations to lactation in rat dams include changes in circadian clocks. Biology Open 1(6): 570-581

Ciofani, G.; Ricotti, L.; Rigosa, J.; Menciassi, A.; Mattoli, V.; Monici, M. 2012: Hypergravity effects on myoblast proliferation and differentiation. Journal of Bioscience and Bioengineering 113(2): 258-261

Ronca, A.E.; Baer, L.A.; Wade, C.E.; Ronca, A.E.; Wade, C.E. 2002: Hypergravity effects on pregnancy and parturition. Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 9(1): P203-P204

Iwata, C.; Abe, C.; Nakamura, M.; Morita, H. 2014: Hypergravity exposure for 14 days increases the effects of propofol in rats. Anesthesia and Analgesia 118(1): 125-131

Koyama, T.; Kimura, C.; Hayashi, M.; Watanabe, M.; Karashima, Y.; Oike, M. 2009: Hypergravity induces ATP release and actin reorganization via tyrosine phosphorylation and RhoA activation in bovine endothelial cells. Pflugers Archiv: European Journal of Physiology 457(4): 711-719

Ishizawa, M.; Iwasaki, K.-I.; Kato, S.; Makishima, M. 2009: Hypergravity modulates vitamin D receptor target gene mRNA expression in mice. American Journal of Physiology. Endocrinology and Metabolism 297(3): E728-E734

Musgrave, M.E.; Kuang, A.; Allen, J.; van Loon, J.J.W.A. 2009: Hypergravity prevents seed production in Arabidopsis by disrupting pollen tube growth. Planta 230(5): 863-870

Li, S.; Shi, Q.; Wang, Z.; Yan, R.; Cheng, H.; Dai, K. 2009: Hypergravity results in human platelet hyperactivity. Journal of Physiology and Biochemistry 65(2): 147-156

Danaee, A.; Howard, J.; Robertson, B.; Robinson, S. 2014: Hyperhaemolysis in a patient with HbH disease. Transfusion Medicine 24(4): 244-245

Rogers, M.; Smith, G. 2014: Hyperhaemolysis in a patient with chronic lymphocytic leukaemia. Transfusion Medicine 24(2): 123-124

Stokes, I.C.; Downie, P.A.; Wood, E.M.; Bowden, D.K.; Monagle, P.T.; Barnes, C.D. 2010: Hyperhaemolysis in sickle cell disease--an unusual and potentially life-threatening complication. Medical Journal of Australia 192(5): 281-282

Senanayake, M.P.; Kuruppu, K.K.S.; Sumanasena, S.P.; Lamabadusuriya, S.P. 2008: Hyperhaemolysis syndrome in haemoglobin e / beta thalassaemia responding to cyclophosphamide therapy. Ceylon Medical Journal 53(4): 134-135

Vagace, J.M.; Casado, M.S.; Bajo, R.; Gervasini, G. 2014: Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: a discussion on underlying mechanisms. Blood Transfusion 12(1): 127-129

Babb, A.; Diamantos, N.; Sekhar, M. 2012: Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma. Transfusion Medicine 22(2): 142-144

Prkacin, I.; Mesarić, J.; Cavrić, G.; Jurenec, S.; Hundrić-Haspl, Z.; Kardum-Skelin, I. 2011: Hyperhaemolytic siyndrome in patient without haemoglobinopathies. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(Suppl 1): 223-227

Willis, M.; Götz, M.; Kandalam, A.K.; Ganteför, G.F.; Jena, P. 2010: Hyperhalogens: discovery of a new class of highly electronegative species. Angewandte Chemie 49(47): 8966-8970

Di Meglio, L.; Busalmen, J.Pablo.; Pastore, J.Ignacio.; Ballarín, V.Laura.; Nercessian, Débora. 2014: Hyperhalophilic archaeal biofilms: growth kinetics, structure, and antagonistic interaction in continuous culture. Biofouling 30(2): 237-245

Yan, M.; Callum, J.; Lin, Y. 2015: Hyperhemolysis associated with marginal zone lymphoma. Leukemia and Lymphoma 56(3): 829-831

Morawakage, L.R.; Perera, B.J.C.; Dias, P.D.N.; Wijewardana, S.K. 2009: Hyperhemolysis in a patient with beta-thalassemia major. Asian Journal of Transfusion Science 3(1): 26-27

Aragona, E.; Kelly, M.J. 2014: Hyperhemolysis in sickle cell disease. Journal of Pediatric Hematology/Oncology 36(1): E54-E56

Mechery, J.; Abidogun, K.; Crosfill, F.; Jip, J. 2012: Hyperhemolysis syndrome complicating pregnancy in homozygous δβ-thalassemia. Hemoglobin 36(2): 183-185

Islam, M.S.; Chia, L. 2010: Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood. European Journal of Haematology 84(2): 188

Gupta, S.; Fenves, A.; Nance, S.T.; Sykes, D.B.; Dzik, W.S. 2015: Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion 55(3): 623-628

Win, N. 2009: Hyperhemolysis syndrome in sickle cell disease. Expert Review of Hematology 2(2): 111-115

Lu, R.P.; Clark, P.; Mintz, P.D. 2008: Hyperhemolysis syndrome: a relative contraindication for transfusion. Journal of Hospital Medicine 3(1): 78-80

Reyes, M.A.; Illoh, O.C. 2008: Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Immunohematology 24(2): 45-51

Allen, J.G. 1947: Hyperheparinemia; the cause of the hemorrhagic disease produced by total body exposure to ionizing irradiation. Federation Proceedings 6(1 Part 2): 68

Pariser, D.M. 2014: Hyperhidrosis. Dermatologic Clinics 32(4): Xi

Glybochko, P.V.; Aliaev, I.G.; Gadzieva, Z.K. 2014: Integrative approaches to the diagnosis and treatment in urology. Urologiia 156(2): 5-14

Ruchinskas, R. 2007: Hyperhidrosis and anxiety: chicken or egg?. Dermatology 214(3): 195-196

Heymann, W.R. 2008: Hyperhidrosis and botulinum toxin: expanding horizons. Journal of the American Academy of Dermatology 59(2): 332-333

Perera, E.; Sinclair, R. 2013: Hyperhidrosis and bromhidrosis -- a guide to assessment and management. Australian Family Physician 42(5): 266-269

Bahmer, F.A.; Sachse, M.M. 2008: Hyperhidrosis area and severity index. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 34(12): 1744-1745

Diamond, A.; Kenney, C.; Almaguer, M.; Jankovic, J. 2007: Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report. Journal of Neurosurgery 107(5): 1036-1038

Fuertes, A.; Martín, A.Fuertes.; Cabrera, S.; Figueroa, S.Cabrera.; Valverde, M.de.la.Paz.; Merino, Mía.de.la.Paz.Valverde.; Domínguez-Gil, A.; Hurléé, A.Domínguez-Gil. 2009: Hyperhidrosis in association with efavirenz. Aids Patient Care and Stds 23(3): 143-145

Hussain, W.; Coulson, I.H. 2010: Hyperhidrosis in association with keratoderma and strikingly large hands and feet: a rare case of pachydermoperiostosis. Clinical and Experimental Dermatology 35(3): e16-e17

Carrier, C.A.; Seeman, J.L.; Hoffmann, G. 2011: Hyperhidrosis in naïve purpose-bred beagle dogs (Canis familiaris). Journal of the American Association for Laboratory Animal Science: Jaalas 50(3): 396-400

Basedow, S.; Kruse, R.; Bruch-Gerharz, D. 2011: Hyperhidrosis of childhood and adolescence: clinical aspects and therapeutic options. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 62(12): 928-934

Komericki, P.; Ardjomand, N. 2012: Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type a. Indian Journal of Dermatology Venereology and Leprology 78(2): 201-202

Streker, M.; Reuther, T.; Hagen, L.; Kerscher, M. 2012: Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride. Journal der Deutschen Dermatologischen Gesellschaft 10(2): 115-119

Huang, W.-L.; Chang, L.-R. 2012: Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole. Psychiatry and Clinical Neurosciences 66(3): 245

Barrichello, A.P.C.; Cecílio, L.B.; Monteiro, R.; Jatene, F.B.; Bernardo, W.M. 2007: Hyperhidrosis versus compensatory sweating: is it a treatment benefit or a risk of a new problem?. Revista da Associacao Medica Brasileira 53(5): 383-384

Sonthalia, S.; Singal, A.; Sharma, R. 2012: Hyperhidrosis, vesicles, and papules over the nose: granulosis rubra nasi. Indian Journal of Dermatology Venereology and Leprology 78(1): 97-98

Schlereth, T.; Dieterich, M.; Birklein, F. 2009: Hyperhidrosis--causes and treatment of enhanced sweating. Deutsches Arzteblatt International 106(3): 32-37

Swartling, C.; Brismar, K.; Aquilonius, S.-M.; Naver, H.; Rystedt, A.; Rosell, K. 2011: Hyperhidrosis--the "silent" handicap. Lakartidningen 108(47): 2428-2432

Anonymous 2012: Hyperhidrosis. Effective reduced sweating with methantheline bromide. MMW Fortschritte der Medizin 154(10): 68-69

McWilliams, R.R.; Wieben, E.D.; Chaffee, K.G.; Antwi, S.O.; Raskin, L.; Olopade, O.I.; Li, D.; Highsmith, W.E.; Colon-Otero, G.; Khanna, L.G.; Permuth, J.B.; Olson, J.E.; Frucht, H.; Genkinger, J.; Zheng, W.; Blot, W.J.; Wu, L.; Almada, L.L.; Fernandez-Zapico, M.E.; Sicotte, H.; Pedersen, K.S.; Petersen, G.M. 2018: CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 27(11): 1364-1370

Weiss, J. 2013: Hyperhidrosis: when perspiration is a problem. Deutsche Medizinische Wochenschrift 138(6): 246-247

Neumaier, J. 2011: Hyperhidrosis: constantly wet from perspiration: what causes should be considered. MMW Fortschritte der Medizin 153(35): 18

Vorkamp, T.; Foo, F.J.; Khan, S.; Schmitto, J.D.; Wilson, P. 2010: Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 8(5): 287-292

Stolman, L.P. 2008: Hyperhidrosis: medical and surgical treatment. Eplasty 8: E22

Brown, A.L.; Gordon, J.; Hill, S. 2014: Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis. Current Opinion in Pediatrics 26(4): 460-465

Shargall, Y.; Spratt, E.; Zeldin, R.A. 2008: Hyperhidrosis: what is it and why does it occur?. Thoracic Surgery Clinics 18(2): 125-132 V

Veal, J.R.; Shadid, J.N. 1949: Hyperhidrosis; observations on the study of 61 cases. Surgery 26(1): 89-98

Taylor, J.; Woodcock, S.; Kavanagh, G.M.; Weller, R.B. 2011: Hyperhidrotic and control subjects have similar sweating responses to pilocarpine administration. Journal of the American Academy of Dermatology 64(3): 603-604

Kerkeni, M.; Added, F.; Ben Farhat, M.; Miled, A.; Trivin, F.ço.; Maaroufi, K. 2008: Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease. Annals of Clinical Biochemistry 45(Part 2): 193-198

Fimognari, F.L.; Loffredo, L.; Di Simone, S.; Sampietro, F.; Pastorelli, R.; Monaldo, M.; Violi, F.; D'Angelo, A. 2009: Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 19(9): 654-659

Hamzaoui, A.; Harzallah, O.; Klii, R.; Mahjoub, S. 2010: Hyperhomocysteinaemia in Behçet's Disease. Biochemistry Research International 2010: 361387

Guaraldi, G.; Ventura, P.; Garlassi, E.; Orlando, G.; Squillace, N.; Nardini, G.; Stentarelli, C.; Zona, S.; Marchini, S.; Moriondo, V.; Tebas, P. 2009: Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. HIV Medicine 10(1): 28-34

Lin, Y.-H.; Huang, S.-Y.; Hsu, M.-I.; Chang, Y.-c.I.; Cheng, C.-Y.; Hsu, C.-S.; Tzeng, C.-R. 2013: Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age. European Journal of Obstetrics Gynecology and Reproductive Biology 171(2): 314-318

Cao, H.; Hu, X.; Zhang, Q.; Li, J.; Liu, B.; Wang, J.; Shao, Y.; Zhang, Z.; Liu, C.; Hu, H.; Zhang, J.; Xin, S. 2014: Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm. Vasa. Zeitschrift für Gefasskrankheiten 43(3): 181-188

He, J.A.; Hu, X.H.; Fan, Y.Y.; Yang, J.; Zhang, Z.S.; Liu, C.W.; Yang, D.H.; Zhang, J.; Xin, S.J.; Zhang, Q.; Duan, Z.Q. 2010: Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 39(4): 508-513

Bibi, S.; Qureshi; Ahmad, M.; Qureshi, P.Mohammad.Ali.; Memon, A.; Qazi, R.Ara. 2010: Hyperhomocysteinaemia, vascular related pregnancy complications and the response to vitamin supplementation in pregnant women of Pakistan. Jpma. Journal of the Pakistan Medical Association 60(9): 741-745

Prieto de Paula, J.é M.ía.; Gómez Barquero, J. 2008: Hyperhomocysteinema, B12 deficit and thromboembolic venous disease. Medicina Clinica 130(10): 399

Yao, D.; Sun, N.-L. 2014: Hyperhomocysteinemia accelerates collagen accumulation in the adventitia of balloon-injured rat carotid arteries via angiotensin Ii type 1 receptor. International Journal of Molecular Sciences 15(11): 19487-19498

Einollahi, B.; Lessan-Pezeshki, M.; Kalantar, E.; Rostami, Z.; Khalili, N.; Ghadiani, M.H.; Ahmadi, J. 2011: Hyperhomocysteinemia after kidney transplantation. Transplantation Proceedings 43(2): 586-587

Ali, A.; Waly, M.I.; Al-Farsi, Y.M.; Essa, M.M.; Al-Sharbati, M.M.; Deth, R.C. 2011: Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochimica Polonica 58(4): 547-551

Damelan, K.; Kom, A.; Kossivi, A.; Koffi, B.A.; Emile, A.k.'a.; Kodjo, G.E. 2010: Hyperhomocysteinemia among ischemic stroke victims in the teaching hospital of Lomé. Annales de Biologie Clinique 68(6): 669-673

Van Dam, F.; Van Gool, W.A. 2009: Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Archives of Gerontology and Geriatrics 48(3): 425-430

Sottilotta, G.; Siboni, S.M.; Latella, C.; Oriana, V.; Romeo, E.; Santoro, R.; Consonni, D.; Trapani Lombardo, V. 2010: Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(5): 549-553

Bharatkumar, V.P.; Nagaraja, D.; Shankar, S.K.; Christopher, R. 2009: Hyperhomocysteinemia and MTHFR C677T homozygosity in a vegetarian male with sinovenous thrombosis of the brain. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 16(10): 1380-1381

Monfared, A.; Azimi, S.Z.; Kazemnezhad, E.; Khosravi, M.; Lebadi, M.; Mirzajani, E.; Ashtiani, M.N. 2014: Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran. Transplantation 98(1): 66-71

Suszyńska-Zajczyk, J.; Luczak, M.; Marczak, L.; Jakubowski, H. 2014: Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration. Journal of Alzheimer's Disease: Jad 40(3): 713-726

Vannucchi, H.; Melo, S.S. 2009: Hyperhomocysteinemia and cardiometabolic risk. Arquivos Brasileiros de Endocrinologia e Metabologia 53(5): 540-549

Pandey, R.; Gupta, S.; Lal, H.; Mehta, H.C.; Aggarwal, S.K. 2000: Hyperhomocysteinemia and cardiovascular disease: the nutritional perspectives. Indian Journal of Clinical Biochemistry: Ijcb 15(Suppl 1): 20-30

Joseph, J.; Joseph, L. 2003: Hyperhomocysteinemia and cardiovascular disease: new mechanisms beyond atherosclerosis. Metabolic Syndrome and Related Disorders 1(2): 97-104

Zharkova, A.V.; Orlovs'kyĭ, V.F. 2014: Hyperhomocysteinemia and cardiovascular risk profile in ischemic heart disease and acid peptic disease comorbidity patients. Likars'ka Sprava 2014(1-2): 35-39

Sagheb, M.M.; Ostovan, M.A.; Sohrabi, Z.; Atabati, E.; Raisjalai, G.A.; Roozbeh, J. 2010: Hyperhomocysteinemia and cardiovascular risks in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 21(5): 863-866

Hou, D.-D.; Zhen, P.-P.; Wang, W. 2011: Hyperhomocysteinemia and endothelial progenitor cells apoptosis. Sheng Li Ke Xue Jin Zhan 42(2): 158-160

Wang, C-hui.; Huang, Y-feng. 2011: Hyperhomocysteinemia and erectile dysfunction: an update. Zhonghua Nan Ke Xue 17(11): 1019-1022

Guran, S.; Kozan, S.; Bahçe, M. 2010: Hyperhomocysteinemia and homozygous MTHFR 677C>T mutation finding in an Alzheimer's disease case with metabolic syndrome diagnosis. Folia Neuropathologica 48(1): 64-65

Cheng, Z.; Jiang, X.; Pansuria, M.; Fang, P.; Mai, J.; Mallilankaraman, K.; Gandhirajan, R.K.; Eguchi, S.; Scalia, R.; Madesh, M.; Yang, X.; Wang, H. 2015: Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation. Diabetes 64(3): 947-959

Ikkruthi, S.; Rajappa, M.; Nandeesha, H.; Satheesh, S.; Sundar, I.; Ananthanarayanan, P.H.; Harichandrakumar, K.T. 2014: Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk. Acta Physiologica Hungarica 101(1): 13-20

Mallat, S.G.; Aoun, M. 2002: Hyperhomocysteinemia and its role in chronic renal failure. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 13(3): 336-343

Studer, M.; Barbaud, A.; Truchetet, F.; N'guyen, P.-L.; Bursztejn, A.-C.; Schmutz, J.-L. 2011: Hyperhomocysteinemia and leg ulcers: a prospective study of 68 patients. Annales de Dermatologie et de Venereologie 138(10): 645-651

Schwartzfarb, E.M.; Romanelli, P. 2008: Hyperhomocysteinemia and lower extremity wounds. International Journal of Lower Extremity Wounds 7(3): 126-136

Hoţoleanu, C.; Chouky, E. 2012: Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in a patient with coronary artery disease and repetitive miscarriages. Romanian Journal of Internal Medicine 50(4): 313-316

Luo, H.; Liu, B.; Hu, J.; Wang, X.; Zhan, S.; Kong, W. 2014: Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in cervical artery dissection: a meta-analysis. Cerebrovascular Diseases 37(5): 313-322

Ansari, R.; Mahta, A.; Mallack, E.; Luo, J.J. 2014: Hyperhomocysteinemia and neurologic disorders: a review. Journal of Clinical Neurology 10(4): 281-288

Brezovska-Kavrakova, J.; Krstevska, M.; Bosilkova, G.; Alabakovska, S.; Panov, S.; Orovchanec, N. 2013: Hyperhomocysteinemia and of Methylenetetrahydrofolate Reductase (C677T) Genetic Polymorphism in Patients with Deep Vein Thrombosis. Materia Socio-Medica 25(3): 170-174

Doguzhieva, R.M.; Pokrovskiĭ, A.V.; Demidova, V.S.; Lebedeva, A.N. 2011: Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations. Angiologiia i Sosudistaia Khirurgiia 17(4): 24-28

Jiang, Y.; Xia, X.; Wang, W.; Lin, L.; Xu, C.; Cai, Z.; Zheng, B.; Pei, J.; Shen, S.; Xia, B. 2012: Hyperhomocysteinemia and related genetic polymorphisms correlate with ulcerative colitis in Chinese Han population in Central China [corrected. Cell Biochemistry and Biophysics 62(1): 203-210

Nie, T.; Lu, T.; Xie, L.; Huang, P.; Lu, Y.; Jiang, M. 2014: Hyperhomocysteinemia and risk of cognitive decline: a meta-analysis of prospective cohort studies. European Neurology 72(3-4): 241-248

Mabrouk, H.; Douki, W.; Mechri, A.; Younes, M.K.; Omezzine, A.; Bouslama, A.; Gaha, L.; Najjar, M.F. 2011: Hyperhomocysteinemia and schizophrenia: case control study. L'Encephale 37(4): 308-313

Malinowska, J.; Nowak, P.ł; Olas, B. 2009: Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 27(161): 413-418

Fonseca, V. 2003: Hyperhomocysteinemia and the metabolic syndrome: is there a connection?. Metabolic Syndrome and Related Disorders 1(2): 95-96

Vayá, A.; Plumé, G.; Bonet, E.; Carrasco, P.; Morales-Suárez-Varela, M.M. 2011: Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis. European Journal of Haematology 86(2): 167-172

Plazar, N.; Jurdana, M. 2010: Hyperhomocysteinemia and the role of B vitamins in cancer. Radiology and Oncology 44(2): 79-85

Perna, A.F. 2009: Hyperhomocysteinemia and treatment with folates: what's new?. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(4): 418

Saifan, C.; El-Charabaty, E.; El-Sayegh, S. 2013: Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. Vascular Health and Risk Management 9: 361-364

Gatt, A.; Makris, M. 2007: Hyperhomocysteinemia and venous thrombosis. Seminars in Hematology 44(2): 70-76

Mishra, D.K.; Gautam, S.; Goyal, B.K.; Kawar, R. 2013: Hyperhomocysteinemia as a cause of left main artery thrombosis manifesting as extensive anterior wall Mi in a 10 year old girl. Journal of the Association of Physicians of India 61(11): 829-831

Fazeli, B.; Ravari, H. 2013: Hyperhomocysteinemia as a consequence of life style among patients suffering from thromboangiitis obliterans. International Angiology: a Journal of the International Union of Angiology 32(4): 442-443

Petras, M.; Tatarkova, Z.; Kovalska, M.; Mokra, D.; Dobrota, D.; Lehotsky, J.; Drgova, A. 2014: Hyperhomocysteinemia as a risk factor for the neuronal system disorders. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 65(1): 15-23

Tascilar, N.; Ekem, S.; Aciman, E.; Ankarali, H.; Mungan, G.; Ozen, B.; Unal, A. 2009: Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population. Tohoku Journal of Experimental Medicine 218(4): 293-300

Feng, C.; Bai, X.; Xu, Y.; Hua, T.; Huang, J.; Liu, X.-Y. 2013: Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. International Journal of Medical Sciences 10(4): 408-412

Veeranki, S.; Givvimani, S.; Pushpakumar, S.; Tyagi, S.C. 2014: Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia. American Journal of Physiology. Heart and Circulatory Physiology 306(8): H1116-H1127

Dworakowska, D.; Kazimierska, E.; Weyer-Hepka, J.; Dworakowski, Rł.; Jakóbiewicz-Banecka, J.; Suwała, W.; Czestochowska, E. 2006: Hyperhomocysteinemia complicated by myocardial infarction and portal vein thrombosis--case report. Polskie Archiwum Medycyny Wewnetrznej 115(3): 234-237

Tyagi, N.; Vacek, T.P.; Fleming, J.T.; Vacek, J.C.; Tyagi, S.C. 2011: Hyperhomocysteinemia decreases bone blood flow. Vascular Health and Risk Management 7: 31-35

Küpeli, E.; Cengiz, C.; Cila, A.; Karnak, D. 2008: Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 14(3): 365-368

De la Calle, M.ía.; Palomo, M.ía.L.; Fernández-Miranda, C. 2013: Hyperhomocysteinemia due to vitamin B12 deficiency after bariatric surgery. Medicina Clinica 140(4): 188-189

Narayanan, N.; Tyagi, N.; Shah, A.; Pagni, S.; Tyagi, S.C. 2013: Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics. International Journal of Physiology Pathophysiology and Pharmacology 5(1): 32-42

Murthy, S.; Fonseca, V.; McNamara, D. 2005: Hyperhomocysteinemia exacerbates the development of intimal hyperplasia in Sprague-Dawley rats: Alleviation by rosiglitazone. Experimental and Clinical Cardiology 10(3): 154-159

Liu, Z.; Luo, H.; Zhang, L.; Huang, Y.; Liu, B.; Ma, K.; Feng, J.; Xie, J.; Zheng, J.; Hu, J.; Zhan, S.; Zhu, Y.; Xu, Q.; Kong, W.; Wang, X. 2012: Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circulation Research 111(10): 1261-1273

Tu, M.-C.; Huang, C.-W.; Chen, N.-C.; Chang, W.-N.; Lui, C.-C.; Chen, C.-F.; Chen, C.; Wang, Y.-L.; Lin, Y.-T.; Chang, C.-C. 2010: Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurologica Taiwanica 19(3): 168-177

Farkas, M.; Keskitalo, S.; Smith, D.E.C.; Bain, N.; Semmler, A.; Ineichen, B.; Smulders, Y.; Blom, H.; Kulic, L.; Linnebank, M. 2013: Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?. Journal of Alzheimer's Disease: Jad 33(4): 1097-1104

Abdollahi, A.; Shoar, T.S. 2012: Hyperhomocysteinemia in HIV-Infected Individuals: Correlation of a Frequent Prothrombotic Factor with CD4+ Cell Count. Oman Medical Journal 27(3): 224-227

Gokay, S.; Ciçek, D.; Müderrisoğlu, H. 2013: Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report. Interventional Medicine and Applied Science 5(1): 39-42

Permoda-Osip, A.; Dorszewska, J.; Skibinska, M.; Chlopocka-Wozniak, M.; Rybakowski, J.K. 2013: Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. Neuropsychobiology 68(4): 193-196

Terreri, M.T.R.A.; Sarni, R.O.S.; do Prado, R.ér.; Nascif, A.K.S.; D'Almeida, V.ân.; Hilário, M.O.E. 2008: Hyperhomocysteinemia in children and adolescents with systemic lupus erythematosus: evolutive evaluation. Acta Reumatologica Portuguesa 33(1): 57-62

Palmero-Fernández, L.; Fernández-Treguerres, F.; Santos-Bueso, E.; Sáenz-Francés, F.; Martínez-de-la-Casa, J.M.; García-Feijóo, J.; García-Sánchez, J. 2014: Hyperhomocysteinemia in chronic alcoholism: a case with retinal manifestations. Archivos de la Sociedad Espanola de Oftalmologia 89(8): 336-339

Bondar', I.A.; Pikalov, I.V.; Pechkovskiĭ, E.V.; Alina, A.R. 2007: Hyperhomocysteinemia in coronary artery disease and hemostasis disorders in patients with type 2 diabetes mellitus. Klinicheskaia Meditsina 85(5): 30-33

Lippi, G.; Plebani, M. 2012: Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here ?. Clinical Chemistry and Laboratory Medicine 50(12): 2075-2080

Erzin, Y.; Uzun, H.; Celik, A.Ferhat.; Aydin, S.; Dirican, A.; Uzunismail, H. 2008: Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications. Journal of Clinical Gastroenterology 42(5): 481-486

Zoccolella, S.; dell'Aquila, C.; Abruzzese, G.; Antonini, A.; Bonuccelli, U.; Canesi, M.; Cristina, S.; Marchese, R.; Pacchetti, C.; Zagaglia, R.; Logroscino, G.; Defazio, G.; Lamberti, P.; Livrea, P. 2009: Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia. Movement Disorders: Official Journal of the Movement Disorder Society 24(7): 1028-1033

Shin, H.-W.; Sohn, Y.H. 2009: Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level. Journal of Movement Disorders 2(1): 33-36

Baszczuk, A.; Kopczyński, Z. 2014: Hyperhomocysteinemia in patients with cardiovascular disease. Postepy Higieny i Medycyny Doswiadczalnej 68: 579-589

Gorgone, G.; Caccamo, D.; Pisani, L.Rosa.; Currò, M.; Parisi, G.; Oteri, G.; Ientile, R.; Rossini, P.Maria.; Pisani, F. 2009: Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. Epilepsia 50 Suppl. 1: 33-36

Cheng, H.-C.; Liu, J.-H.; Lee, S.-M.; Lin, P.-K. 2014: Hyperhomocysteinemia in patients with polypoidal choroidal vasculopathy: a case control study. Plos one 9(10): E110818

Cellai, A.P.; Lami, D.; Antonucci, E.; Liotta, A.A.; Rogolino, A.; Fedi, S.; Fiorillo, C.; Becatti, M.; Cenci, C.; Marcucci, R.; Abbate, R.; Prisco, D. 2014: Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity. Journal of Thrombosis and Thrombolysis 38(1): 45-49

Durmazlar, S.P.K.; Akgul, A.; Eskioglu, F. 2009: Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications. Journal of Dermatological Treatment 20(6): 336-339

Ferechide, D.; Radulescu, D. 2009: Hyperhomocysteinemia in renal diseases. Journal of Medicine and Life 2(1): 53-59

Perna, A.F.; Ingrosso, D.; Violetti, E.; Luciano, M.G.; Sepe, I.; Lanza, D.; Capasso, R.; Ascione, E.; Raiola, I.; Lombardi, C.; Stenvinkel, P.; Massy, Z.; De Santo, N.G. 2009: Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit. Seminars in Dialysis 22(4): 351-356

D'Uva, M.; Di Micco, P.; Strina, I.; Alviggi, C.; Iannuzzo, M.; Ranieri, A.; Mollo, A.; De Placido, G. 2007: Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: a preliminary report. Thrombosis journal 5: 10

Zhang, C.-E.; Wei, W.; Liu, Y.-H.; Peng, J.-H.; Tian, Q.; Liu, G.-P.; Zhang, Y.; Wang, J.-Z. 2009: Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. American Journal of Pathology 174(4): 1481-1491

Guo, H.-Y.; Xu, F.-K.; Lv, H.-T.; Liu, L.-B.; Ji, Z.; Zhai, X.-Y.; Tang, W.-L.; Chi, J.-F. 2014: Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice. Journal of Geriatric Cardiology: Jgc 11(1): 74-78

De Andrade, C.R.; Tirapelli, C.R.; Haddad, R.; Eberlin, M.N.; Ramalho, L.N.Z.; Iyomasa, M.M.; Uyemura, S.A.; de Oliveira, A.M. 2009: Hyperhomocysteinemia induced by feeding rats diets rich in DL-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure. Vascular Pharmacology 51(4): 291-298

Hrnčić, D.; Rašić-Marković, A.; Stojković, T.; Velimirović, M.; Puškaš, N.; Obrenović, R.; Macut, D.; Sušić, V.; Jakovljević, V.; Djuric, D.; Petronijević, N.ša.; Stanojlović, O. 2014: Hyperhomocysteinemia induced by methionine dietary nutritional overload modulates acetylcholinesterase activity in the rat brain. Molecular and Cellular Biochemistry 396(1-2): 99-105

Sen, S.; Reddy, P.L.; Grewal, R.P.; Busby, M.; Chang, P.; Hinderliter, A. 2010: Hyperhomocysteinemia is Associated with Aortic Atheroma Progression in Stroke/TIA Patients. Frontiers in Neurology 1: 131

Chengfeng, S.; Wei, L.; Xinxing, W.; Lei, W.; Rui, Z.; Lingjia, Q. 2014: Hyperhomocysteinemia is a result, rather than a cause, of depression under chronic stress. Plos one 9(10): E106625

Nazef, K.; Khelil, M.; Chelouti, H.; Kacimi, G.; Bendini, M.; Tazir, M.; Belarbi, S.; El Hadi Cherifi, M.; Djerdjouri, B. 2014: Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. Archives of Medical Research 45(3): 247-250

Lim, Y.J.; Kim, J.H.; Park, S.K.; Son, H.J.; Kim, J.J.; Kim, Y.-H. 2012: Hyperhomocysteinemia is a risk factor for colorectal adenoma in women. Journal of Clinical Biochemistry and Nutrition 51(2): 132-135

Mazza, A.; Cuppini, S.; Schiavon, L.; Zuin, M.; Ravenni, R.; Balbi, G.; Montemurro, D.; Opocher, G.; Pelizzo, M.R.; Colletti, P.M.; Rubello, D. 2014: Hyperhomocysteinemia is an independent predictor of sub-clinical carotid vascular damage in subjects with grade-1 hypertension. Endocrine 46(2): 340-346

Albu, E.; Filip, C.; Zamosteanu, N.; Jaba, I.M.; Linic, I.S.; Sosa, I. 2012: Hyperhomocysteinemia is an indicator of oxidant stress. Medical Hypotheses 78(4): 554-555

Grenz, A.; Hermes, M.; Hammel, P.; Roll, J.B.; Osswald, H.; Kloor, D. 2010: Hyperhomocysteinemia is associated with decreased erythropoietin expression in rats. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 26(3): 449-456

Mikael, L.G.; Wang, X.-L.; Wu, Q.; Jiang, H.; Maclean, K.N.; Rozen, R. 2009: Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency. Molecular Genetics and Metabolism 98(1-2): 187-194

Claes, L.; Schmalenbach, J.; Herrmann, M.; Olkü, I.; Garcia, P.; Histing, T.; Obeid, R.; Schorr, H.; Herrmann, W.; Pohlemann, T.; Menger, M.D.; Holstein, J.H. 2009: Hyperhomocysteinemia is associated with impaired fracture healing in mice. Calcified Tissue International 85(1): 17-21

Marti, F.; Vollenweider, P.; Marques-Vidal, P.-M.; Mooser, V.; Waeber, G.ér.; Paccaud, F.; Bochud, M. 2011: Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. Bmc Public Health 11: 733

Lijfering, W.M.; Coppens, M.; Veeger, N.J.G.M.; Middeldorp, S.; Hamulyák, K.; Prins, M.H.; Büller, H.R.; van der Meer, J. 2008: Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIIi levels. Thrombosis Research 123(2): 244-250

Holstein, J.H.; Herrmann, M.; Splett, C.; Herrmann, W.; Garcia, P.; Histing, T.; Klein, M.; Kurz, K.; Siebel, T.; Pohlemann, T.; Menger, M.D. 2010: Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis. Clinical Chemistry and Laboratory Medicine 48(6): 821-827

Falcao, S.ép.; Bisotto, S.; Gutkowska, J.; Lavoie, J.L. 2009: Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. American Journal of Obstetrics and Gynecology 200(2): 198.E1-5

Fang, P.; Zhang, D.; Cheng, Z.; Yan, C.; Jiang, X.; Kruger, W.D.; Meng, S.; Arning, E.; Bottiglieri, T.; Choi, E.T.; Han, Y.; Yang, X.-F.; Wang, H. 2014: Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis. Diabetes 63(12): 4275-4290

Zhang, D.; Jiang, X.; Fang, P.; Yan, Y.; Song, J.; Gupta, S.; Schafer, A.I.; Durante, W.; Kruger, W.D.; Yang, X.; Wang, H. 2009: Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 120(19): 1893-1902

Li, Y.; Zhang, H.; Jiang, C.; Xu, M.; Pang, Y.; Feng, J.; Xiang, X.; Kong, W.; Xu, G.; Li, Y.; Wang, X. 2013: Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. Journal of Biological Chemistry 288(14): 9583-9592

Tan, H.; Shi, C.; Jiang, X.; Lavelle, M.; Yu, C.; Yang, X.; Wang, H. 2014: Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice. Frontiers in Bioscience 19(6): 958-966

Belcastro, V.; Pierguidi, L.; Castrioto, A.; Menichetti, C.; Gorgone, G.; Ientile, R.; Pisani, F.; Rossi, A.; Calabresi, P.; Tambasco, N. 2010: Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. European Journal of Neurology 17(5): 661-665

Matté, C.; Mussulini, B.H.M.; dos Santos, T.M.; Soares, F.áv.M.S.; Simão, F.íc.; Matté, A.; de Oliveira, D.L.; Salbego, C.G.; Wofchuk, S.T.; Wyse, A.T.S. 2010: Hyperhomocysteinemia reduces glutamate uptake in parietal cortex of rats. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 28(2): 183-187

Chen, W.H.; Lin, H.S.; Kao, Y.F.; Lan, M.Y.; Liu, J.S. 2007: Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(4): 398-403

Yu, X.; Huang, Y.; Hu, Q.; Ma, L. 2009: Hyperhomocysteinemia stimulates hepatic glucose output and PEPCK expression. Acta Biochimica et Biophysica Sinica 41(12): 1027-1032

Salem-Berrabah, O.B.; Mrissa, R.; Machghoul, S.; Hamida, A.B.; N'siri, B.; Mazigh, C.; Aouni, Z.; Louati, I.; Layouni, S.; El Oudi, M.; Fekih-Mrissa, N.; Gritli, N. 2010: Hyperhomocysteinemia, C677T MTHFR polymorphism and ischemic stroke in Tunisian patients. La Tunisie Medicale 88(9): 655-659

Talikoti, P.; Bobby, Z.; Hamide, A. 2014: Hyperhomocysteinemia, Insulin Resistance and High HS- CRP Levels in Prehypertension. Journal of Clinical and Diagnostic Research: Jcdr 8(8): Cc07-Cc09

Arnadottir, M. 1997: Hyperhomocysteinemia, a cardiovascular risk factor. Laeknabladid 83(11): 731-742

Ranucci, M.; Romitti, F.; Costa, E. 2008: Hyperhomocysteinemia, antithrombin consumption, and early venous graft closure in surgical coronary revascularization. Minerva Anestesiologica 74(7-8): 439-442

Omrani, H.Q.; Shandiz, E.E.; Qabai, M.; Chaman, R.; Fard, H.A.; Qaffarpoor, M. 2011: Hyperhomocysteinemia, folateo and B12 vitamin in Iranian patients with acute ischemic stroke. Arya Atherosclerosis 7(3): 97-101

Lazzerini, P.E.; Capecchi, P.L.; Selvi, E.; Lorenzini, S.; Bisogno, S.; Galeazzi, M.; Laghi Pasini, F. 2007: Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmunity Reviews 6(7): 503-509

Gorgone, G.; Ursini, F.; Altamura, C.; Bressi, F.; Tombini, M.; Curcio, G.; Chiovenda, P.; Squitti, R.; Silvestrini, M.; Ientile, R.; Pisani, F.; Rossini, P.M.; Vernieri, F. 2009: Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment. Atherosclerosis 206(1): 309-313

Baszczuk, A.; Musialik, K.; Kopczyński, J.ła.; Thielemann, A.; Kopczyński, Z.; Kęsy, L.; Dopierała, G. 2014: Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Advances in Medical Sciences 59(1): 68-73

Zacho, J.; Yazdanyar, S.; Bojesen, S.E.; Tybjærg-Hansen, A.; Nordestgaard, Børge.G. 2011: Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. International Journal of Cancer 128(3): 644-652

Vayá, A.; Ejarque, I.; Tembl, J.; Corella, D.; Laiz, B. 2011: Hyperhomocysteinemia, obesity and cryptogenic stroke. Clinical Hemorheology and Microcirculation 47(1): 53-58

Pulvirenti, D.; Signorelli, S.; Sciacchitano, S.; Di Pino, L.; Tsami, A.; Ignaccolo, L.; Neri, S. 2007: Hyperhomocysteinemia, oxidative stress, endothelial dysfunction in postmenopausal women. La Clinica Terapeutica 158(3): 213-217

Kerkeni, M.; Letaief, A.; Achour, A.; Miled, A.; Trivin, F.; Maaroufi, K. 2009: Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease. Clinical Biochemistry 42(9): 777-782

Hoţoleanu, C.; Dronca, M.; Dronca, E.; Rusu, R.; Andercou, A. 2009: Hyperhomocysteinemia, risk factor in deep venous thrombosis: a case-control study. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 68-72

Sokolova, M.A.; Khoroshko, N.D.; Tsvetaeva, N.V.; Turkina, A.G.; Levina, A.A.; Mamukova, I.I.; Rokhnianskaia, A.A.; Sudarikov, A.B.; Romanova, E.A.; Vasil'ev, S.A.; Sukhanova, G.A.; Orel, E.B.; Rudakova, V.E.; Tutaeva, V.V.; Manakova, T.E.; Semenova, E.A.; Kulikov, S.M. 2007: Hyperhomocysteinemia--one of the factors underlying thrombotic complications in patients with chronic myeloproliferative diseases. Terapevticheskii Arkhiv 79(12): 57-62

Wang, J.; Jiang, Y.; Yang, A.; Sun, W.; Ma, C.; Ma, S.; Gong, H.; Shi, Y.; Wei, J. 2013: Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice. Bioresearch Open Access 2(2): 118-127

Raaf, L.; Noll, C.; Cherifi, M.; Benazzoug, Y.; Delabar, J.-M.; Janel, N. 2010: Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats. International Journal of Cardiology 145(2): 306-307

Peoples, K.; Kobe, D.; Campana, C.; Simon, E. 2014: Hyperhomocysteinemia-induced myocardial infarction in a young male using anabolic steroids. American Journal of Emergency Medicine 32(8): 948.E1

Thiengburanatham, S. 2009: Hyperhomocysteinemia-induced myocardial injury after coronary artery bypass. Asian Cardiovascular and Thoracic Annals 17(5): 483-489

Derouiche, F.; Bôle-Feysot, C.; Naïmi, D.; Coëffier, M.ïs. 2014: Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart and aorta. Biochemical and Biophysical Research Communications 452(3): 740-745

Govindaraju, V.; Neelam; Manjunath, C.N.; Venkataramiah, H.; Raghu, T.R. 2003: Hyperhomocysteinemia: An emerging risk factor for cardiovascular disease. Indian Journal of Clinical Biochemistry: Ijcb 18(1): 8-14

Aggarwal, S.; Verma, S.; Singh, B.; Kumar, M. 2014: Hyperhomocysteinemia: Anesthetic concerns. Saudi Journal of Anaesthesia 8(1): 143-144

Petramala, L.; Acca, M.; Francucci, C.M.; D'Erasmo, E. 2009: Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?. Journal of Endocrinological Investigation 32(4 Suppl): 10-14

Namazi, M.R.; Feily, A. 2010: Hyperhomocysteinemia: can't it account for retinoid-induced fracture proneness?. Indian Journal of Dermatology Venereology and Leprology 76(2): 186-187

Hoţoleanu, C.; Porojan-Iuga, M.; Rusu, M.L.; Andercou, A. 2007: Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis. Romanian Journal of Internal Medicine 45(2): 159-164

Ray, J.G. 2008: Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism. Current Opinion in Pulmonary Medicine 14(5): 369-373

Iacobazzi, V.; Infantino, V.; Castegna, A.; Andria, G. 2014: Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. Molecular Genetics and Metabolism 113(1-2): 27-33

Rhodehouse, B.C.; Erickson, M.A.; Banks, W.A.; Bearden, S.E. 2013: Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype. Journal of Alzheimer's Disease: Jad 35(1): 59-66

Al Wadani, F.; Khandekar, R.; Salim, G.; Al Ali, M.; Ramzi, S. 2014: Hyperhomocysteinia is a risk factor for retinal venous occlusion: a case control study. Indian Journal of Ophthalmology 62(3): 291-294

Callejas, M.A.; Grimalt, R.; Cladellas, E. 2010: Hyperhydrosis update. Actas Dermo-Sifiliograficas 101(2): 110-118

Schneider-Yin, X.; Kurmanaviciene, A.; Roth, M.; Roos, M.; Fedier, A.é; Minder, E.I.; Walt, H. 2009: Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis and Photodynamic Therapy 6(1): 12-18

Vacek, J.; Klejdus, B.; Kubán, V. 2007: Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). their isolation, analysis and study of physiological effect. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 56(2): 62-66

Zubek, S.; Mielcarek, S.; Turnau, K. 2012: Hypericin and pseudohypericin concentrations of a valuable medicinal plant Hypericum perforatum L. are enhanced by arbuscular mycorrhizal fungi. Mycorrhiza 22(2): 149-156

Jiang, C.; Li, Y.; Jiang, X.; Yao, N.; Gao, M.; Zhang, X.; Wang, J.; Wang, X.; Sun, Z.; Zhang, J.; Ni, Y. 2014: Hypericin as a marker for determination of myocardial viability in a rat model of myocardial infarction. Photochemistry and Photobiology 90(4): 867-872

Van de Putte, M.; Wang, H.; Chen, F.; de Witte, P.A.M.; Ni, Y. 2008: Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Academic Radiology 15(1): 107-113

Pillai, P.P.; Nair, A.R. 2014: Hypericin biosynthesis in Hypericum hookerianum Wight and Arn: investigation on biochemical pathways using metabolite inhibitors and suppression subtractive hybridization. Comptes Rendus Biologies 337(10): 571-580

Li, Z.-h.; Meng, D.-s.; Li, Y.-y.; Lu, L.-c.; Yu, C.-p.; Zhang, Q.; Guan, H.-y.; Li, C.-w.; Yang, X.; Fu, R.-q. 2014: Hypericin damages the ectatic capillaries in a Roman cockscomb model and inhibits the growth of human endothelial cells more potently than hematoporphyrin does through induction of apoptosis. Photochemistry and Photobiology 90(6): 1368-1375

Lima, A.M.; Pizzol, C.Dal.; Monteiro, Fíola.B.F.; Creczynski-Pasa, Tânia.B.; Andrade, G.P.; Ribeiro, A.O.; Perussi, J.R. 2013: Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency. Journal of Photochemistry and Photobiology. B Biology 125: 146-154

Vuong, T.T.K.; Vever-Bizet, C.; Bonneau, S.ép.; Bourg-Heckly, G.èv. 2011: Hypericin incorporation and localization in fixed Hela cells for various conditions of fixation and incubation. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 10(4): 561-568

Wang, Y.; Shi, X.; Qi, Z. 2010: Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels. British Journal of Pharmacology 159(7): 1402-1407

Ouyang, Z.; Zhai, Z.; Li, H.; Liu, X.; Qu, X.; Li, X.; Fan, Q.; Tang, T.; Qin, A.; Dai, K. 2014: Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway. Biochemical Pharmacology 90(3): 276-287

Ritz, R.; Müller, M.; Dietz, K.; Duffner, F.; Bornemann, A.; Roser, F.; Tatagiba, M. 2008: Hypericin uptake: a prognostic marker for survival in high-grade glioma. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 15(7): 778-783

Chang, Y.; Wang, S.-J. 2010: Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway. European Journal of Pharmacology 634(1-3): 53-61

Sharma, K.V.; Davids, L.M. 2012: Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment. Cell Biology International 36(12): 1261-1266

Zheng, Y.; Yin, G.; Le, V.; Zhang, A.; Lu, Y.; Yang, M.; Fei, Z.; Liu, J. 2014: Hypericin-based Photodynamic Therapy Induces a Tumor-Specific Immune Response and an Effective DC-based cancer Immunotherapy. Biochemical Pharmacology 2014

Garg, A.D.; Krysko, D.V.; Vandenabeele, P.; Agostinis, P. 2012: Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunology Immunotherapy: Cii 61(2): 215-221

Barras, A.; Boussekey, L.; Courtade, E.; Boukherroub, R. 2013: Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro. Nanoscale 5(21): 10562-10572

Cole, C.D.; Liu, J.K.; Sheng, X.; Chin, S.S.; Schmidt, M.H.; Weiss, M.H.; Couldwell, W.T. 2008: Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model. Journal of Neuro-Oncology 87(3): 255-261

Huang, L.-F.; Wang, Z.-H.; Chen, S.-L. 2014: Hypericin: chemical synthesis and biosynthesis. Chinese Journal of Natural Medicines 12(2): 81-88

Sorrentino, F.; Karioti, A.; Gratteri, P.; Rigobello, M.P.; Scutari, G.; Messori, L.; Bindoli, A.; Chioccioli, M.; Gabbiani, C.; Bergonzi, M.C.; Bilia, A.R. 2011: Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones. Bioorganic and Medicinal Chemistry 19(1): 631-641

Karioti, A.; Bilia, A.R. 2010: Hypericins as potential leads for new therapeutics. International Journal of Molecular Sciences 11(2): 562-594

Murthy, H.N.; Kim, Y.-S.; Park, S.-Y.; Paek, K.-Y. 2014: Hypericins: biotechnological production from cell and organ cultures. Applied Microbiology and Biotechnology 98(22): 9187-9198

El-Bakly, W.M.; Hasanin, A.H. 2014: Hypericum Perforatum Decreased Hippocampus TNF-α and Corticosterone Levels with no Effect on Kynurenine/Tryptophan Ratio in Bilateral Ovariectomized Rats. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 18(3): 233-239

Carpenter, C.; Crigger, N.; Kugler, R.; Loya, A. 2008: Hypericum and nurses: a comprehensive literature review on the efficacy of St. John's Wort in the treatment of depression. Journal of Holistic Nursing: Official Journal of the American Holistic Nurses' Association 26(3): 200-7; Discussion 208-11

Xavier, C.P.R.; Lima, C.F.; Fernandes-Ferreira, M.; Pereira-Wilson, C. 2012: Hypericum androsaemum water extract inhibits proliferation in human colorectal cancer cells through effects on MAP kinases and PI3K/Akt pathway. Food and Function 3(8): 844-852

Assafim, M.; de Coriolano, E.C.; Benedito, S.ér.E.áz.; Fernandes, C.P.; Lobo, J.F.R.; Sanchez, E.F.; Rocha, L.M.; Fuly, A.é L. 2011: Hypericum brasiliense plant extract neutralizes some biological effects of Bothrops jararaca snake venom. Journal of Venom Research 2: 11-16

Da Conceição, A.O.; von Poser, G.L.; Barbeau, B.; Lafond, J. 2014: Hypericum caprifoliatum and Hypericum connatum affect human trophoblast-like cells differentiation and Ca(2+) influx. Asian Pacific Journal of Tropical Biomedicine 4(5): 367-373

Gastpar, M. 2013: Hypericum extract WS ® 5570 for depression--an overview. International Journal of Psychiatry in Clinical Practice 17(Suppl 1): 1-7

Baruch, Y. 2009: Hypericum extract for treatment of depression: what's new?. Harefuah 148(3): 183-5 210 209

Sánchez-Mateo, C.C.; Bonkanka, C.X.; Rabanal, R.M. 2009: Hypericum grandifolium Choisy: a species native to Macaronesian Region with antidepressant effect. Journal of Ethnopharmacology 121(2): 297-303

Esposito, F.; Sanna, C.; Del Vecchio, C.; Cannas, V.; Venditti, A.; Corona, A.; Bianco, A.; Serrilli, A.M.; Guarcini, L.; Parolin, C.; Ballero, M.; Tramontano, E. 2013: Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. Pathogens and Disease 68(3): 116-124

Birt, D.F.; Widrlechner, M.P.; Hammer, K.Dp.; Hillwig, M.L.; Wei, J.; Kraus, G.A.; Murphy, P.A.; McCoy, J.; Wurtele, E.S.; Neighbors, J.D.; Wiemer, D.F.; Maury, W.J.; Price, J.P. 2009: Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharmaceutical Biology 47(8): 774-782

Liu, L.-S.; Liu, M.-H.; He, J.-Y. 2014: Hypericum japonicum Thunb. ex Murray: phytochemistry, pharmacology, quality control and pharmacokinetics of an important herbal medicine. Molecules 19(8): 10733-10754

Weber, W.; Vander Stoep, A.; McCarty, R.L.; Weiss, N.S.; Biederman, J.; McClellan, J. 2008: Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA 299(22): 2633-2641

Ruedeberg, C.; Wiesmann, U.N.; Brattstroem, A.; Honegger, U.E. 2010: Hypericum perforatum L. (St John's wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment?. PhytoTherapy Research: Ptr 24(2): 249-251

Liu, Y.-R.; Jiang, Y.-L.; Huang, R.-Q.; Yang, J.-Y.; Xiao, B.-K.; Dong, J.-X. 2014: Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety. Climacteric: the Journal of the International Menopause Society 17(4): 325-335

Shang, R.; He, C.; Chen, J.; Pu, X.; Liu, Y.; Hua, L.; Wang, L.; Liang, J. 2012: Hypericum perforatum extract therapy for chickens experimentally infected with infectious bursal disease virus and its influence on immunity. Canadian Journal of Veterinary Research 76(3): 180-185

Cayci, M.K.; Dayioglu, H. 2009: Hypericum perforatum extracts healed gastric lesions induced by hypothermic restraint stress in Wistar rats. Saudi Medical Journal 30(6): 750-754

Ghazanfarpour, M.; Kaviani, M.; Asadi, N.; Ghaffarpasand, F.; Ziyadlou, S.; Tabatabaee, H.R.; Dehghankhalili, M. 2011: Hypericum perforatum for the treatment of premenstrual syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 113(1): 84-85

Jepson, C.; Karppinen, K.; Daku, R.M.; Sterenberg, B.T.; Suh, D.-Y. 2014: Hypericum perforatum hydroxyalkylpyrone synthase involved in sporopollenin biosynthesis--phylogeny, site-directed mutagenesis, and expression in nonanther tissues. Febs Journal 281(17): 3855-3868

Nazıroğlu, M.; Sahin, M.; Ciğ, B.; Aykur, M.; Erturan, I.; Ugan, Y. 2014: Hypericum perforatum modulates apoptosis and calcium mobilization through voltage-gated and TRPM2 calcium channels in neutrophil of patients with Behcet's disease. Journal of Membrane Biology 247(3): 253-262

Crupi, R.; Mazzon, E.; Marino, A.; La Spada, G.; Bramanti, P.; Battaglia, F.; Cuzzocrea, S.; Spina, E. 2011: Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. Bmc Complementary and Alternative Medicine 11: 7

Van Die, M.D.; Burger, H.G.; Bone, K.M.; Cohen, M.M.; Teede, H.J. 2009: Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause 16(1): 156-163

Agollo, M.Costa.; Miszputen, S.Jankiel.; Diament, J. 2014: Hypericum perforatum-induced hepatotoxicity with possible association with copaiba (Copaifera langsdorffii Desf):case report. Einstein 12(3): 355-357

Marrelli, M.; Conforti, F.; Toniolo, C.; Nicoletti, M.; Statti, G.; Menichini, F. 2014: Hypericum perforatum: Influences of the habitat on chemical composition, photo-induced cytotoxicity, and antiradical activity. Pharmaceutical Biology 52(7): 909-918

Russo, E.; Scicchitano, F.; Whalley, B.J.; Mazzitello, C.; Ciriaco, M.; Esposito, S.; Patanè, M.; Upton, R.; Pugliese, M.; Chimirri, S.; Mammì, M.; Palleria, C.; De Sarro, G. 2014: Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. PhytoTherapy Research: Ptr 28(5): 643-655

García-de la Cruz, L.; Galvan-Goiz, Y.; Caballero-Caballero, S.; Zamudio, S.; Alfaro, A.; Navarrete, A.és. 2013: Hypericum silenoides Juss. and Hypericum philonotis Cham. and Schlecht. extracts: in-vivo hypolipidaemic and weight-reducing effects in obese rats. Journal of Pharmacy and Pharmacology 65(4): 591-603

Crockett, S.; Eberhardt, M.; Kunert, O.; Schühly, W. 2010: Hypericum species in the Páramos of Central and South America: a special focus upon H. irazuense Kuntze ex N. Robson. Phytochemistry Reviews: Proceedings of the Phytochemical Society of Europe 9(2): 255-269

Saad, B.; Abouatta, B.Soudah.; Basha, W.; Hmade, A.; Kmail, A.; Khasib, S.; Said, O. 2011: Hypericum triquetrifolium-Derived Factors Downregulate the Production Levels of LPS-Induced Nitric Oxide and Tumor Necrosis Factor-α in THP-1 Cells. Evidence-Based Complementary and Alternative Medicine: Ecam 2011: 586470

Raja, M.; Azzoni, A. 2006: Hypericum-induced mood disorder: switch from depression to mixed episodes in two patients. International Journal of Psychiatry in Clinical Practice 10(2): 146-148

Harris, W. 1924: Hyperidrosis in Syringomyelia. Proceedings of the Royal Society of Medicine 17(Neurol Sect): 31-32

Adamson, H.G. 1915: Hyperidrosis of the Palms. Proceedings of the Royal Society of Medicine 8(Dermatol Sect): 81-82

Spengler, S.; Bird, G.; Brass, M. 2010: Hyperimitation of actions is related to reduced understanding of others' minds in autism spectrum conditions. Biological Psychiatry 68(12): 1148-1155

Howitt, B. 1934: Hyperimmune Antipoliomyelitic Horse Serum. Science 80(2087): 621-622

Joob, B.; Wiwanitkit, V. 2013: Hyperimmune IV immunoglobulin treatment of 2009 influenza A(H1N1). Chest 144(2): 712

Hung, I.F.N.; To, K.K.W.; Lee, C.-K.; Lee, K.-L.; Yan, W.-W.; Chan, K.; Chan, W.-M.; Ngai, C.-W.; Law, K.-I.; Chow, F.-L.; Liu, R.; Lai, K.-Y.; Lau, C.C.Y.; Liu, S.-H.; Chan, K.-H.; Lin, C.-K.; Yuen, K.-Y. 2013: Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest 144(2): 464-473

Bihl, F.; Russmann, S.; Gurtner, V.; Di Giammarino, L.; Pizzi-Bosman, L.; Michel, M.; Cerny, A.; Hadengue, A.; Majno, P.; Giostra, E.; Castelli, D.; Mentha, G. 2010: Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation. Bmc Gastroenterology 10: 71

Sponseller, J.K.; Steele, J.A.; Schmidt, D.J.; Kim, H.B.; Beamer, G.; Sun, X.; Tzipori, S. 2015: Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection. Journal of Infectious Diseases 211(8): 1334-1341

Steele, J.; Sponseller, J.; Schmidt, D.; Cohen, O.; Tzipori, S. 2013: Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile. Human Vaccines and Immunotherapeutics 9(7): 1565-1568

Morningstar, M.W. 2004: Hyperimmune egg powder for the treatment of irritable bowel syndrome: a case series. Journal of Chiropractic Medicine 3(1): 12-14

Makhoul, B.; Braun, E.; Herskovitz, M.; Ramadan, R.; Hadad, S.; Norberto, K. 2009: Hyperimmune gammaglobulin for the treatment of West Nile virus encephalitis. Israel Medical Association Journal: Imaj 11(3): 151-153

Hamprecht, K.; Kagan, K-Oliver.; Goelz, R. 2014: Hyperimmune globulin to prevent congenital CMV infection. New England Journal of Medicine 370(26): 2543

van Leeuwen, E.; Oude Rengerink, K.; Pajkrt, E. 2014: Hyperimmune globulin to prevent congenital CMV infection. New England Journal of Medicine 370(26): 2543-2544

Menis, M.; Sridhar, G.; Selvam, N.; Ovanesov, M.V.; Divan, H.A.; Liang, Y.; Scott, D.; Golding, B.; Forshee, R.; Ball, R.; Anderson, S.A.; Izurieta, H.S. 2013: Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011. American journal of hematology 88(12): 1035-1040

Hohenadl, C.; Wodal, W.; Kerschbaum, A.; Fritz, R.; Howard, M.K.; Farcet, M.R.; Portsmouth, D.; McVey, J.K.; Baker, D.A.; Ehrlich, H.J.; Barrett, P.N.; Kreil, T.R. 2014: Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice. Virology Journal 11: 70

Deresinski, S.C. 2000: Hyperimmune products in the prevention and therapy of infectious disease: a report of a hyperimmune products expert advisory panel. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(3): 147-158

Kohn, J.L.; Rudel, G. 1947: Hyperimmune serums in treatment of whooping cough; clinical results, with notes on bacteriologic studies and cutaneous tests. American Journal of Diseases of Children 74(3): 321-333

Vygodchikov, G.V.; Trushina, E.F. 1947: Hyperimmune whooping-cough serum; preparation and examination of hyperimmune whooping-cough serum. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 54(5): 28-33

Van der Hilst, J.C.H.; Frenkel, J. 2010: Hyperimmunoglobulin D syndrome in childhood. Current Rheumatology Reports 12(2): 101-107

Tămaş, M.-M.; Baican, C.; Rednic, S. 2008: Hyperimmunoglobulin e syndrome (Job's syndrome). Romanian Journal of Internal Medicine 46(2): 169-171

Minegishi, Y.; Karasuyama, H. 2007: Hyperimmunoglobulin e syndrome and tyrosine kinase 2 deficiency. Current Opinion in Allergy and Clinical Immunology 7(6): 506-509

Hawilo, A.; Zaraa, I.ès.; Trojjet, S.; Zribi, H.; Rouhou, R.C.; Euch, D.E.; Mokni, M.; Osman, A.B. 2011: Hyperimmunoglobulin e syndrome in two siblings. Dermatology Reports 3(3): E41

Lo, C-Shou.; Yang, C-Yi.; Ko, J-Hung.; Lee, W-Yi.; Shih, I-Hsin.; Lin, Y-Chen. 2015: Hyperimmunoglobulin E syndrome presenting as eosinophilic pustular folliculitis: a case report. International Journal of Dermatology 54(2): 211-214

Yüksekkaya, H.; Ozbek, O.; Goncu, F.; Keser, M.; Hasibe, A.; Harun, P.; Keles, S. 2012: Hyperimmunoglobulin e syndrome presenting with renal abscess. Journal of Investigational Allergology and Clinical Immunology 22(2): 143-145

Anolik, R.; Elmariah, S.; Lehrhoff, S.; Votava, H.J.; Martiniuk, F.T.; Levis, W. 2009: Hyperimmunoglobulin e syndrome with a novel STAT3 mutation. Dermatology Online Journal 15(8): 16

Saikia, B.; Aneja, H.; Jain, J.; Puliyel, J.M. 2013: Hyperimmunoglobulin e syndrome with juvenile dermatomyositis and calcinosis. Clinical Rheumatology 32(Suppl 1): S51-S53

Yokota, K.; Kanemitsu, T.; Igaki, N. 2013: Hyperimmunoglobulin e syndrome-like symptoms in a hemodialysis patient who developed multiple subcutaneous Staphylococcus aureus abscesses. Internal Medicine 52(20): 2367-2370

Zhang, Q.; Su, H.C. 2011: Hyperimmunoglobulin e syndromes in pediatrics. Current Opinion in Pediatrics 23(6): 653-658

Nigro, G.; Adler, S.P. 2013: Hyperimmunoglobulin for prevention of congenital cytomegalovirus disease. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57 Suppl. 4: S193-S195

Cakmak, A.; Zeyrek, D.; Shermatov, K.; Himet Karazeybek, A. 2008: Hyperimmunoglobulin syndrome in a patient applying with meningitis diagnosis. Minerva Pediatrica 60(2): 260-261

Meazza, C.; Travaglino, P.; Pagani, S.; Laarej, K.; Duse, M.; Bozzola, M. 2009: Hyperimmunoglobulinaemia in Babinga Pygmies is present from infancy. International Journal of Immunopathology and Pharmacology 22(4): 1117-1120

Agbo-kpati, K.-P.; Condor, R.; Hollenberg, H.; Chalvon Demersay, A.; Cuisset, L.; Quartier, P. 2014: Hyperimmunoglobulinemia D and periodic fever syndrome. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 21(7): 765-767

Korppi, M.; Van Gijn, M.E.; Antila, K. 2011: Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. Acta Paediatrica 100(1): 21-25

Topaloğlu, R.; Ayaz, N.A.; Waterham, H.R.; Yüce, A.; Gumruk, F.; Sanal, O. 2008: Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clinical Rheumatology 27(10): 1317-1320

Kolkhir, P.V.; Pogorelov, D.S.; Nekrasova, T.P.; Nikitin, E.A.; Olisova, O.Y.; Kovrigina, A.M.; Melikyan, A.L.; Plieva, L.R.; Moiseev, S.V.; Novikov, P.I. 2014: Hyperimmunoglobulinemia e and efficacy of elimination diet in two patients with Schnitzler syndrome. European Annals of Allergy and Clinical Immunology 46(6): 229-231

Young, T.Y.; Jerome, D.; Gupta, S. 2007: Hyperimmunoglobulinemia e syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 98(4): 389-392

Rimar, D.; Slobodin, G.; Rosner, I.; Boulman, N.; Rozenbaum, M. 2011: Hyperimmunoglobulinemia d syndrome variant--seek and you shall find. Journal of Rheumatology 38(10): 2276

Vairo, F.; Alegra, T.; Dornelles, A.; Mittelstadt, S.; Netto, C.B.O.; Schwartz, I.V.D. 2012: Hyperimmunoglobulinemia in pediatric Gaucher patients in Southern Brazil. Pediatric Blood and Cancer 59(2): 339

Arıkan-Ayyıldız, Z.; Yuce, A.; Uslu-Kızılkan, N.; Demir, H.; Gürakan, F. 2012: Hyperimmunoglobulinemia in pediatric patients with Gaucher disease in Southern Brazil. Pediatric Blood and Cancer 59(2): 340

Wine, E.; Yaniv, I.; Cohen, I.J. 2007: Hyperimmunoglobulinemia in pediatric-onset type 1 Gaucher disease and effects of enzyme replacement therapy. Journal of Pediatric Hematology/Oncology 29(7): 451-457

Kim, Y.J. 2012: Hyperin and quercetin modulate oxidative stress-induced melanogenesis. Biological and Pharmaceutical Bulletin 35(11): 2023-2027

Li, F.-R.; Yu, F.-X.; Yao, S.-T.; Si, Y.-H.; Zhang, W.; Gao, L.-L. 2012: Hyperin extracted from Manchurian rhododendron leaf induces apoptosis in human endometrial cancer cells through a mitochondrial pathway. Asian Pacific Journal of Cancer Prevention: Apjcp 13(8): 3653-3656

Incani, R.Nino.; Hernández, M.; González, Mía.Elena. 2010: Hyperinfection by Strongyloides stercoralis probably associated with Rituximab in a patient with mantle cell lymphoma and hyper eosinophilia. Revista do Instituto de Medicina Tropical de Sao Paulo 52(4): 221-224

Llagunes, J.; Mateo, E.; Peña, J.J.; Carmona, P.; de Andrés, J. 2010: Hyperinfection caused by Strongyloides stercoralis. Medicina Intensiva 34(5): 353-356

Tiwari, S.; Rautaraya, B.; Tripathy, K.P. 2012: Hyperinfection of Strongyloides stercoralis in an immunocompetent patient. Tropical Parasitology 2(2): 135-137

Lichtenberger, P.; Rosa-Cunha, I.; Morris, M.; Nishida, S.; Akpinar, E.; Gaitan, J.; Tzakis, A.; Doblecki-Lewis, S. 2009: Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transplant Infectious Disease: An Official Journal of the Transplantation Society 11(2): 137-142

Khuroo, M.S. 2014: Hyperinfection strongyloidiasis in renal transplant recipients. BMJ Case Reports

Neva, F.A. 1984: Hyperinfection syndrome in a renal transplant recipient. Western Journal of Medicine 140(6): 940-941

Girija, S.; Kannan, S.; Jeyakumari, D.; Gopal, R. 2012: Hyperinfection with Strongyloides in a HIV-negative elderly male. Tropical Parasitology 2(1): 64-66

Romero-Cabello, R.úl.; Villagroy Gómez, J.; Hernández González, M.; Romero Feregrino, R.úl. 2012: Hyperinfection with Strongyloides stercoralis. BMJ Case Reports

Jacquot, J.; Tabary, O.; Clement, A. 2008: Hyperinflammation in airways of cystic fibrosis patients: what's new?. Expert Review of Molecular Diagnostics 8(4): 359-363

Schäppi, M.G.; Jaquet, V.; Belli, D.C.; Krause, K.-H. 2008: Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Seminars in Immunopathology 30(3): 255-271

Weaver, L.K.; Behrens, E.M. 2014: Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Current Opinion in Rheumatology 26(5): 562-569

Hill, H.R. 2011: Hyperinflammatory pulmonary disease in chronic granulomatous disease. Pediatric Infectious Disease Journal 30(9): 808-810

Krieger, B.P. 2009: Hyperinflation and intrinsic positive end-expiratory pressure: less room to breathe. Respiration; International Review of Thoracic Diseases 77(3): 344-350

Puente-Maestu, L.; Stringer, W.W. 2006: Hyperinflation and its management in COPD. International Journal of Chronic Obstructive Pulmonary Disease 1(4): 381-400

Bartels, S.; van Luttikhuizen, J.L.; Christgen, M.; Mägel, L.; Luft, A.; Hänzelmann, S.; Lehmann, U.; Schlegelberger, B.; Leo, F.; Steinemann, D.; Kreipe, H. 2018: CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer. Journal of Pathology 245(3): 373-383

Theerakittikul, T.; Hatipoğlu, U.; Aboussouan, L.S. 2014: Hyperinflation on chest radiograph as a marker of low adherence to positive airway pressure therapy in the overlap syndrome. Respiratory Care 59(8): 1267-1274

Lemes, D.Aires.; Zin, W.Araujo.; Guimaraes, F.Silva. 2009: Hyperinflation using pressure support ventilation improves secretion clearance and respiratory mechanics in ventilated patients with pulmonary infection: a randomised crossover trial. Australian Journal of PhysioTherapy 55(4): 249-254

Simpson, J.A.; Brunt, K.R.; Collier, C.P.; Iscoe, S. 2009: Hyperinflation-induced cardiorespiratory failure in rats. Journal of Applied Physiology 107(1): 275-282

Wang, G.; Tokushige, N.; Russell, P.; Dubinovsky, S.; Markham, R.; Fraser, I.S. 2009: Hyperinnervation in intestinal deep infiltrating endometriosis. Journal of Minimally Invasive Gynecology 16(6): 713-719

Espinoza, T.R.; Bryant, S.M.; Aks, S.E. 2013: Hyperinsulin therapy for calcium channel antagonist poisoning: a seven-year retrospective study. American Journal of Therapeutics 20(1): 29-31

Mascitelli, L.; Pezzetta, F.; Goldstein, M.R. 2009: Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes. International Journal of Clinical Practice 63(4): 672

Gruber, H.-J.; Bernecker, C.; Pailer, S.; Fauler, G.; Horejsi, R.; Möller, R.; Lechner, A.; Fazekas, F.; Truschnig-Wilders, M. 2010: Hyperinsulinaemia in migraineurs is associated with nitric oxide stress. Cephalalgia: An International Journal of Headache 30(5): 593-598

Mutschlechner, H.; Lorenz, I.; Oberhammer, R.; Brugger, H.; Paal, P. 2009: Hyperinsulinaemia may impair outcome after hypothermic cardiac arrest. Resuscitation 80(8): 959

Bortoletto, G.; Scribano, L.; Realdon, S.; Marcolongo, M.; Mirandola, S.; Franceschini, L.; Bonisegna, S.; Noventa, F.; Plebani, M.; Martines, D.; Alberti, A. 2010: Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance. Journal of Viral Hepatitis 17(7): 475-480

Gaspard, U. 2009: Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 62(4): 362-365

Kapoor, R.R.; Flanagan, S.E.; James, C.T.; McKiernan, J.; Thomas, A.M.; Harmer, S.C.; Shield, J.P.; Tinker, A.; Ellard, S.; Hussain, K. 2011: Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia 54(10): 2575-2583

Huang, Z.; Li, Y.; Tang, T.; Xu, W.; Liao, Z.; Yao, B.; Hu, G.; Weng, J. 2009: Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene. Clinical Endocrinology 71(5): 659-665

Hussain, K.; Blankenstein, O.; De Lonlay, P.; Christesen, H.T. 2007: Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Archives of Disease in Childhood 92(7): 568-570

Mohamed, Z.; Arya, V.B.; Hussain, K. 2012: Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management. Journal of Clinical Research in Pediatric Endocrinology 4(4): 169-181

Chiumello, G.; Bosio, L.; Di Candia, S.; Sogno Valin, P. 2007: Hyperinsuline hypoglycemias. Minerva Pediatrica 59(5): 547

Unfer, V.; Carlomagno, G.; Papaleo, E.; Vailati, S.; Candiani, M.; Baillargeon, J.-P. 2014: Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients with PCOS. Reproductive Sciences 21(7): 854-858

De Laat, M.A.; Gruntmeir, K.J.; Pollitt, C.C.; McGowan, C.M.; Sillence, M.N.; Lacombe, V.ér.A. 2014: Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart. Frontiers in Endocrinology 5: 120

Minamino, T.; Komuro, I. 2007: Hyperinsulinemia and aging. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(6): 1147-1154

Marecki, J.C.; Ronis, M.J.J.; Shankar, K.; Badger, T.M. 2011: Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats. Journal of Nutritional Biochemistry 22(2): 142-152

Porrini, E.; Bayes, B.; Diaz, J.M.; Ibernon, M.; Benitez, R.; Domínguez, R.; Moreno, J.M.; Delgado, P.; Lauzurica, R.; Silva, I.; Moreso, F.; Lampreabe, I.; Arias, M.; Osuna, A.; Torres, A. 2009: Hyperinsulinemia and hyperfiltration in renal transplantation. Transplantation 87(2): 274-279

Bonora, E.; Capaldo, B.; Perin, P.Cavallo.; Del Prato, S.; De Mattia, G.; Frittitta, L.; Frontoni, S.; Leonetti, F.; Luzi, L.; Marchesini, G.; Marini, M.Adelaide.; Natali, A.; Paolisso, G.; Piatti, P.Marco.; Pujia, A.; Solini, A.; Vettor, R.; Bonadonna, R.C.; Marchesini, G.; Baratta, R.; Frittitta, L.; Graci, S.; Montalcini, T.; Pujia, A.; Sesti, G.; Luzi, L.; Monti, L.; Piatti, P.Marco.; Setola, E.; Capaldo, B.; Paolisso, G.; de Kreutzenberg, S.Vigili.; Vettor, R.; Del Prato, S.; Ferrannini, E.; Natali, A.; Solini, A.; De Mattia, G.; Leonetti, F 2008: Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 18(9): 624-631

Hamasaki, H.; Mishima, S.; Yanai, H. 2012: Hyperinsulinemia and insulin resistance in a patient with type 2 diabetes complicated with myelofibrosis. World Journal of Diabetes 3(8): 156-157

Farasat, T.; Cheema, A.M.; Khan, M.N. 2012: Hyperinsulinemia and insulin resistance is associated with low T₃/T₄ ratio in pre diabetic euthyroid Pakistani subjects. Journal of Diabetes and its Complications 26(6): 522-525

Lindblad, Y.T.; Axelsson, J.; Bárány, P.; Celsi, G.; Lindholm, B.; Qureshi, A.R.; Carrea, A.; Canepa, A. 2008: Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purification 26(6): 518-525

Morrison, J.A.; Glueck, C.J.; Umar, M.; Daniels, S.; Dolan, L.M.; Wang, P. 2011: Hyperinsulinemia and metabolic syndrome at mean age of 10 years in black and white schoolgirls and development of impaired fasting glucose and type 2 diabetes mellitus by mean age of 24 years. Metabolism, Clinical and Experimental 60(1): 24-31

Donadon, V.; Balbi, M.; Zanette, G. 2009: Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus. Expert Review of Gastroenterology and Hepatology 3(5): 465-467

Rhee, E.-J.; Lee, W.-Y.; Cho, Y.-K.; Kim, B.-I.; Sung, K.-C. 2011: Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults. American Journal of Medicine 124(1): 69-76

Novosyadlyy, R.; LeRoith, D. 2010: Hyperinsulinemia and type 2 diabetes: impact on cancer. Cell Cycle 9(8): 1449-1450

Hashikawa, N. 2012: Hyperinsulinemia as a risk factor for peripheral nervous system disorders. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 140(1): 47

Saraiya, A.; Al-Shoha, A.; Brodell, R.T. 2013: Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trélat. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 19(3): 522-525

Chung, K.-H.; Tsai, S.-Y. 2010: Hyperinsulinemia associated with overweight medicated bipolar patients during full remission. Psychiatry and Clinical Neurosciences 64(6): 620-624

Mehran, A.E.; Templeman, N.M.; Brigidi, G.S.; Lim, G.E.; Chu, K.-Y.; Hu, X.; Botezelli, J.D.; Asadi, A.; Hoffman, B.G.; Kieffer, T.J.; Bamji, S.X.; Clee, S.M.; Johnson, J.D. 2012: Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabolism 16(6): 723-737

Polymeris, A.; Papapetrou, P.D.; Papandroulaki, F.; Thanou, S. 2011: Hyperinsulinemia during oral glucose tolerance test and high normal serum cortisol are associated with increased secretion of calcitonin in normal subjects. Hormones 10(4): 304-312

Ferguson, R.D.; Novosyadlyy, R.; Fierz, Y.; Alikhani, N.; Sun, H.; Yakar, S.; Leroith, D. 2012: Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Research: Bcr 14(1): R8

Agarwal, A.; Yu, S.W.; Rehman, A.; Henkle, J.Q. 2012: Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report. Texas Heart Institute Journal 39(4): 575-578

Lteif, A.A.; Fulford, A.D.; Considine, R.V.; Gelfand, I.; Baron, A.D.; Mather, K.J. 2008: Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans. American Journal of Physiology. Endocrinology and Metabolism 295(6): E1510-E1517

Heck, P.M.; Hoole, S.P.; Khan, S.N.; Dutka, D.P. 2010: Hyperinsulinemia improves ischemic LV function in insulin resistant subjects. Cardiovascular Diabetology 9: 27

Hannon, T.S.; Bacha, F.; Lin, Y.; Arslanian, S.A. 2008: Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function?. Diabetes care 31(7): 1445-1447

Filik, L. 2011: Hyperinsulinemia in nonalcoholic fatty liver disease in nondiabetic adults. American Journal of Medicine 124(9): E13; Author Reply E15

Lemay, Aé.; Turcot, L.; Déchêne, F.; Dodin, S.; Forest, J-Claude. 2010: Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance. Menopause 17(2): 321-325

Lu, H.; Qian, J.-y.; Yao, K.; Sun, A.-j.; Huang, R.-c.; Hao, Y.; Shi, H.-y.; Wang, K.-q.; Zou, Y.-z.; Ge, J.-b. 2007: Hyperinsulinemia induced immune maturation of human monocyte derived dendritic cells: bridging between diabetes and atherosclerosis. Zhonghua Xin Xue Guan Bing Za Zhi 35(12): 1151-1154

Jiang, X.; Wang, H.; Shi, W.; Shen, Z.; Shen, H.; Li, M. 2014: Hyperinsulinemia induces hepatic iron overload by increasing liver TFR1 via the PI3K/IRP2 pathway. Journal of Molecular Endocrinology 53(3): 381-392

Marín-Juez, R.én.; Jong-Raadsen, S.; Yang, S.; Spaink, H.P. 2014: Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish. Journal of Endocrinology 222(2): 229-241

Hiriart, M.; Sanchez-Soto, C.; Diaz-Garcia, C.M.; Castanares, D.T.; Avitia, M.; Velasco, M.; Mas-Oliva, J.; Macias-Silva, M.; González-Villalpando, C.; Delgado-Coello, B.; Sosa-Garrocho, M.; Vidaltamayo, R.án.; Fuentes-Silva, D. 2014: Hyperinsulinemia is Associated with Increased Soluble Insulin Receptors Release from Hepatocytes. Frontiers in Endocrinology 5: 95

García, R.G.; Rincón, M.Y.; Arenas, W.D.; Silva, S.Y.; Reyes, L.M.; Ruiz, S.L.; Ramirez, Fán.; Camacho, P.A.; Luengas, C.; Saaibi, Jé.F.; Balestrini, Sán.; Morillo, C.; López-Jaramillo, P. 2011: Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction. International Journal of Cardiology 148(1): 85-90

Shan, W.; Ning, C.; Luo, X.; Zhou, Q.; Gu, C.; Zhang, Z.; Chen, X. 2014: Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study. Gynecologic Oncology 132(3): 606-610

Nie, Z.; Jacoby, D.B.; Fryer, A.D. 2014: Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. American Journal of Respiratory Cell and Molecular Biology 51(2): 251-261

Gray, S.L.; Donald, C.; Jetha, A.; Covey, S.D.; Kieffer, T.J. 2010: Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endocrinology 151(9): 4178-4186

Woodske, M.E.; Yokoe, T.; Zou, B.; Romano, L.C.; Rosa, T.C.; Garcia-Ocana, A.; Alonso, L.C.; O'Donnell, C.P.; McVerry, B.J. 2009: Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness. Critical Care Medicine 37(9): 2596-2603

Shimamoto, K. 2006: Hyperinsulinemia, insulin resistance. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 191-195

Zhong, Y.; Miao, Y.; Jia, W.P.; Yan, H.; Wang, B.Y.; Jin, J. 2012: Hyperinsulinemia, insulin resistance and cognitive decline in older cohort. Biomedical and Environmental Sciences: Bes 25(1): 8-14

Abhijit, S.; Bhaskaran, R.; Narayanasamy, A.; Chakroborty, A.; Manickam, N.; Dixit, M.; Mohan, V.; Balasubramanyam, M. 2013: Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress. Molecular and Cellular Biochemistry 373(1-2): 95-105

Argov-Argaman, N.; Mbogori, T.; Sabastian, C.; Shamay, A.; Mabjeesh, S.J. 2012: Hyperinsulinemic clamp modulates milk fat globule lipid composition in goats. Journal of Dairy Science 95(10): 5776-5787

Vanderschuren, A.; Hantson, P. 2009: Hyperinsulinemic euglycemia therapy for stunned myocardium following subarachnoid hemorrhage. Journal of Neurosurgery 110(1): 64-66

Patel, N.P.; Pugh, M.E.; Goldberg, S.; Eiger, G. 2007: Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review. American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 16(5): 498-503

Patel, N.P.; Pugh, M.E.; Goldberg, S.; Eiger, G. 2007: Hyperinsulinemic euglycemia therapy for verapamil poisoning: case report. American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 16(5): 520 518-9

Gjessing, P.F.; Fuskevåg, O.-M.; Hagve, M.; Revhaug, A.; Irtun, Øi. 2010: Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs. American Journal of Physiology. Endocrinology and Metabolism 298(6): E1305-E1312

Rabiee, A.; Magruder, J.T.; Salas-Carrillo, R.; Carlson, O.; Egan, J.M.; Askin, F.B.; Elahi, D.; Andersen, D.K. 2011: Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. Journal of Surgical Research 167(2): 199-205

Aasheim, E.T.; Frigstad, S-Oskar.; Søvik, T.T.; Birkeland, Kåre.I.; Haukeland, J.W. 2010: Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 6(4): 441-443

Filippella, M.; Davì, M.V.; Doveri, G.; Lillaz, E.; Ciccarelli, A.; Massimetti, E.; Toaiari, M.; Falconi, M.; Colao, A.; Faggiano, A. 2011: Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association. Journal of Endocrinological Investigation 34(3): 175-179

Bantle, J.P.; Ikramuddin, S.; Kellogg, T.A.; Buchwald, H. 2007: Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obesity Surgery 17(5): 592-594

Hong, R.; Choi, D-Youl.; Lim, S-Chul. 2008: Hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report. World Journal of Gastroenterology 14(1): 140-142

Vieira, T.C.; Bergamin, C.S.; Gurgel, L.C.; Moisés, R.S. 2010: Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation. Pediatric Diabetes 11(7): 505-508

Kovács, Eébet.; Németh, H.; Pásztor, E.; Pfliegler, Görgy. 2008: Hyperinsulinemic hypoglycemia in adults. Case reports and a short review. Orvosi Hetilap 149(35): 1659-1664

Matsuo, T.; Ihara, K.; Ochiai, M.; Kinjo, T.; Yoshikawa, Y.; Kojima-Ishii, K.; Noda, M.; Mizumoto, H.; Misaki, M.; Minagawa, K.; Tominaga, K.; Hara, T. 2013: Hyperinsulinemic hypoglycemia of infancy in Sotos syndrome. American Journal of Medical Genetics. Part a 161a (1): 34-37

Liberatore Junior, R.D.R.; Negri, A.A.; Martinelli Junior, C.E.; Kochi, C.; Silva, I.N.; Collett-Solberg, P.F. 2012: Hyperinsulinemic hypoglycemia of the infancy: analysis of clinical data from a Brazilian sample. Arquivos Brasileiros de Endocrinologia e Metabologia 56(9): 666-671

Breitschwerdt, E.B.; Goldkamp, C.; Castleman, W.L.; Cullen, J.M.; Mascarelli, P.E.; Thalhem, L.; Schaer, M. 2014: Hyperinsulinemic hypoglycemia syndrome in 2 dogs with bartonellosis. Journal of Veterinary Internal Medicine 28(4): 1331-1335

Ağladıoğlu, S.Y.ıl.; Savaş Erdeve, S.; Cetinkaya, S.; Baş, V.N.; Peltek Kendirci, H.N.; Onder, A.şa.; Aycan, Z. 2013: Hyperinsulinemic hypoglycemia: experience in a series of 17 cases. Journal of Clinical Research in Pediatric Endocrinology 5(3): 150-155

Kaleva, N.N.; Ivanov, I.S.; Panova, M.V.; Shabanova, T.D.; Delgyanska, D.S. 2010: Hyperinsulinemic hypoglycemias in infancy and childhood--diagnostic therapeutic algorithm with contribution of two cases. Folia Medica 52(3): 62-69

de Laat, M.A.; McGowan, C.M.; Sillence, M.N.; Pollitt, C.C. 2010: Hyperinsulinemic laminitis. Veterinary Clinics of North America. Equine Practice 26(2): 257-264

Rao, M.N.; Chau, A.; Madden, E.; Inslicht, S.; Talbot, L.; Richards, A.; O'Donovan, A.; Ruoff, L.; Grunfeld, C.; Neylan, T.C. 2014: Hyperinsulinemic response to oral glucose challenge in individuals with posttraumatic stress disorder. Psychoneuroendocrinology 49: 171-181

Kelly, C.T.; Mansoor, J.; Dohm, G.L.; Chapman, W.H.H.; Pender, J.R.; Pories, W.J. 2014: Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think. Surgery 156(2): 405-411

Hughey, C.C.; Hittel, D.S.; Johnsen, V.L.; Shearer, J. 2011: Hyperinsulinemic-euglycemic clamp in the conscious rat. Journal of Visualized Experiments: Jove 2011(48)

Kim, J.K. 2009: Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods in Molecular Biology 560: 221-238

Tamura, Y. 2012: Hyperinsulinemic-euglycemic clamp, SSPG and minimal model. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 481-485

Ayala, J.E.; Bracy, D.P.; Malabanan, C.; James, F.D.; Ansari, T.; Fueger, P.T.; McGuinness, O.P.; Wasserman, D.H. 2011: Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. Journal of Visualized Experiments: Jove 2011(57)

Magner, W. 1941: Hyperinsulinism : (A Report of Two Cases). Canadian Medical Association Journal 45(1): 49-52

Rynearson, E.H. 1947: Hyperinsulinism among malingerers. Medical Clinics of North America 31: 477-480

Anonymous 1955: Hyperinsulinism and Islet-Cell Adenoma. Canadian Medical Association Journal 72(1): 39

Remedi, M.Sara.; Nichols, C.G. 2009: Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice. Cell Metabolism 10(6): 442-453

Pérez Errazquin, F.; Sempere Fernández, J.; García Martín, G.; Chamorro Muñoz, M.I.; Romero Acebal, M. 2011: Hyperinsulinism and hyperammonaemia syndrome and severe myoclonic epilepsy of infancy. Neurologia 26(4): 248-252

Chik, K.-K.; Chan, C.-W.; Lam, C.-W.; Ng, K.-L. 2008: Hyperinsulinism and hyperammonaemia syndrome due to a novel missense mutation in the allosteric domain of the glutamate dehydrogenase 1 gene. Journal of Paediatrics and Child Health 44(9): 517-519

Guthrie, R.F.; Buck, G.C. 1948: Hyperinsulinism and islet cell tumors with report of case. Journal of the Medical Association of the State of Alabama 18(3): 73-76

Mieldazis, S.F.A.; Azzalis, L.A.; Junqueira, V.B.C.; Souza, F.ío.I.S.; Sarni, R.O.S.; Fonseca, F.L.A. 2010: Hyperinsulinism assessment in a sample of prepubescent children. Jornal de Pediatria 86(3): 245-249

Gisslen, T.; Nathan, B.; Thompson, T.; Rao, R. 2011: Hyperinsulinism associated with gestational exposure to bupropion in a newborn infant. Journal of Pediatric Endocrinology and Metabolism: Jpem 24(9-10): 819-822

Leech, C.H.; Noble, G.E. 1949: Hyperinsulinism caused by islet cell adenoma; review of the literature and report of a successful surgical case. Ohio State Medical Journal 45(7): 707-713

Murray, W.G.D. 1949: Hyperinsulinism due to an islet-cell adenoma; a cure, with metabolic studies before and after operation. British Medical Journal 1(4603): 521-523

Blanco, M.; Khan, O.; Stanley, K.; Hageman, J.R.; Greeley, S.A.W. 2014: Hyperinsulinism in a neonate. Pediatric Annals 43(3): E56-E60

Brunelle, F.; Ribeiro, M.; Boddaert, N.; Nihoul-Fekete, C.; Jaubert, F.; Rahier, J.; de Lonlay, P. 2008: Hyperinsulinism in children: new concepts - the role of imaging. Bulletin de l'Academie Nationale de Medecine 192(1): 59-70; Discussion: 71-72

Kapoor, R.R.; James, C.; Hussain, K. 2009: Hyperinsulinism in developmental syndromes. Endocrine Development 14: 95-113

Palladino, A.A.; Bennett, M.J.; Stanley, C.A. 2009: Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Annales de Biologie Clinique 67(3): 245-254

Darendeliler, F.; Bas, F. 2006: Hyperinsulinism in infancy--genetic aspects. Pediatric Endocrinology Reviews: Per 3(Suppl 3): 521-526

Conn, J.W.; Johnston, M.W.; Conn, E.S. 1946: Hyperinsulinism of an unusual type; a metabolic study. Annals of Internal Medicine 24: 487-498

Billig, H.E.; Spaulding, C.A. 1947: Hyperinsulinism of menses. Industrial Medicine and Surgery 16(7): 336-339

Patterson, M.E.; Mao, C.S.; Yeh, M.W.; Ipp, E.; Cortina, G.; Barank, D.; Vasinrapee, P.; Pawlikowska-Haddal, A.; Lee, W.N.P.; Yee, J.K. 2012: Hyperinsulinism presenting in childhood and treatment by conservative pancreatectomy. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 18(3): E52-E56

Anonymous 1936: Hyperinsulinism-Hypoglycemia. California and Western Medicine 45(5): 425-429

Kapoor, R.R.; Flanagan, S.E.; Fulton, P.; Chakrapani, A.; Chadefaux, B.; Ben-Omran, T.; Banerjee, I.; Shield, J.P.; Ellard, S.; Hussain, K. 2009: Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. European Journal of Endocrinology 161(5): 731-735

Corrêa-Giannella, M.L.úc.; Freire, D.S.; Cavaleiro, A.M.; Fortes, M.A.Z.; Giorgi, R.R.; Pereira, M.A.A. 2012: Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene. Arquivos Brasileiros de Endocrinologia e Metabologia 56(8): 485-489

Arstila, K.E. 1948: Hyperinsulinism; four cases accompanied with attacks resembling epilepsy. Duodecim; Laaketieteellinen Aikakauskirja 64(12): 937-952

Irvin, L.; Johnson, T.D.; Foster, D.P. 1948: Hyperinsulinism; relief of hypoglycemia by removal of a pancreatic islet cell adenoma. Ohio State Medical Journal 44(9): 909-913

Kim, J.Y.; Kim, M.-J.; Kim, K.A.; Jeong, H.T.; Park, Y.N. 2012: Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. European Journal of Radiology 81(12): 3877-3882

Beyer, J.L.; Young, R.; Kuchibhatla, M.; Krishnan, K.Ranga.R. 2009: Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. International Review of Psychiatry 21(4): 394-409

Rozanski, M.; Ebinger, M.; Schmidt, W.U.; Hotter, B.; Pittl, S.; Heuschmann, P.U.; Jungehuelsing, J.G.; Fiebach, J.B. 2010: Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly. European Radiology 20(12): 2990-2996

de Lima, Pínio.M.G.; Piazera, Fávia.Z.; Bitencourt, M.A.; Nunes, E.C.; Morando, J.; Fortier, Sérgio.C.; Koliski, A.; Pasquini, R.; Zavala, J.; Teive, Hélio.A.G. 2011: Hyperintense basal ganglia on MR imaging in hematopoietic stem cell transplantation recipient. Arquivos de Neuro-Psiquiatria 69(4): 724

Carette, M.-F.; Brugières, P.; Khalil, A. 2007: Hyperintense basal ganglia on T1-weighted images in Rendu-Osler-Weber disease. Presse Medicale 36(6 Part 1): 883-884

Gawlitza, M.; Quäschling, U.; Hobohm, C.; Otto, J.; Voigt, P.; Hoffmann, K.-T.; Lobsien, D. 2014: Hyperintense basilar artery on FLAIR MR imaging: diagnostic accuracy and clinical impact in patients with acute brain stem stroke. AJNR. American Journal of Neuroradiology 35(8): 1520-1526

Van der Kolk, A.G.; de Borst, G.J.; den Hartog, A.G.; Kooi, M.E.; Mali, W.P.T.M.; Hendrikse, J. 2010: Hyperintense carotid plaque on T(1)-weighted turbo-field echo MRi in symptomatic patients with low-grade carotid stenosis and carotid occlusion. Cerebrovascular Diseases 30(3): 221-229

Khoury, M.N.; Alsop, D.C.; Agnihotri, S.P.; Pfannl, R.; Wuthrich, C.; Ho, M.-L.; Hackney, D.; Ngo, L.; Anderson, M.P.; Koralnik, I.J. 2014: Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Annals of Neurology 75(5): 659-669

Kasahara, S.; Miki, Y.; Kanagaki, M.; Yamamoto, A.; Mori, N.; Sawada, T.; Taoka, T.; Okada, T.; Togashi, K. 2011: Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation. Radiology 258(1): 222-228

Renard, D.; Delorme, M.; Castelnovo, G. 2013: Hyperintense intramural hematoma on time-of-flight sequences in carotid dissection. EuropeanNeurology 70(3-4): 141

Hacein-Bey, L.; Mukundan, G.; Shahi, K.; Chan, H.; Tajlil, A.T. 2014: Hyperintense ipsilateral cortical sulci on FLAIR imaging in carotid stenosis: ivy sign equivalent from enlarged leptomeningeal collaterals. Clinical Imaging 38(3): 314-317

Steiner, T.; Ettinger, J.; Peng, Z.; Hofmann, J.ör.; Hartmann, M.; Burkhardt, U.; Schnitzler, P. 2012: Hyperintense lesion in the corpus callosum associated with Puumala hantavirus infection. Journal of Neurology 259(8): 1742-1745

Benz, M.R.; Lee, S.-H.; Kellner, L.; Döhlemann, C.; Berweck, S. 2011: Hyperintense lesions in brain MRi after exposure to a mercuric chloride-containing skin whitening cream. European Journal of Pediatrics 170(6): 747-750

Viets, R.; Parsons, M.; Van Stavern, G.; Hildebolt, C.; Sharma, A. 2013: Hyperintense optic nerve heads on diffusion-weighted imaging: a potential imaging sign of papilledema. AJNR. American Journal of Neuroradiology 34(7): 1438-1442

Ehara, S.; Hasegawa, T.; Nakata, S.; Matsumoto, K.; Nishimura, S.; Iguchi, T.; Kataoka, T.; Yoshikawa, J.; Yoshiyama, M. 2012: Hyperintense plaque identified by magnetic resonance imaging relates to intracoronary thrombus as detected by optical coherence tomography in patients with angina pectoris. European Heart Journal. Cardiovascular Imaging 13(5): 394-399

Tanaka, A.; Kawasaki, T.; Noguchi, T.; Koga, S.; Hiramatsu, Y.; Fukuyama, T.; Koga, N. 2009: Hyperintense plaque with noncontrast T1-weighted magnetic resonance coronary plaque imaging leading to acute coronary syndrome. Circulation 120(23): 2400-2401

Medrano Martorell, S.; Cuadrado Blázquez, M.; García Figueredo, D.; González Ortiz, S.; Capellades Font, J. 2012: Hyperintense punctiform images in the white matter: a diagnostic approach. Radiologia 54(4): 321-335

Rogerio, R.M.; Pedroso, J.é L.; Oliveira, A.S.B.; Amaral, L.áz.L.F.d. 2013: Hyperintense signal in pyramidal tract neurons in postoperative brain tumor: wallerian degeneration or neoplastic dissemination?. Arquivos de Neuro-Psiquiatria 71(11): 907-908

Tian, C. 2011: Hyperintense signal on spinal cord diffusion-weighted imaging in a patient with subacute combined degeneration. Neurology India 59(3): 429-431

Takeuchi, M.; Matsuzaki, K.; Nishitani, H. 2009: Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging. Journal of Computer Assisted Tomography 33(6): 834-837

Sasiadek, M.; Bladowska, J. 2011: Hyperintense vertebral lesions. Neuroradiology 53 Suppl. 1: S169-S174

Dani, K.A.; Latour, L.L.; Warach, S. 2012: Hyperintense vessel sign on fluid-attenuated inversion recovery MR imaging is reduced by gadolinium. Ajnr. American Journal of Neuroradiology 33(8): E112-E114

Thamburaj, K.; Choudhary, A. 2009: Hyperintense vessel sign: isolated cortical venous thrombosis after L-asparaginase therapy. Pediatric Radiology 39(7): 757

Liu, W.; Xu, G.; Yue, X.; Wang, X.; Ma, M.; Zhang, R.; Wang, H.; Zhou, C.; Liu, X. 2011: Hyperintense vessels on FLAIR: a useful non-invasive method for assessing intracerebral collaterals. European Journal of Radiology 80(3): 786-791

Cheng, B.; Ebinger, M.; Kufner, A.; Köhrmann, M.; Wu, O.; Kang, D-Wha.; Liebeskind, D.; Tourdias, T.; Singer, O.C.; Christensen, S.; Warach, S.; Luby, M.; Fiebach, J.B.; Fiehler, J.; Gerloff, C.; Thomalla, Götz.; Warach, S.; Albers, G.; Davis, S.; Donnan, G.; Fisher, M.; Furlan, T.; Grotta, J.; Hacke, W.; Kang, D-Wa.; Kidwell, C.; Lees, K.R.; Lev, M.; Liebeskind, D.; Thijs, V.; Thomalla, Götz.; Wardlaw, J.; Wintermark, M. 2012: Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings. Stroke 43(11): 2957-2961

Chen, S.-P.; Wang, S.-J. 2014: Hyperintense vessels: an early MRi marker of reversible cerebral vasoconstriction syndrome?. Cephalalgia: An International Journal of Headache 34(13): 1038-1039

McGuire, S.A.; Sherman, P.M.; Brown, A.C.; Robinson, A.Y.; Tate, D.F.; Fox, P.T.; Kochunov, P.V. 2012: Hyperintense white matter lesions in 50 high-altitude pilots with neurologic decompression sickness. Aviation Space and Environmental Medicine 83(12): 1117-1122

Vattakatuchery, J.J.; Joy, J. 2010: Hyperintensities on MRI. White matter and depression. Bmj 341: C4611

Vardi, N.; Freedman, N.; Lester, H.; Gomori, J.M.; Chisin, R.; Lerer, B.; Bonne, O. 2011: Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implications. Psychiatry Research 192(2): 125-130

Mendióroz, M.; Jericó-Pascual, I.; Méndez, I.; Gastón-Zubimendi, I.; Arteaga, J.; Montaner, J. 2009: Hyperintensity in the anterior region of the temporal lobes in Fabry's disease. Revista de Neurologia 48(11): 599-600

Morís, G.án.; Arias, M.ón.; López, M.V.; Alvarez, V. 2010: Hyperintensity in the basis pontis: atypical neuroradiological findings in a woman with FXTAS. Movement Disorders: Official Journal of the Movement Disorder Society 25(5): 649-650

Stuckey, S.L.; Goh, T.D.; Heffernan, T.; Rowan, D. 2007: Hyperintensity in the subarachnoid space on FLAIR MRi. AJR. American Journal of Roentgenology 189(4): 913-921

Kang, K.; Lee, S. 2013: Hyperintensity in the subarachnoid space on contrast-enhanced fluid-attenuated inversion-recovery magnetic resonance imaging after central venous catheter removal. Journal of Thrombosis and Thrombolysis 36(3): 346-347

Pérez de la Ossa, N.; Hernández-Pérez, M.; Domènech, S.; Cuadras, P.; Massuet, A.; Millán, M.; Gomis, M.; López-Cancio, E.; Dorado, L.; Dávalos, A. 2012: Hyperintensity of distal vessels on FLAIR is associated with slow progression of the infarction in acute ischemic stroke. Cerebrovascular Diseases 34(5-6): 376-384

Beltz, E.E.; Mullins, M.E. 2010: Hyperintensity of the basal ganglia and cortex on FLAIR and diffusion-weighted imaging: self-assessment module. Ajr. American Journal of Roentgenology 195(3 Suppl): S9-11

Arrese Regańón, I.; Alday, R.; González, P.A.; Campollo, J.; Ramos, A.; Domínguez, P.; Fernández-Letón, J.P.; Pérez-Núñez, A.; Lobato, R.D. 2009: Hyperintensity on T2 MRi and size as predictors of obliteration in radiosurgically treated arteriovenous malformations. Neurocirugia 20(2): 97-102

Otsuka, Y.; Noguchi, T.; Goto, Y.; Nonogi, H.; Yamada, N. 2008: Hyperintensity on T2-weighted magnetic resonance imaging in Takotsubo cardiomyopathy. International Journal of Cardiology 130(1): 113-116

Liu, X.; Tian, W.; Li, L.; Kolar, B.; Qiu, X.; Chen, F.; Dogra, V.S. 2012: Hyperintensity on diffusion weighted image along ipsilateral cortical spinal tract after cerebral ischemic stroke: a diffusion tensor analysis. European Journal of Radiology 81(2): 292-297

Yura, S.; Nobata, K.; Shima, T. 2010: Hyperintensity signal in the joint space of the temporomandibular joint on fat-saturated T2-weighted magnetic resonance imaging. British Journal of Oral and Maxillofacial Surgery 48(8): 621-623

Backasch, B.; Straube, B.; Pyka, M.; Klöhn-Saghatolislam, F.; Müller, M.J.; Kircher, T.T.J.; Leube, D.T. 2013: Hyperintentionality during automatic perception of naturalistic cooperative behavior in patients with schizophrenia. Social Neuroscience 8(5): 489-504

Belohlavek, J.; Kucera, K.; Jarkovsky, J.; Franek, O.; Pokorna, M.; Danda, J.; Skripsky, R.; Kandrnal, V.; Balik, M.; Kunstyr, J.; Horak, J.; Smid, O.; Valasek, J.; Mrazek, V.; Schwarz, Z.; Linhart, A. 2012: Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups comparative study proposal. "Prague OHCA study". Journal of Translational Medicine 10: 163

Anonymous 1926: Hyperirritability of the Vagus Nerve in Intradermic Injections. California and western medicine 25(1): 78

Naeger, D.M.; Levine, M.S.; Renjen, P.; Rubesin, S.E.; Laufer, I. 2008: Hyperirritable stomach as a cause of nausea and vomiting: clinical and radiographic findings. AJR. American Journal of Roentgenology 190(6): 1517-1520

Nyirenda, M.J.; Tang, J.I.; Padfield, P.L.; Seckl, J.R. 2009: Hyperkalaemia. Bmj 339: B4114

Cobo Sánchez, J.é L.; Alconero Camarero, A.R.; Casaus Pérez, M.ía.; Maza Sota, M.A.; Villa Llamazares, C.; Hiquera Roldán, C.; Menezo Viadero, R.; Alonso Nates, R. 2007: Hyperkalaemia and haemodialysis patients: eletrocardiographic changes. Journal of Renal Care 33(3): 124-129

Marusic, S.; Gojo-Tomic, N.; Bacic-Vrca, V.; Bozikov, V. 2011: Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera. European Journal of Clinical Pharmacology 67(7): 757-758

Nalcacioglu, H.; Genc, G.; Meydan, B.C.; Ozkaya, O. 2012: Hyperkalaemia in a female patient with systemic lupus erythematosus. Pediatric Nephrology 27(9): 1499-1503

Grgic, I.; Si, H.; Depboylu, C.; Höglinger, G.ün.U.; Busch, C.; Heyken, W.-T.; Kuhlmann, U.; Maier, T.; Köhler, R.; Hoyer, J. 2008: Hyperkalaemia in a tetraplegic adolescent due to de novo sodium channel mutation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(4): 1449-1451

De Sequera, P.; Alcázar, R.; Albalate, M.; Pérez-García, R.; Corchete, E.; Asegurado, P.; Puerta, M.; Ortega-Díaz, M. 2014: Hyperkalaemia in hospitalised patients. how to avoid it?. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 34(3): 417-419

Dent, A.; Walmsley, D.; Dhandapani, S. 2011: Hyperkalaemia is a risk with low sodium salt in vulnerable patients. Bmj 343: D4514

Siniorakis, E.; Arvanitakis, S.; Psatheris, G.; Flessas, N.; Prokovas, E.; Exadactylos, N. 2011: Hyperkalaemia, pseudohyperkalaemia and electrocardiographic correlates. International Journal of Cardiology 148(2): 242-243

Ur Rehman, H. 2009: Hyperkalaemia. Benzylpenicillin potassium. Bmj 339: B4822

Floyd, C.N. 2009: Hyperkalaemia. time to flag up "detox" drinks?. Bmj 339: B4824

Lyons, K.S.; McGlinchey, P. 2009: Hyperkalaemic cardiac arrhythmia due to prolonged ingestion of potassium citrate. International Journal of Cardiology 131(3): E134-E136

La Rocca, R.; Materia, V.; Falliano, M.F.; Sciacca, N.; Marte, F.; Patanè, S. 2012: Hyperkalaemic cardiac arrhythmia with pacemaker/implantable cardioverter-defibrillator action disturbance. International Journal of Cardiology 156(3): E49-E50

Jayawardena, S.; Burzyantseva, O.; Shetty, S.; Niranjan, S.; Khanna, A. 2008: Hyperkalaemic paralysis presenting as ST-elevation myocardial infarction: a case report. Cases Journal 1(1): 232

Vacca, V. 2008: Hyperkalemia. Nursing 38(7): 72

Rocha Filho, J.A.; Nani, R.S.; D'Albuquerque, L.A.C.; Holms, C.A.; Rocha, J.ão.P.ín.S.; Sá Malbouisson, L.ís.M.; Machado, M.C.C.és.; Carmona, M.J.é C.; Auler Júnior, J.é O.áv.C. 2009: Hyperkalemia accompanies hemorrhagic shock and correlates with mortality. Clinics 64(6): 591-597

Khanagavi, J.; Gupta, T.; Aronow, W.S.; Shah, T.; Garg, J.; Ahn, C.; Sule, S.; Peterson, S. 2014: Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. Archives of medical science: AMS 10(2): 251-257

Hemmer, N.; Venkat, A. 2011: Hyperkalemia and atrial pacemakers: what can the electrocardiogram tell you?. Cjem 13(6): 409-410

Irani, F.; Kasmani, R.; Kanjwal, Y. 2010: Hyperkalemia and cocaine induced dynamic Brugada-type electrocardiogram. European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 17(2): 113-115

Zuckerman, M.; Heeley-Ray, T.M.; Morrissey, R.P.; Hoffman, R.S. 2010: Hyperkalemia and death from crotalid envenomation. Clinical Toxicology 48(5): 473; Author Reply 473

Perkins, J.D. 2008: Hyperkalemia and liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 14(2): 252-253

Mugmon, M. 2011: Hyperkalemia and severe rhabdomyolysis. Journal of Community Hospital Internal Medicine Perspectives 1(3)

Wyrick, S.; Couloures, K.G.; Dupuis, G.M.; Williams, R.S. 2013: Hyperkalemia and ventricular tachycardia after outpatient ureteral valve reimplantation: a case report. Pediatric Emergency Care 29(5): 650-652

Epstein, M. 2009: Hyperkalemia as a constraint to therapy with combination Renin-Angiotensin system blockade: the elephant in the room. Journal of Clinical Hypertension 11(2): 55-60

Musso, C.G.; Luque, K.; Schreck, C.; Imperiali, N.; Algarnati, L. 2007: Hyperkalemia associated to hepatitis in a peritoneal dialysis patient. International Urology and Nephrology 39(2): 661-663

Desai, A. 2008: Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation 118(16): 1609-1611

Raebel, M.A. 2012: Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovascular Therapeutics 30(3): E156-E166

Hirata, E.Sizue.; Pereira, R.Inês.Costa.; Filho, G.Alves.; Braga, Aélica.de.Fátima.Assunção. 2013: Hyperkalemia by Euro-Collins solution in anesthesia for renal transplantation: a case report. Brazilian Journal of Anesthesiology 63(5): 429-432

Thiele, A.; Rehman, H.U. 2008: Hyperkalemia caused by penicillin. American Journal of Medicine 121(8): E1-E2

Pavlakovic, H.; Kietz, S.; Lauerer, P.; Zutt, M.; Lakomek, M. 2010: Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 126(6): E1589-E1593

Korade, M.B.; Sangle, S.A.; Deshpande, N.S.; Dhadke, S.V. 2013: Hyperkalemia due to fertilizer (N:P:K) poisoning. Journal of Postgraduate Medicine 59(4): 333-334

Lima, M.V.ça.; Ochiai, M.E.; Cardoso, J.N.; Morgado, P.C.és.; Munhoz, R.T.; Barretto, A.C.P. 2008: Hyperkalemia during spironolactone use in patients with decompensated heart failure. Arquivos Brasileiros de Cardiologia 91(3): 177-182; 194-199

Mali, A.R.; Patil, V.P.; Pramesh, C.S.; Mistry, R.C. 2009: Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome?. Journal of Anesthesia 23(3): 421-423

Au, B.K.; Dutton, W.D.; Zaydfudim, V.; Nunez, T.C.; Young, P.P.; Cotton, B.A. 2009: Hyperkalemia following massive transfusion in trauma. Journal of Surgical Research 157(2): 284-289

Song, H.K.; Jang, Y.; Nam, J.W.; You, J.-H. 2011: Hyperkalemia from preoperative non-steroidal anti-inflammatory drugs and angiotensin Ii receptor blockers in patients with nephropathy. Korean Journal of Anesthesiology 61(6): 533-534

Miyata, M.; Kato, N.; Kubota, M.; Suzuki, K.; Yamazaki, T. 2009: Hyperkalemia in a neonate with congenital myotonic dystrophy. Pediatrics International: Official Journal of the Japan Pediatric Society 51(2): 296-297

Park, S.Eun.; Kim, D-Young.; Park, E-Sun. 2010: Hyperkalemia in a patient with rhabdomyolysis and compartment syndrome -A case report-. Korean Journal of Anesthesiology 59 Suppl: S37-S40

Al-Murayeh, M.A.; Kjellstrand, C.M. 1995: Hyperkalemia in an elderly patient receiving standard doses of trimethoprim-sulfamethoxazol - Case report and brief review of the literature. Annals of Saudi Medicine 15(4): 402-403

Cetin, N.; Yildiz, B.; Kural, N. 2013: Hyperkalemia in children with nephrotic syndrome. Iranian Journal of Kidney Diseases 7(4): 326

Butler, M.-L.; Persson, H. 2011: Hyperkalemia in chronic lymphatic leukemia. Careful specimen handling revealed pseudohyperkalemia. Lakartidningen 108(5): 212-213

Constable, P.D.; Grünberg, W. 2013: Hyperkalemia in diarrheic calves: Implications for diagnosis and treatment. Veterinary Journal 195(3): 271-272

Shimizu, J.; Inatsu, A.; Oshima, S.; Shimizu, E.; Hirata, H.; Yasuda, H.; Kubota, T. 2008: Hyperkalemia in familial mitochondrial cytopathy. Clinical Nephrology 70(4): 348-353

Pani, A.; Floris, M.; Rosner, M.H.; Ronco, C. 2014: Hyperkalemia in hemodialysis patients. Seminars in Dialysis 27(6): 571-576

Trefz, F.M.; Constable, P.D.; Sauter-Louis, C.; Lorch, A.; Knubben-Schweizer, G.; Lorenz, I. 2013: Hyperkalemia in neonatal diarrheic calves depends on the degree of dehydration and the cause of the metabolic acidosis but does not require the presence of acidemia. Journal of Dairy Science 96(11): 7234-7244

Desai, A.S. 2009: Hyperkalemia in patients with heart failure: incidence, prevalence, and management. Current Heart Failure Reports 6(4): 272-280

Palmer, B.F. 2012: Hyperkalemia in predialysis patients. Clinical Journal of the American Society of Nephrology: Cjasn 7(8): 1201-1202

Pfortmüller, C.Andrea.; Leichtle, A.Benedikt.; Fiedler, G.Martin.; Exadaktylos, A.Konstantinos.; Lindner, G. 2013: Hyperkalemia in the emergency department: etiology, symptoms and outcome of a life threatening electrolyte disorder. European Journal of Internal Medicine 24(5): E59-E60

Kassem, H.; Hajjar, C.; El Gharbi, T.; Turner, L. 2009: Hyperkalemia induced by atenolol. La Revue de Medecine Interne 30(8): 714-716

Pavletic, A.J. 2011: Hyperkalemia induced by excessive consumption of dried fruits--manifestation of an undiagnosed eating disorder?. Psychosomatics 52(5): 494-495

Schiraldi, F.; Guiotto, G.; Paladino, F. 2008: Hyperkalemia induced failure of pacemaker capture and sensing. Resuscitation 79(1): 161-164

Pothiawala, S.E. 2014: Hyperkalemia induced pseudo-myocardial infarction in septic shock. Journal of Postgraduate Medicine 60(3): 338-340

Vernay, J.; Briard, D.; Roubini, A. 2013: Hyperkalemia linked to intense physical activity: a rare complication in anorexia nervosa. Presse Medicale 42(5): 906-908

Sai Naresh, V.V.; Ramakrishna, V.; Ramakrishna, P.; Siva Kumar, V. 2008: Hyperkalemia masking left ventricular hypertrophy in electrocardiogram in a patient with end-stage renal disease. Indian Journal of Nephrology 18(1): 22-23

Recasens, L.; Meroño, O.; Ribas, N. 2013: Hyperkalemia mimicking a pattern of Brugada syndrome. Revista Espanola de Cardiologia 66(4): 309

Gupta, A.; Bhatt, A.P.; Khaira, A.; Bhowmik, D.M.; Tiwari, S.C. 2010: Hyperkalemia presenting as wide-complex tachycardia in a dialysis patient. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 21(2): 339-341

Segura, J.; Ruilope, L.M. 2008: Hyperkalemia risk and treatment of heart failure. Heart Failure Clinics 4(4): 455-464

Sica, D.A. 2009: Hyperkalemia risk in chronic kidney disease: deterrent to the use of aldosterone receptor antagonism or not. Hypertension 53(5): 749-750

Bugge, J.F. 2010: Hyperkalemia, heart failure and reduced renal function. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 130(13): 1354-1355

Wu, M.-L.; Yang, C.-C.; Deng, J.-F.; Wang, K.-Y. 2014: Hyperkalemia, hyperphosphatemia, acute kidney injury, and fatal dysrhythmias after consumption of palytoxin-contaminated goldspot herring. Annals of Emergency Medicine 64(6): 633-636

Tanawuttiwat, T.; Harindhanavudhi, T.; Bhan, A.; Dia, M. 2010: Hyperkalemia-induced Brugada pattern: an unusual manifestation. Journal of Cardiovascular Medicine 11(4): 285-287

Gul, E.E.; Erdogan, H.I.; Yıldırım, O.; Soylu, A.; Nikus, K.C. 2012: Hyperkalemia-induced accelerated idioventricular rhythm in a patient with acute renal failure. Renal Failure 34(4): 543-544

Romeo, E.; D'Alto, M.; Santarpia, G.; Di Nardo, G.; Sarubbi, B.; Russo, M.Giovanna.; Calabrò, R. 2011: Hyperkalemia-induced conversion of permanent atrial fibrillation to normal sinus rhythm: a case report. Journal of Cardiovascular Medicine 12(9): 678-680

Srivali, N.; Ratanapo, S.; Cheungpasitporn, W.; Chongnarungsin, D.; Bischof, E.F. 2013: Hyperkalemia-induced pacemaker dysfunction. American Journal of Emergency Medicine 31(5): 879-880

Wilson, N.S.; Hudson, J.Q.; Cox, Z.; King, T.; Finch, C.K. 2009: Hyperkalemia-induced paralysis. PharmacoTherapy 29(10): 1270-1272

Garg, S.Kumar.; Saxena, S.; Juneja, D.; Singh, O.; Kumar, M.; Mukherji, J.Dev. 2014: Hyperkalemia: A rare cause of acute flaccid quadriparesis. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(1): 46-48

El Fassi, D.; Nielsen, G. 2013: Hyperkalemia: a clue to the diagnosis of adrenal insufficiency. Circulation 128(24): 2620-2621

Welch, A.; Maroz, N.; Wingo, C.S. 2013: Hyperkalemia: getting to the heart of the matter. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 28(1): 15-16

Bansal, A.D.; Goldfarb, D.S. 2007: Hyperkalemia: newer considerations. Virtual Mentor: Vm 9(4): 295-299

Crawford, A.H. 2014: Hyperkalemia: recognition and management of a critical electrolyte disturbance. Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society 37(3): 167-175

Belthur, M.V.; Campos, C.J.; Lotze, T.E.; Weinberg, J. 2012: Hyperkalemic cardiac arrest in a 14-month-old following spica cast application. Journal of Pediatric Orthopedics. Part B 21(3): 292-293

Sesok-Pizzini, D.; Pizzini, M.-A. 2014: Hyperkalemic cardiac arrest in pediatric patients undergoing massive transfusion: unplanned emergencies. Transfusion 54(1): 4-7

Dobson, G.P.; Faggian, G.; Onorati, F.; Vinten-Johansen, J. 2013: Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?. Frontiers in Physiology 4: 228

Riveiro-Barciela, M.; Campos-Varela, I.; Tovar, J.L.; Vargas, V.; Simón-Talero, M.; Ventura-Cots, M.; Crespo, M.; Bilbao, I.; Castells, L. 2011: Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report. Transplantation Proceedings 43(10): 4016-4018

McCormick, J.A.; Yang, C.-L.; Zhang, C.; Davidge, B.; Blankenstein, K.I.; Terker, A.S.; Yarbrough, B.; Meermeier, N.P.; Park, H.J.; McCully, B.; West, M.; Borschewski, A.; Himmerkus, N.; Bleich, M.; Bachmann, S.; Mutig, K.; Argaiz, E.R.; Gamba, G.; Singer, J.D.; Ellison, D.H. 2014: Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3. Journal of Clinical Investigation 124(11): 4723-4736

Mishra, A.; Pandya, H.V.; Dave, N.; Sapre, C.M.; Chaudhary, S. 2014: Hyperkalemic paralysis in primary adrenal insufficiency. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(8): 527-529

Narberhaus, B.; Cormand, B.; Cuenca-León, E.; Ribasés, M.; Monells, J. 2008: Hyperkalemic periodic paralysis: a Spanish family with the p.Thr704Met mutation in the SCN4A gene. Neurologia 23(7): 427-435

Schuh, A.; Hönle, W. 2007: Hyperkeratoses. MMW Fortschritte der Medizin 149(27-28): 42

Stieler, K.; Blume-Peytavi, U.; Vogel, A.; Atugoda, S. 2012: Hyperkeratoses as paraneoplastic syndrome. Journal der Deutschen Dermatologischen Gesellschaft 10(8): 593-595

Jahnke, I.; Stieler, K.; Garcia Bartels, N.; Blume-Peytavi, U. 2013: Hyperkeratoses on the finger joints. Painless hyperkeratoses on the interphalangeal joints of both hands. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 64(5): 382-383

Feito-Rodríguez, M.; Sendagorta-Cudós, E.; Moratinos Martínez, M.; Floristán-Muruzábal, U.; González-Beato, M.J.; Herranz Pinto, P.; Casado Jiménez, M. 2008: Hyperkeratosic plaques located exclusively on hand palms and sole of feet. Revista Clinica Espanola 208(8): 407-408

Hagan, W.A. 1950: Hyperkeratosis (X-Disease) of Cattle in New York State. Canadian Journal of Comparative Medicine and Veterinary Science 14(1): 10-11

Doble, F.C. 1921: Hyperkeratosis Blenorrhagica. Proceedings of the Royal Society of Medicine 14(Dermatol Sect): 91-92

Simpson, J.R. 1947: Hyperkeratosis Follicularis et Parafollicularis in Cutem Penetrans (Kyrle). Proceedings of the Royal Society of Medicine 40(5): 262

Yoshida, M.; Oiso, N.; Kawada, A. 2010: Hyperkeratosis and Frictional Dermatitis from Practicing Kendo. Case Reports in Dermatology 2(2): 65-68

Medina-Gil, C.; Gómez-Duaso, A.J.; Carretero-Hernández, G. 2012: Hyperkeratosis and scaling in identical twins. Actas Dermo-Sifiliograficas 103(10): 925-926

Cebeci, A.şe.N.; Ekici, B.ış 2013: Hyperkeratosis as a clue to diagnosis in a patient with myopathy. Annals of Indian Academy of Neurology 16(4): 668-669

Sterneberg-Vos, H.; van Marion, A.M.W.; Frank, J.; Poblete-Gutierrez, P. 2008: Hyperkeratosis lenticularis perstans (Flegel's disease) - successful treatment with topical corticosteroids. International Journal of Dermatology 47(Suppl 1): 38-41

Fernández-Crehuet, P.; Rodríguez-Rey, E.; Ríos-Martín, J.J.; Camacho, F.M. 2009: Hyperkeratosis lenticularis perstans, or Flegel disease, with palmoplantar involvement. Actas Dermo-Sifiliograficas 100(2): 157-159

Patel, K.B. 2013: Hyperkeratosis lenticularis perstans: case report of a rare entity. Indian Journal of Dermatology 58(2): 161

Frigerio, M.; Santi, V.; Di Micoli, A.; Trevisani, F. 2009: Hyperkeratosis of nipple skin during sorafenib treatment. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41(8): 611

Chopra, A.; Gill, S.S. 1997: Hyperkeratosis of palms and soles : clinical study. Indian Journal of Dermatology Venereology and Leprology 63(2): 85-88

Starr, F.N. 1928: Hyperkeratosis of the Oesophagus. Canadian Medical Association Journal 18(1): 22-24

Adamson, H.G. 1911: Hyperkeratosis of the Palms and Soles. Proceedings of the Royal Society of Medicine 4(Dermatol Sect): 18

Barber, H.W. 1933: Hyperkeratosis of the Palms associated with a High Blood Uric Acid. Proceedings of the Royal Society of Medicine 26(5): 497

Hunt, E. 1933: Hyperkeratosis of the Soles. Proceedings of the Royal Society of Medicine 26(7): 835-836

Yorke, A. 1947: Hyperkeratosis of the feet. Chiropodist 2(9): 225-236

Kartal Durmazlar, S.Pelin.; Eskioglu, F.; Bodur, Z. 2008: Hyperkeratosis of the nipple and areola: 2 years of remission with low-dose acitretin and topical calcipotriol therapy. Journal of dermatological treatment 19(6): 337-340

Barker, L.P. 1947: Hyperkeratosis of the palms and soles due to the ingestion of quinacrine hydrochloride. Archives of Dermatology and Syphilology 55(2): 256

Dundas-Grant, J.; Dickson, W.E. 1934: Hyperkeratosis or Pachydermia Laryngis associated with Unusual Bacterial Concretions around Ectopic Epithelial Cells in the Submucous Coat. Inspiratory Stridor. Proceedings of the Royal Society of Medicine 27(9): 1275-1278

Arnold, H.L. 1947: Hyperkeratosis penetrans; report of a case of a probable variant of Kyrle's disease. Archives of Dermatology and Syphilology 55(5): 633-638

Stiefelhagen, P. 2008: Hyperkeratosis reveals gastric carcinoma. MMW Fortschritte der Medizin 150(42): 24

Verma, S.B. 2008: Hyperkeratotic Bowen disease--a case report. Dermatology Online Journal 14(6): 24

Madke, B.; Gutte, R.; Doshi, B.; Khopkar, U. 2013: Hyperkeratotic Palmoplantar Lichen Planus in a child. Indian Journal of Dermatology 58(5): 405

Hargreaves, A. 1947: Hyperkeratotic Systematized Naevus with ? Bromide Eruption. Proceedings of the Royal Society of Medicine 40(8): 477-479

Kaur, R.; Maheshwari, M. 2013: Hyperkeratotic Warty Skin Lesion of Foot Caused by Fusarium oxysporum. Indian Journal of Dermatology 58(2): 159

Cerny, E. 1949: Hyperkeratotic and rhagadiforme dermatitis caused by tricresolformaline at the dentist's. Ceskoslovenska Dermatologie 24(5): 184-190

Yesilova, Y.; Turan, E.; Sürücü, H.Altun.; Bozkurt, F.; Zeyrek, F.Yıldız.; Tanrıkulu, O. 2013: Hyperkeratotic cutaneous leishmaniasis: A rare presentation. Balkan Medical Journal 30(1): 129-130

Feldmeyer, L.; Baumann-Vogel, H.; Tournier-Lasserve, E.; Riant, F.; Jung, H.H.; French, L.E.; Kamarashev, J. 2014: Hyperkeratotic cutaneous vascular malformation associated with familial cerebral cavernous malformations (FCCM) with KRIT1/CCM1 mutation. European Journal of Dermatology: Ejd 24(2): 255-257

Tougeron, D.; Wierzbicka-Hainaut, E.; Osdoit, S.; Chagneau-Derrode, C.; Yacoub, M.; Silvain, C. 2010: Hyperkeratotic eczema of the nipple and areola associated with sorafenib treatment. European Journal of Dermatology: Ejd 20(6): 854-856

Sahai, S.; Swick, B.L. 2010: Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib. International Journal of Dermatology 49(10): 1203-1206

Halleck, P.; Loddenkemper, C.; Hummel, M.; Scherer, H.; Haisch, A. 2009: Hyperkeratotic inverted seborrheic keratosis of the outer auditory canal : a first description. Hno 57(5): 480-483

Samimi, M.; Maître, F.; Estève, E. 2008: Hyperkeratotic lesion of the nipple revealing cutaneous leiomyoma. Annales de Dermatologie et de Venereologie 135(8-9): 571-574

Chraïbi, R.; Ismaïli, N.; Senouci, K.; Khatibi, B.; Hassam, B.; Cribier, B. 2007: Hyperkeratotic mammilated lesion of congenital club foot. Annales de Dermatologie et de Venereologie 134(11): 877-879

Khan, F.; Ramirez-Fort, M.K.; Chan, C.Stanley.; Rosen, T. 2013: Hyperkeratotic necrobiosis lipoidica. Dermatology Practical and Conceptual 3(1): 13-15

Chopra, A.; Kaur, M. 1999: Hyperkeratotic oral lichen planus role of vitamin a. Indian Journal of Dermatology Venereology and Leprology 65(5): 233-234

Bellew, S.; Del Rosso, J.Q.; Mobini, N. 2010: Hyperkeratotic papular eruptions on legs, arms, and back. International Journal of Dermatology 49(7): 729-731

Martínez-Casimiro, L.; Zaragoza, V.; Sánchez-Carazo, J.L.; Alegre, V. 2009: Hyperkeratotic papules on the hands. Actas Dermo-Sifiliograficas 100(1): 73-74

Khandpur, S.; Kathuria, S.D.; Gupta, R.; Singh, M.K.; Sharma, V.K. 2010: Hyperkeratotic pitted plaques on the palms and soles. Indian Journal of Dermatology Venereology and Leprology 76(1): 52-55

Illes, M.; Grunewald, S.; Treudler, R.; Bodendorf, M.O.; Simon, J.C. 2010: Hyperkeratotic plaques and generalized pruritus in a 47 year-old man. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 61(5): 439-442

Lee, S.; Park, H.S.; Yun, S.K.; Kang, K.P.; Kim, W.; Park, S.K. 2011: Hyperkeratotic pruritic papules in a hemodialysis patient. Clinical Nephrology 75(5): 484

Niesmann, J.; Bierhoff, E.; Dirschka, T. 2010: Hyperkeratotic pruritic papules in the submammary area. Diagnose: Granular parakeratosis. Journal der Deutschen Dermatologischen Gesellschaft 8(8): 631-633

Kumar, P.; Anand, V.; Mallik, S.Kumar. 2012: Hyperkeratotic scaly lesions. Indian Pediatrics 49(11): 935

Inazawa, M.; Satoh, T.; Yokozeki, H. 2014: Hyperkeratotic variant of inflammatory disseminated superficial porokeratosis with lichenoid reaction and extensive amyloid deposition. International Journal of Dermatology 53(2): E94-E95

Uenishi, T.; Teramura, K.; Kitamura, M.; Fujii, N.; Nakanishi, G.; Tanaka, T.; Uehara, M. 2010: Hyperkeratotic variant of porokeratosis Mibelli with dermal amyloid deposits. Journal of Dermatology 37(5): 475-479

Rains, J.L.; Jain, S.K. 2011: Hyperketonemia decreases mitochondrial membrane potential and its normalization with chromium (III) supplementation in monocytes. Molecular and Cellular Biochemistry 349(1-2): 77-82

Zarrin, M.; Wellnitz, O.; van Dorland, H.A.; Gross, J.J.; Bruckmaier, R.M. 2014: Hyperketonemia during lipopolysaccharide-induced mastitis affects systemic and local intramammary metabolism in dairy cows. Journal of Dairy Science 97(6): 3531-3541

Lindholm, E.B.; Alberty, J.B.; Hansbourgh, F.; Upp, J.R.; Lopoo, J. 2013: Hyperkinetic gallbladder: an indication for cholecystectomy?. American Surgeon 79(9): 882-884

Laufer, M.W.; Denhoff, E.; Solomons, G. 2011: Hyperkinetic impulse disorder in children's behavior problems. Journal of Attention Disorders 15(8): 620-625

Carroll, E.; Sanchez-Ramos, J. 2011: Hyperkinetic movement disorders associated with HIV and other viral infections. Handbook of Clinical Neurology 100: 323-334

Gadhikar, M.A.; Zhang, J.; Shen, L.; Rao, X.; Wang, J.; Zhao, M.; Kalu, N.N.; Johnson, F.M.; Byers, L.A.; Heymach, J.; Hittelman, W.N.; Udayakumar, D.; Pandita, R.K.; Pandita, T.K.; Pickering, C.R.; Redwood, A.B.; Piwnica-Worms, H.; Schlacher, K.; Frederick, M.J.; Myers, J.N. 2018: CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Research 78(3): 781-797

Aftab, A.; Shahzad, S.; Hussain, H.Muhammad.Jafar.; Khan, R.; Irum, S.; Tabassum, S. 2019: CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis. Breast Cancer 26(1): 11-28

Edwards, M.J.; Schrag, A. 2011: Hyperkinetic psychogenic movement disorders. Handbook of Clinical Neurology 100: 719-729

Antropov, I.F.; Balabanova, V.A.; Baranova, V.A. 2010: Hyperkinetic symptoms in children and adolescents with psychosomatic disorders. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(8): 8-15

Zrull, J.P.; McDermott, J.F.; Poznanski, E. 1970: Hyperkinetic syndrome: the role of depression. Child Psychiatry and Human Development 1(1): 33-40

Grenader, T. 2012: Hyperkyphosis. Internal and Emergency Medicine 7(Suppl 1): S55-S56

Kado, D.M.; Lui, L.-Y.; Ensrud, K.E.; Fink, H.A.; Karlamangla, A.S.; Cummings, S.R. 2009: Hyperkyphosis predicts mortality independent of vertebral osteoporosis in older women. Annals of Internal Medicine 150(10): 681-687

Kado, D.M.; Miller-Martinez, D.; Lui, L.-Y.; Cawthon, P.; Katzman, W.B.; Hillier, T.A.; Fink, H.A.; Ensrud, K.E. 2014: Hyperkyphosis, kyphosis progression, and risk of non-spine fractures in older community dwelling women: the study of osteoporotic fractures (SOF). Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 29(10): 2210-2216

Kado, D.M.; Huang, M.-H.; Nguyen, C.B.; Barrett-Connor, E.; Greendale, G.A. 2007: Hyperkyphotic posture and risk of injurious falls in older persons: the Rancho Bernardo Study. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 62(6): 652-657

Chlouverakis, K.E.; Sprott, J.C. 2007: Hyperlabyrinth chaos: from chaotic walks to spatiotemporal chaos. Chaos 17(2): 023110

Jee, R.; Brownlow, H. 2007: Hyperlactaemia due to nebulised salbutamol. Anaesthesia 62(7): 751-752

Hulme, J. 2007: Hyperlactaemia in asthmatics. Anaesthesia 62(10): 1084-1085

Guinat, M.; Vincent, J.-L. 2010: Hyperlactataemia : not only useful in circulatory shock. Revue Medicale de Bruxelles 31(5): 451-457

Green, J.P.; Berger, T.; Garg, N.; Horeczko, T.; Suarez, A.; Radeos, M.S.; Hagar, Y.; Panacek, E.A. 2012: Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis. Academic emergency medicine: official journal of the Society for Academic Emergency Medicine 19(11): 1268-1275

Waiswa, M.; Byarugaba, B.B.; Ocama, P.; Mayanja-Kizza, H.; Seremba, E.; Ganguli, S.; Crowther, M.; Colebunders, R. 2012: Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda. African Health Sciences 12(3): 268-275

Soler-Palacín, P.; Martín-Nalda, A.; Martínez-Gómez, X.; Melendo, S.; Riudor, E.ó; Arranz, J.A.; Espiau, M.; Figueras, C.ó 2012: Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?. Aids Research and Human Retroviruses 28(8): 752-758

Ben-Hamouda, N.; Haesler, L.; Liaudet, L. 2013: Hyperlactatemia and lactic acidosis in the critically ill patient. Revue Medicale Suisse 9(410): 2335-2340

D'Aranda, E.; Prunet, B.; Lacroix, G.; Cotte, J.; Bordes, J.; Meaudre, E. 2011: Hyperlactatemia as a complication of renal embolization in a blunt trauma patient. Annales Francaises d'Anesthesie et de Reanimation 30(7-8): 605-607

Almeida, S.L.S.; Amendola, C.P.; Horta, V.M.; Sousa, E.; Gusmão, C.él.A.B.; Silva Júnior, J.ão.M.; Rezende, E. 2006: Hyperlactatemia at ICU admission is a morbid-mortality determinant in high risk non-cardiac surgeries. Revista Brasileira de Terapia Intensiva 18(4): 360-365

Katayama, S.; Nunomiya, S.; Wada, M.; Misawa, K.; Tanaka, S.; Koyama, K.; Koinuma, T. 2012: Hyperlactatemia caused by intra-venous administration of glycerol: A case study. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 16(4): 241-244

Mamiafo, C.T.; Moor, V.J.A.; Nansseu, J.R.N.; Pieme, C.A.; Tayou, C.; Yonkeu, J.N. 2014: Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon. Aids Research and Therapy 11(1): 2

O'Connor, E.D.; Fraser, J.F. 2010: Hyperlactatemia in critical illness and cardiac surgery. Critical Care 14(3): 421

Rossi, A.F.; Lopez, L.; Dobrolet, N.; Khan, D.; Bolivar, J. 2010: Hyperlactatemia in neonates admitted to the cardiac intensive care unit with critical heart disease. Neonatology 98(2): 212-216

Carmona, P.; Mateo, E.; Hornero, F.; Errando, C.L.; Vázquez, A.; Llagunes, J.; De Andrés, J. 2014: Hyperlactatemia in surgical ablation of atrial fibrillation and cardiac surgery. Is it a predictive factor of postoperative morbidity?. Revista Espanola de Anestesiologia y Reanimacion 61(6): 311-318

Watanabe, I.; Mayumi, T.; Arishima, T.; Takahashi, H.; Shikano, T.; Nakao, A.; Nagino, M.; Nimura, Y.; Takezawa, J. 2007: Hyperlactemia can predict the prognosis of liver resection. Shock 28(1): 35-38

Fujii, M.; Kawabata, Y.; Hayashi, T.; Nishimae, H.; Masuko, S. 2012: Hyperlactemia during undiagnosed pheochromocytoma resection under laparoscopy. Masui. Japanese Journal of Anesthesiology 61(2): 197-199

Zagatto, A.M.; Padulo, J.; Müller, P.T.G.; Miyagi, W.E.; Malta, E.S.; Papoti, M. 2014: Hyperlactemia induction modes affect the lactate minimum power and physiological responses in cycling. Journal of Strength and Conditioning Research 28(10): 2927-2934

Yamadori, A.; Osumi, Y.; Tabuchi, M.; Mori, E.; Yoshida, T.; Ohkawa, S.; Yoneda, Y. 1990: Hyperlalia: a right cerebral hemisphere syndrome. Behavioural Neurology 3(3): 143-151

Pantoja Zarza, L.ía.; Díez Morrondo, C.; Alexis, D. 2014: Hyperlax Ehlers-Danlos syndrome: benign hypermobility?. Reumatologia Clinica 10(3): 189-190

Tsai, J.-P.; Tsai, C.-C.; Liu, H.-M.; Lee, C.-J.; Liou, H.-H.; Hsu, B.-G. 2011: Hyperleptinaemia positively correlated with metabolic syndrome in hemodialysis patients. European Journal of Internal Medicine 22(6): E105-E109

Shaikh, M.G.; Grundy, R.G.; Kirk, J.M.W. 2008: Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. European Journal of Endocrinology 159(6): 791-797

Kelly, A.S.; Metzig, A.M.; Schwarzenberg, S.J.; Norris, A.L.; Fox, C.K.; Steinberger, J. 2012: Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity. Metabolic Syndrome and Related Disorders 10(2): 123-127

Mendieta Zerón, H.; García Solorio, V.ón.J.; Nava Díaz, P.M.; Garduño Alanís, A.; Santillán Benítez, J.G.; Domínguez García, V.; Escobar Briones, C.; Denova Gutiérrez, E. 2012: Hyperleptinemia as a prognostic factor for preeclampsia: a cohort study. Acta Medica 55(4): 165-171

Kim, S.-K.; Kim, H.-J.; Ahn, C.-W.; Park, S.-W.; Cho, Y.-W.; Lim, S.-K.; Lee, H.-C.; Cha, B.-S. 2008: Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients. Endocrine Journal 55(6): 1085-1092

Yuan, M.; Huang, G.; Li, J.; Zhang, J.; Li, F.; Li, K.; Gao, B.; Zeng, L.; Shan, W.; Lin, P.; Huang, L. 2014: Hyperleptinemia directly affects testicular maturation at different sexual stages in mice, and suppressor of cytokine signaling 3 is involved in this process. Reproductive Biology and Endocrinology: Rb&e 12: 15

Huff, N.K.; Thompson, D.L.; Mitcham, P.B.; Storer, W.A. 2010: Hyperleptinemia in horses: responses to administration of a small dose of lipopolysaccharide endotoxin in mares and geldings. Journal of Animal Science 88(3): 926-936

Caltabilota, T.J.; Earl, L.R.; Thompson, D.L.; Clavier, S.E.; Mitcham, P.B. 2010: Hyperleptinemia in mares and geldings: assessment of insulin sensitivity from glucose responses to insulin injection. Journal of Animal Science 88(9): 2940-2949

Kitamura, E.; Kanazawa, N.; Hamada, J. 2015: Hyperleptinemia increases the susceptibility of the cortex to generate cortical spreading depression. Cephalalgia: An International Journal of Headache 35(4): 327-334

Homann, D.; Carvalho, H.M.; Stefanello, J.M.F.; Góes, S.M.; Lopes, A.é L.; de Oliveira, A.R.; Leite, N. 2014: Hyperleptinemia independent of body adiposity in women with fibromyalgia. Rheumatology International 34(11): 1593-1598

Lowndes, J.; Zoeller, R.F.; Kyriazis, G.E.; Miles, M.P.; Seip, R.L.; Moyna, N.M.; Visich, P.; Pescatello, L.; Gordon, P.; Thompson, P.D.; Angelopoulos, T.J. 2014: Hyperleptinemia is associated with CRP, but not apolipoprotein E, and is reduced by exercise training. International Journal of Sport Nutrition and Exercise Metabolism 24(5): 524-531

Galletti, F.; D'Elia, L.; De Palma, D.; Russo, O.; Barba, G.; Siani, A.; Miller, M.A.; Cappuccio, F.P.; Rossi, G.; Zampa, G.; Strazzullo, P. 2012: Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 22(3): 300-306

Leon-Cabrera, S.; Solís-Lozano, L.; Suárez-Álvarez, K.; González-Chávez, A.; Béjar, Y.L.; Robles-Díaz, G.; Escobedo, G. 2013: Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings. Frontiers in Integrative Neuroscience 7: 62

Knight, Z.A.; Hannan, K.S.; Greenberg, M.L.; Friedman, J.M. 2010: Hyperleptinemia is required for the development of leptin resistance. Plos one 5(6): E11376

Lee, M.-C.; Lee, C.-J.; Ho, G.-J.; Lee, C.-C.; Shih, M.-H.; Chou, K.-C.; Hsu, B.-G. 2010: Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients. Clinical Transplantation 24(4): E124-E129

Mishra, S.; Harris, T.B.; Hue, T.; Miljkovic, I.; Satterfield, S.; de Rekeneire, N.; Mehta, M.; Sahyoun, N.R. 2013: Hyperleptinemia, adiposity, and risk of metabolic syndrome in older adults. Journal of Nutrition and Metabolism 2013: 327079

Bossola, M.; Tazza, L. 2011: Hyperleptinemia, leptin resistance, and cognition in hemodialysis patients. Renal Failure 33(10): 1049-1050

Selthofer-Relatić, K.; Radić, R.; Vizjak, V.; Vcev, A.; Kosović, P.; Bosnjak, I.; Selthofer, R. 2008: Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females. Collegium Antropologicum 32(3): 681-685

Morabito, M.V.; Berman, D.E.; Schneider, R.T.; Zhang, Y.; Leibel, R.L.; Small, S.A. 2014: Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobiology of Disease 65: 188-192

Akkök, Çi.ğd.A.ın.; Bergrem, A.; Tangen, J.M. 2014: Hyperleukocytosis. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(14): 1365

Levy, M.; Wofford, M.M.; Powell, B.L.; McLean, T.W. 2008: Hyperleukocytosis from arsenic trioxide. Pediatric Blood and Cancer 50(6): 1265-1267

Sushanth; Avabratha, K.S.; Tauro, K.J.; Shwethadri, G.K. 2010: Hyperleukocytosis in a neonate: a diagnostic dilemma. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 31(3): 86-88

Sussman, L.N.; Litwins, J. 1949: Hyperleukocytosis occurring in carcinoma of the bladder. New York State Journal of Medicine 49(2): 174-176

Gong, J.; Wu, B.; Guo, T.; Zhou, S.; He, B.; Peng, X. 2014: Hyperleukocytosis: A report of five cases and review of the literature. Oncology Letters 8(4): 1825-1827

Jain, R.; Bansal, D.; Marwaha, R.K. 2013: Hyperleukocytosis: emergency management. Indian Journal of Pediatrics 80(2): 144-148

Zhou, Y.; Wang, X.-B.; Qiu, X.-P.; Shuai Zhang; Wang, C.; Zheng, F. 2018: CDKN2A promoter methylation and hepatocellular carcinoma risk: a meta-analysis. Clinics and Research in Hepatology and Gastroenterology 42(6): 529-541

Gupta, V.; Abhinay, A. 2014: Hyperleukocytosis: emergency management : correspondence. Indian Journal of Pediatrics 81(3): 322

Dimeski, G.; Bird, R. 2009: Hyperleukocytosis: pseudohyperkalaemia and other biochemical abnormalities in hyperleukocytosis. Clinical Chemistry and Laboratory Medicine 47(7): 880-881

Hackanson, B.ör.; Rückert, A.; Lübbert, M. 2009: Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML). European Journal of Haematology 83(6): 611-612

Taniguchi, M.; Higashi, N.; Ono, E.; Mita, H.; Akiyama, K. 2008: Hyperleukotrieneuria in patients with allergic and inflammatory disease. Allergology International: Official Journal of the Japanese Society of Allergology 57(4): 313-320

Treffert, D.A. 2011: Hyperlexia III: separating 'autistic-like' behaviors from autistic disorder; assessing children who read early or speak late. Wmj: Official Publication of the State Medical Society of Wisconsin 110(6): 281-286; Quiz 287

Suzuki, T.; Itoh, S.; Hayashi, M.; Kouno, M.; Takeda, K. 2009: Hyperlexia and ambient echolalia in a case of cerebral infarction of the left anterior cingulate cortex and corpus callosum. Neurocase 15(5): 384-389

Healy, J.M.; Aram, D.M. 1986: Hyperlexia and dyslexia: a family study. Annals of Dyslexia 36(1): 237-252

Imanishi, T.; Nakaoka, H. 2009: Hyperlink Management System and ID Converter System: enabling maintenance-free hyperlinks among major biological databases. Nucleic Acids Research 37(Web Server Issue): W17-W22

Chen, Y.; Li, G.; Fan, H.; Guo, S.; Li, R.; Yin, J.; Zhang, X.; Li, X.; He, X.; Duan, C. 2017: CDKN2BAS gene polymorphisms and the risk of intracranial aneurysm in the Chinese population. Bmc Neurology 17(1): 214

Rabe, M.B.; Cadorna-Carlos, J. 2007: Hyperlinked case presentation to promote self-directed learning. Medical Education 41(5): 511

Kemp, C.G.; Collings, S.C. 2011: Hyperlinked suicide: assessing the prominence and accessibility of suicide websites. Crisis 32(3): 143-151

Flynn, L.; Hall, G. 1949: Hyperlipaemia with secondary xanthomatosis in chronic pancreatitis. Medical Journal of Australia 1(26): 842-845

Kanee, B. 1964: Hyperlipemia and Chronic Relapsing Pancreatitis. Canadian Medical Association Journal 90(16): 986

Aviram, M. 2007: Hyperlipidaemia and cardiovascular disease. Current Opinion in Lipidology 18(4): 473-475

Ansell, B.J. 2008: Hyperlipidaemia and cardiovascular disease. Current Opinion in Lipidology 19(4): 433-434

Peter, R.; Bajwa, H.; Anthony, S. 2013: Hyperlipidaemia and cardiovascular disease -- newer antihyperglycaemic agents and cardiovascular disease. Current Opinion in Lipidology 24(2): 189-190

Dominiczak, M.H. 2011: Hyperlipidaemia and cardiovascular disease--back to basics: dietary patterns, foods and cardiovascular risk. Current Opinion in Lipidology 22(6): 509-511

Nofer, J.-R. 2012: Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH study. Current Opinion in Lipidology 23(3): 260-262

Deans, K.A.; Dominiczak, M.H. 2008: Hyperlipidaemia and cardiovascular disease: apolipoprotein measurements and metabolic syndrome as predictors of cardiovascular risk. Current Opinion in Lipidology 19(6): 624-626

Saha, S.A.; Arora, R.R. 2011: Hyperlipidaemia and cardiovascular disease: do fibrates have a role?. Current Opinion in Lipidology 22(4): 270-276

Aviram, M. 2009: Hyperlipidaemia and cardiovascular disease: inflammation and oxidative stress in diabetic patients. Current Opinion in Lipidology 20(3): 258-259

Choudhury, R.P. 2010: Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?. Current Opinion in Lipidology 21(2): 161-162

Karpe, F.; Chamas, L. 2010: Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue. Current Opinion in Lipidology 21(3): 282-283

Dominiczak, M.H. 2008: Hyperlipidaemia and cardiovascular disease: nonfasting triglycerides gain momentum--but nothing changes on the metabolic syndrome front. Current Opinion in Lipidology 19(3): 326-327

Dominiczak, M. 2009: Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates. Current Opinion in Lipidology 20(1): 79-81

Nofer, J.-R. 2013: Hyperlipidaemia and cardiovascular disease: the quantity does not turn into quality!. Current Opinion in Lipidology 24(4): 366-368

Chen, S.; Ding, Y.; Zhang, Z.; Wang, H.; Liu, C. 2014: Hyperlipidaemia impairs the circadian clock and physiological homeostasis of vascular smooth muscle cells via the suppression of Smarcd1. Journal of Pathology 233(2): 159-169

Wierzbicki, A.S.; Viljoen, A. 2010: Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice. Drug Safety 33(2): 115-125

Chou, Y.-T.; Chuang, L.-P.; Li, H.-Y.; Fu, J.-Y.; Lin, S.-W.; Yang, C.-T.; Chen, N.-H. 2010: Hyperlipidaemia in patients with sleep-related breathing disorders: prevalence and risk factors. Indian Journal of Medical Research 131: 121-125

Kokrdová, Z.; Košťál, M. 2013: Hyperlipidaemia in pregnancy. Ceska Gynekologie 78(2): 150-156

Giricz, Z.; Görbe, A.; Pipis, J.; Burley, D.S.; Ferdinandy, P.; Baxter, G.F. 2009: Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats. British Journal of Pharmacology 158(6): 1495-1502

Jick, S.S.; Choi, H.; Li, L.; McInnes, I.B.; Sattar, N. 2009: Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases 68(4): 546-551

Srivastava, G.; Rahman, N.; Elsandabesee, D.; Kumaranayakan, P. 2010: Hyperlipidaemic pancreatitis in pregnancy. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 30(1): 59-60

Ascenzi, M.-G.; Lutz, A.; Du, X.; Klimecky, L.; Kawas, N.; Hourany, T.; Jahng, J.; Chin, J.; Tintut, Y.; Nackenhors, U.; Keyak, J. 2014: Hyperlipidemia affects multiscale structure and strength of murine femur. Journal of Biomechanics 47(10): 2436-2443

Raees-Jalali, G.; Eshraghian, A.; Faghihi, A.; Roozbeh, J.; Sagheb, M.M.; Eshraghian, H.; Behzadi, S. 2012: Hyperlipidemia after kidney transplantation: long-term graft outcome. Iranian Journal of Kidney Diseases 6(1): 49-55

Ma, Y.; Wang, W.; Zhang, J.; Lu, Y.; Wu, W.; Yan, H.; Wang, Y. 2012: Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. Plos one 7(4): E35835

Malloy, M.J.; Kane, J.P. 2012: Hyperlipidemia and cardiovascular disease. Current Opinion in Lipidology 23(6): 591-592

Le, N-Anh. 2008: Hyperlipidemia and cardiovascular disease: cardiovascular update. Current Opinion in Lipidology 19(5): 545-547

Tietge, U.J.F. 2014: Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis. Current Opinion in Lipidology 25(1): 94-95

Nofer, J.-R. 2010: Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease. Current Opinion in Lipidology 21(4): 392-393

Nofer, J.-R. 2011: Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?. Current Opinion in Lipidology 22(4): 319-321

Ambroskina, V.V.; Kriachok, T.A.; Larionov, O.P.; Talaieva, T.V.; Bratus', V.V. 2007: Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis. Fiziolohichnyi Zhurnal 53(6): 19-28

Wakatsuki, A. 2007: Hyperlipidemia and hormone replacement therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 499-503

Uchida, K.; Urabe, K.; Naruse, K.; Ogawa, Z.; Mabuchi, K.; Itoman, M. 2009: Hyperlipidemia and hyperinsulinemia in the spontaneous osteoarthritis mouse model, STR/Ort. Experimental Animals 58(2): 181-187

Lee, C.K.; Corcoran, S.F.; Parsons, J.R. 1980: Hyperlipidemia and idiopathic aseptic necrosis of the femoral head in adults. Orthopedics 3(7): 651-655

Chawla, V.; Greene, T.; Beck, G.J.; Kusek, J.W.; Collins, A.J.; Sarnak, M.J.; Menon, V. 2010: Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clinical Journal of the American Society of Nephrology: Cjasn 5(9): 1582-1587

Al-Ghamdi, K.S.; Rehman, R. 1998: Hyperlipidemia and obesity among diabetics at jubail miiltary hospital. Journal of Family and Community Medicine 5(1): 45-50

Dukić, A.; Zivancević-Simonović, S.; Varjacić, M.; Dukić, S. 2009: Hyperlipidemia and pregnancy. Medicinski Pregled 62(Suppl 3): 80-84

Lewis, A.; Segal, A. 2010: Hyperlipidemia and primary prevention of stroke: does risk factor identification and reduction really work?. Current Atherosclerosis Reports 12(4): 225-229

Jimenez-Conde, J.; Biffi, A.; Rahman, R.; Kanakis, A.; Butler, C.; Sonni, S.; Massasa, E.; Cloonan, L.; Gilson, A.; Capozzo, K.; Cortellini, L.; Ois, A.; Cuadrado-Godia, E.; Rodriguez-Campello, A.; Furie, K.L.; Roquer, J.; Rosand, J.; Rost, N.S. 2010: Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 41(3): 437-442

Esposito, K.; Ciotola, M.; Maiorino, M.I.; Giugliano, F.; Autorino, R.; De Sio, M.; Cozzolino, D.; Saccomanno, F.; Giugliano, D. 2009: Hyperlipidemia and sexual function in premenopausal women. Journal of Sexual Medicine 6(6): 1696-1703

Nelson, R.H. 2013: Hyperlipidemia as a risk factor for cardiovascular disease. Primary Care 40(1): 195-211

Tiric Campara, M.; Sijaric-Voloder, S.; Denislic, M.; Tupkovic, E.; Djelilovic Vranic, J.; Alajbegovic, A. 2014: Hyperlipidemia as a risk factor for persons in specific professions. Materia Socio-Medica 26(1): 17-20

Ridker, P.M. 2012: Hyperlipidemia as an instigator of inflammation: inaugurating new approaches to vascular prevention. Journal of the American Heart Association 1(1): 3-5

Zechariah, A.; ElAli, A.; Hagemann, N.; Jin, F.; Doeppner, T.Roland.; Helfrich, I.; Mies, Günter.; Hermann, D.Matthias. 2013: Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 33(7): 1561-1567

Chen, S.; Lin, G.; You, X.; Lei, L.; Li, Y.; Lin, M.; Luo, K.; Yan, F. 2014: Hyperlipidemia causes changes in inflammatory responses to periodontal pathogen challenge: implications in acute and chronic infections. Archives of Oral Biology 59(10): 1075-1084

Xu, Q.-C.; Hao, P.-J.; Yu, X.-B.; Chen, S.-L.; Yu, M.-J.; Zhang, J.; Yang, P.-S. 2014: Hyperlipidemia compromises homing efficiency of systemically transplanted BMSCs and inhibits bone regeneration. International Journal of Clinical and Experimental Pathology 7(4): 1580-1587

Zhao, H.; Wang, Y.; Wu, Y.; Li, X.; Yang, G.; Ma, X.; Zhao, R.; Liu, H. 2009: Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation. Acta Biochimica et Biophysica Sinica 41(9): 745-753

Yeh, H.; Kitchens, W.H.; Elias, N.; Kelsey, P.B.; Markmann, J.F.; Hertl, M. 2011: Hyperlipidemia due to biliary stricture after living-donor liver transplantation. Transplantation 92(6): E29-E30

Lei, L.; Li, H.; Yan, F.; Xiao, Y. 2013: Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein e knockout mice. Plos one 8(8): E71849

Huang, M.S.; Lu, J.; Ivanov, Y.; Sage, A.P.; Tseng, W.; Demer, L.L.; Tintut, Y. 2008: Hyperlipidemia impairs osteoanabolic effects of PTH. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 23(10): 1672-1679

Gozzetti, A.; Fabbri, A.; Defina, M.; Chitarrelli, I.; Bocchia, M. 2010: Hyperlipidemia in a myeloma patient after bortezomib treatment. Leukemia Research 34(9): E250

Mahmud, S.; Jahan, S.; Hossain, M.M. 2011: Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse. Mymensingh Medical Journal: Mmj 20(3): 402-406

Koletzko, B. 2008: Hyperlipidemia in children and adolescents. MMW Fortschritte der Medizin 150(47): 34-37

Derakhshan, N.; Derakhshan, D.; Derakhshan, A.; Hashemi, G.; Fallahzadeh, M.H.; Basiratnia, M.; Bazargani, Z.; Jalaeian, H.; Malek-Hosseini, S.A. 2011: Hyperlipidemia in children with normal allograft function. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 22(2): 339-340

Hayashi, N.; Funahashi, T. 2007: Hyperlipidemia in endocrine disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 417-420

Bernier, A.V.; Sentner, C.P.; Correia, C.E.; Theriaque, D.W.; Shuster, J.J.; Smit, G.P.A.; Weinstein, D.A. 2008: Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control. Journal of Inherited Metabolic Disease 31(6): 729-732

Bai, L.; Fu, T.; Jia, Y.; Borensztajn, J.; Reddy, J.K.; Yang, G. 2011: Hyperlipidemia in hepatic MED1 deficient mice in response to fasting. Sheng Wu Gong Cheng Xue Bao 27(10): 1490-1498

Saito, T. 2007: Hyperlipidemia in kidney diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 407-411

Saberi, A.; Hatamian, H.R.; Kazemnejad, E.; Ghorbannejad, N. 2011: Hyperlipidemia in migraine: Is it more frequent in migraineurs?. Iranian Journal of Neurology 10(3-4): 46-50

Chang, N.-C.; Yu, M.-L.; Ho, K.-Y.; Ho, C.-K. 2007: Hyperlipidemia in noise-induced hearing loss. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 137(4): 603-606

Aslam, F.; Haque, A.; Lee, L.V.; Foody, J. 2009: Hyperlipidemia in older adults. Clinics in Geriatric Medicine 25(4): 591-606 Vii

Hsu, J-Hwa.; Chien, I-Chia.; Lin, C-Heng.; Chou, Y-Jenq.; Chou, P. 2012: Hyperlipidemia in patients with schizophrenia: a national population-based study. General Hospital Psychiatry 34(4): 360-367

Chen, Z.-x.; Xie, X.-y.; Yu, R.-c.; Zhang, J.; Lei, M.-x. 2008: Hyperlipidemia induced by high fat diet ingestion activates TGF-beta/Smad signaling pathway in the kidney of diabetic rats. Zhong Nan da Xue Xue Bao. Yi Xue Ban 33(10): 906-912

Ivan, L.; Antohe, F. 2010: Hyperlipidemia induces endothelial-derived foam cells in culture. Journal of Receptor and Signal Transduction Research 30(2): 106-114

Sage, A.P.; Lu, J.; Atti, E.; Tetradis, S.; Ascenzi, M.-G.; Adams, D.J.; Demer, L.L.; Tintut, Y. 2011: Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 26(6): 1197-1206

Lei, L.; Li, H.-x.; Huang, M.-x.; Chen, S.; Yan, F.-h. 2014: Hyperlipidemia inhibited inflammatory response to Porphyromonas gingivalis in apolipoprotein e knockout mice. Shanghai Kou Qiang Yi Xue 23(4): 409-412

Gary, T.; Starz, I.; Belaj, K.; Steidl, K.; Hafner, F.; Froehlich, H.; Pilger, E.; Brodmann, M. 2012: Hyperlipidemia is associated with a higher pulmonary artery systolic pressure in patients after pulmonary embolism. Thrombosis Research 129(1): 86-88

Stephany, B.R.; Alao, B.; Budev, M.; Boumitri, M.; Poggio, E.D. 2007: Hyperlipidemia is associated with accelerated chronic kidney disease progression after lung transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7(11): 2553-2560

Malík, J.; Stulc, T.; Wichterle, D.; Melenovský, V.; Chytilová, E.; Lacinová, Z.; Marek, J.; Ceska, R. 2008: Hyperlipidemia is associated with altered levels of insulin-like growth factor-i. Physiological Research 57(6): 919-925

Shuster, J.E.; Jeffres, M.N.; Barclay, S.M.; Bhakta, R. 2011: Hyperlipidemia medication management in patients admitted for a myocardial infarction. Pharmacy Practice 9(1): 31-36

Chen, S.; Lin, G.; Lei, L.; You, X.; Wu, C.; Xu, W.; Huang, M.; Luo, L.; Wang, Z.; Li, Y.; Zhao, X.; Yan, F. 2013: Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-κB signaling pathway. Inflammation 36(4): 968-976

Ghosh, J.; Das, S.; Guha, R.; Ghosh, D.; Naskar, K.; Das, A.; Roy, S. 2012: Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. Journal of Lipid Research 53(12): 2560-2572

Koral, K.; McMenamy, J.; Hauser, N.; Rollins, N. 2010: Hyperlipidemia resulting in abnormal density and signal intensity of blood in a neonate with lipoprotein lipase deficiency. AJNR. American Journal of Neuroradiology 31(10): 1999-2000

Miller, C.E.; Hirani, B.; Bain, B.J. 2013: Hyperlipidemia revealed by erythrocyte morphology. American Journal of Hematology 88(7): 625

Gauer, R. 2010: Hyperlipidemia treatment in children: the younger, the better. American Family Physician 82(5): 460

Chanoine, P.; Spector, N.D. 2008: Hyperlipidemia, eating disorders, and smoking cessation. Current Opinion in Pediatrics 20(6): 734-739

Giri, R.; Kesavulu, M.M.; Rao, B.K.; Ramana, V.; Rao, C.A. 1999: Hyperlipidemia, increased lipid peroxidation and changes in antioxidant enzymes, Na(+)-K(+)-ATPase in erythrocytes of type 2 diabetic patients in andhra pradesh. Indian Journal of Clinical Biochemistry: Ijcb 14(2): 168-175

Chuang, C-Sen.; Yang, T-Yen.; Muo, C-Hsin.; Su, H-Lin.; Sung, F-Chang.; Kao, C-Hung. 2014: Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study. General Hospital Psychiatry 36(5): 497-501

Owens, A.P.; Byrnes, J.R.; Mackman, N. 2014: Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends in Cardiovascular Medicine 24(3): 95-98

Whitten, A.E.; Lorenz, R.P.; Smith, J.M. 2011: Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate. Obstetrics and Gynecology 117(2 Part 2): 517-519

Sastre, C.; Rubio-Navarro, A.; Buendía, I.; Gómez-Guerrero, C.; Blanco, J.; Mas, S.; Egido, J.ús.; Blanco-Colio, L.M.; Ortiz, A.; Moreno, J.A. 2013: Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice. Plos one 8(12): E83713

Drechsler, M.; Megens, R.T.A.; van Zandvoort, M.; Weber, C.; Soehnlein, O. 2010: Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122(18): 1837-1845

Ecker-Schlipf, B. 2014: Hyperlipidemia. new treatment option with Evolocumab. Medizinische Monatsschrift für Pharmazeuten 37(7): 271-272

Vincent, A.M.; Hinder, L.M.; Pop-Busui, R.; Feldman, E.L. 2009: Hyperlipidemia: a new therapeutic target for diabetic neuropathy. Journal of the Peripheral Nervous System: Jpns 14(4): 257-267

Kim, H.; Matsumoto, A. 2007: Hyperlipidemia: alimentary therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 442-446

Mishkel, M.A. 1985: Hyperlipidemia: time to treat?. Canadian Family Physician Medecin de Famille Canadien 31: 107-111

Durval, A.; Zamidei, L.; Bettocchi, D.; Luzzio, M.G.; Consales, G. 2011: Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir. Minerva Anestesiologica 77(10): 1018-1021

Ayala, I.; Castillo, A.M.ín.; Adánez, G.; Fernández-Rufete, A.; Pérez, B.é G.ía.; Castells, M.T. 2009: Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis. Experimental Biology and Medicine 234(1): 10-16

Thiebaud, N.; Johnson, M.C.; Butler, J.L.; Bell, G.A.; Ferguson, K.L.; Fadool, A.R.; Fadool, J.C.; Gale, A.M.; Gale, D.S.; Fadool, D.A. 2014: Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 34(20): 6970-6984

Yang, R.; Guo, P.; Song, X.; Liu, F.; Gao, N. 2011: Hyperlipidemic guinea pig model: mechanisms of triglyceride metabolism disorder and comparison to rat. Biological and Pharmaceutical Bulletin 34(7): 1046-1051

Gozzetti, A.; Defina, M.; Bocchia, M.; Lauria, F. 2010: Hyperlipidemic myeloma. Annals of Hematology 89(9): 939-940

Zhang, W.; Wang, X.-P.; Yu, Z.-W.; Wang, L.-S.; Zhu, Y.; Yu, X.-F.; Wu, K.; Zeng, Y.; Xu, M.-Y. 2010: Hyperlipidemic versus healthy pancreases: a proteomic analysis using an animal model. Iubmb Life 62(10): 781-789

Zhang, W.; Zhao, Y.; Zeng, Y.; Yu, X.; Yao, J.; Zhao, S.; Bao, Z.; Chen, J.; Wang, X. 2012: Hyperlipidemic versus normal-lipid acute necrotic pancreatitis: proteomic analysis using an animal model. Pancreas 41(2): 317-322

Picone, O.; Laigre, P.; Fortun-Lamothe, L.; Archilla, C.; Peynot, N.; Ponter, A.A.; Berthelot, V.; Cordier, A.-G.; Duranthon, V.; Chavatte-Palmer, P. 2011: Hyperlipidic hypercholesterolemic diet in prepubertal rabbits affects gene expression in the embryo, restricts fetal growth and increases offspring susceptibility to obesity. Theriogenology 75(2): 287-299

Ichinose, A. 2008: Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene. Brain and Nerve 60(11): 1307-1317

Ceska, R.; Kvasilová, M.; Procházková, R.; Smelková, G.; Vrablík, M. 2010: Hyperlipoproteinaemia and dyslipoproteinaemia I. Classification, diagnostics, cardiovascular, cardiometabolic and residual risk. Vnitrni Lekarstvi 56(6): 526-531

Ceska, R.; Krutská, S.; Kasná, L.; Smelková, G.; Zlatohlávek, L.; Vrablík, M. 2010: Hyperlipoproteinaemia and dyslipoproteinaemia II. Therapy: non-pharmacological and pharmacological approaches. Vnitrni Lekarstvi 56(7): 647-654

Abel, T.án.; Blázovics, A.; Kemény, M.ár.; Lengyel, G. 2011: Hyperlipoproteinemia in pregnancy. Orvosi Hetilap 152(19): 753-757

Hopkins, P.N.; Brinton, E.A.; Nanjee, M.N. 2014: Hyperlipoproteinemia type 3: the forgotten phenotype. Current Atherosclerosis Reports 16(9): 440

Huang, P.; Liu-Chen, L.-Y.; Unterwald, E.M.; Cowan, A. 2009: Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice. Neuroscience Letters 465(1): 66-70

Ishikawa, J.; Ogawa, Y.; Owada, Y.; Ishikawa, A. 2014: Hyperlocomotor activity and stress vulnerability during adulthood induced by social isolation after early weaning are prevented by voluntary running exercise before normal weaning period. Behavioural Brain Research 264: 197-206

Jentzsch, T.; Geiger, J.; König, M.A.; Werner, Cément.M.L. 2013: Hyperlordosis is Associated with Facet Joint Pathology at the Lower Lumbar Spine. Clinical Spine Surgery (): -

Patton, J.M.; Gonzales, J.; Dillard, T.A.; Szerlip, H.M. 2008: Hyperlucent left hemithorax and respiratory distress. Chest 134(4): 872-875

Górska, L.; Kuziemski, K.; Wajda, B.; Damps-Konstańska, I.; Tokarska, B.; Jassem, E. 2008: Hyperlucent lung syndrom caused by pulmonary artery hypoplasia in patient with diagnosed asthma--case report. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(143): 436-438

Yoon, H.E.; Kim, Y.W.; Ha, K.S.; Sim, E.H.; Go, S.W.; Shin, S.J. 2013: Hypermagnesemia accompanied with colonic perforation in a hemodialysis patient. Yonsei Medical Journal 54(3): 797-800

Bjerring, P.Nissen.; Eefsen, M.; Larsen, F.Stolze.; Bernal, W.; Wendon, J. 2011: Hypermagnesemia does not prevent intracranial hypertension and aggravates cerebral hyperperfusion in a rat model of acute hyperammonemia. Hepatology 53(6): 1986-1994

Shashidhar, K.N.; Kunder, M.; Shenoy, K.A.; Hemalatha, A.; Kutty, A.; Shetty, H. 2007: Hypermagnesemia in diabetic end stage renal disease (ESRD) patients. Indian Journal of Clinical Biochemistry: Ijcb 22(2): 164

Corbi, G.; Acanfora, D.; Iannuzzi, G.L.; Longobardi, G.; Cacciatore, F.; Furgi, G.; Filippelli, A.; Rengo, G.; Leosco, D.; Ferrara, N. 2008: Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use. Rejuvenation Research 11(1): 129-138

Herrero Hernández, E.; Discalzi, G. 2009: Hypermanganesemia, hereditary hemorrhagic telangiectasia, brain abscess: the hepatic connection. Neurology 73(5): 405; Author Reply 405-6

LaPollo, A.B.; Bond, L.; Lauby, J.L. 2014: Hypermasculinity and Sexual Risk Among Black and White Men who have Sex with Men and Women. American Journal of Men's Health 8(5): 362-372

Vasquez Guerrero, D.A. 2009: Hypermasculinity, intimate partner violence, sexual aggression, social support, and child maltreatment risk in urban, heterosexual fathers taking parenting classes. Child Welfare 88(4): 135-155

Kusec, S.; Jaksić, Z.; Vuletić, G.; Kovacić, L.; Pavleković, G. 2002: Hypermedia in medical education: quality of health care. Lijecnicki Vjesnik 124(Suppl 2): 28-31

Benson, J. 2015: Hypermedicalization in White Noise. Journal of Medical Humanities 36(3): 199-215

Taïeb, A.; Boralevi, F. 2007: Hypermelanoses of the newborn and of the infant. Dermatologic Clinics 25(3): 327-336 Viii

Römer, T. 2013: Hypermenorrhoea. Medizinische Monatsschrift für Pharmazeuten 36(1): 4

Goodman, M.; Siever, L.J. 2011: Hypermentalization in adolescents with borderline personality traits: extending the conceptual framework to younger ages. Journal of the American Academy of Child and Adolescent Psychiatry 50(6): 536-537

Sharp, C.; Ha, C.; Carbone, C.; Kim, S.; Perry, K.; Williams, L.; Fonagy, P. 2013: Hypermentalizing in adolescent inpatients: treatment effects and association with borderline traits. Journal of Personality Disorders 27(1): 3-18

Park, J.S.; Lee, A.Y.; Bae, S.G.; Lee, S.M. 2010: Hypermetabolic Axillary Mass on (18)F FDG PET/CT: Breast Cancer Arising from Accessory Breast Tissue. Nuclear Medicine and Molecular Imaging 44(4): 300-303

Young, P.M.; Peterson, J.J.; Calamia, K.T. 2008: Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases. Annals of Nuclear Medicine 22(1): 87-92

Battistella, M.; Trabelsi, S.; Terrier-Lacombe, M.-J.ée.; Leboulleux, S.; Robert, C. 2008: Hypermetabolic dermatofibroma on Positron Emission Tomography/Computed tomography with 18F-FluoroDeoxyGlucose : a misleading false positive in the follow-up of a metastatic melanoma. European Journal of Dermatology: Ejd 18(4): 461-462

Dong, A.; Dong, H.; Zhang, L.; Zuo, C. 2013: Hypermetabolic lesions of the pancreas on FDG PET/CT. Clinical Nuclear Medicine 38(9): E354-E366

Banzo, J.; Ubieto, M.A.; López, L.; Tardín, L.; Santapau, A.; Parra, A. 2011: Hypermetabolic lymphoadenopathic pattern in a patient with toxoplasmosis. Revista Espanola de Medicina Nuclear 30(3): 185-186

Dong, A.; Wang, Y.; Lu, J.; Zuo, C. 2014: Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma. Clinical Nuclear Medicine 39(3): E229-E232

Kaida, H.; Kurata, S.; Hirose, Y.; Okamura, T.; Oshima, K.; Ishibashi, M. 2014: Hypermetabolic pulmonary and bone marrow lesions in a patient with chronic adult T-cell leukemia. Hellenic Journal of Nuclear Medicine 17(2): 145-147

Zade, A.; Rangarajan, V.; Purandare, N.; Shah, S.; Agrawal, A.; Jha, A.; Kulkarni, M. 2012: Hypermetabolic subcutaneous fat in patients on highly active anti-retroviral therapy treatment: Subtle finding with implications. Indian Journal of Nuclear Medicine: Ijnm: the Official Journal of the Society of Nuclear Medicine India 27(3): 183-184

Namer, I.J.; Valenti-Hirsch, M.P.; Scholly, J.; Lannes, B.éa.; Imperiale, A.; Hirsch, E. 2014: Hypermetabolism during resting-state FDG-PET suggesting intrinsic epileptogenicity in focal cortical dysplasia. Clinical Nuclear Medicine 39(11): 993-995

Foley, N.; Marshall, S.; Pikul, J.; Salter, K.; Teasell, R. 2008: Hypermetabolism following moderate to severe traumatic acute brain injury: a systematic review. Journal of Neurotrauma 25(12): 1415-1431

Floeth, F.W.; Galldiks, N.; Eicker, S.; Stoffels, G.; Herdmann, J.ör.; Steiger, H.-J.; Antoch, G.; Rhee, S.; Langen, K.-J. 2013: Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 54(9): 1577-1583

Bouteloup, C.; Desport, J.-C.; Clavelou, P.; Guy, N.; Derumeaux-Burel, H.; Ferrier, A.; Couratier, P. 2009: Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of Neurology 256(8): 1236-1242

Knight, E.M.; Verkhratsky, A.; Luckman, S.M.; Allan, S.M.; Lawrence, C.B. 2012: Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease. Neurobiology of Aging 33(1): 187-193

Ho, L. 2009: Hypermetabolism in bilateral basal ganglia in Sydenham chorea on F-18 FDG PET-CT. Clinical Nuclear Medicine 34(2): 114-116

Miyazawa, N.; Shinohara, T.; Nagasaka, T.; Hayashi, M. 2010: Hypermetabolism in patients with dementia with Lewy bodies. Clinical Nuclear Medicine 35(7): 490-493

Choi, B.W.; Kim, S.H.; Kim, H.W.; Won, K.S.; Zeon, S.K. 2010: Hypermetabolism of skeletal muscles following sexual activity: a normal variation. Nuclear Medicine and Molecular Imaging 44(3): 228-229

Silver, S.; Crohn, E.B.; Porto, P. 1949: Hypermetabolism without hyperthyroidism. Bulletin of the new York Academy of Medicine 25(7): 441

Yeh, T.-Y.J.; Beiswenger, K.K.; Li, P.; Bolin, K.E.; Lee, R.M.; Tsao, T.-S.; Murphy, A.N.; Hevener, A.L.; Chi, N.-W. 2009: Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 58(11): 2476-2485

Weijs, P.J.M. 2011: Hypermetabolism, is it real? the example of amyotrophic lateral sclerosis. Journal of the American Dietetic Association 111(11): 1670-1673

Couce, M.L.; Bóveda, M.D.; Castiñeiras, D.E.; Corrales, F.J.; Mora, M.I.; Fraga, J.M.; Mudd, S.H. 2008: Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme. Journal of Inherited Metabolic Disease 31 Suppl. 2: S233-S239

López-Suárez, O.; Couce Pico, M.L.; Pérez-Muñuzuri, A.; Castiñeiras Ramos, D.E.; Fernández-Lorenzo, J.R. 2010: Hypermethioninemia in the preterm newborn. Predisposing factors. Anales de Pediatria 72(3): 179-184

Stefanello, F.M.; Matté, C.; Pederzolli, C.D.; Kolling, J.ín.; Mescka, C.P.; Lamers, M.L.; de Assis, A.M.; Perry, M.L.; dos Santos, M.F.; Dutra-Filho, C.S.; Wyse, A.T.S. 2009: Hypermethioninemia provokes oxidative damage and histological changes in liver of rats. Biochimie 91(8): 961-968

Mudd, S.H. 2011: Hypermethioninemias of genetic and non-genetic origin: a review. American Journal of Medical Genetics. Part C Seminars in Medical Genetics 157c (1): 3-32

Babiloni, F.; Cincotti, F.; Mattia, D.; Mattiocco, M.; De Vico Fallani, F.; Tocci, A.; Bianchi, L.; Marciani, M.G.; Astolfi, L. 2006: Hypermethods for EEG hyperscanning. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 3666-3669

Zurita, M.; Lara, P.C.; del Moral, R.; Torres, B.; Linares-Fernández, J.é L.; Arrabal, S.R.ío.; Martínez-Galán, J.; Oliver, F.J.; Ruiz de Almodóvar, J.é M. 2010: Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis. Bmc Cancer 10: 217

Häfner, N.; Diebolder, H.; Jansen, L.; Hoppe, I.; Dürst, M.; Runnebaum, I.B. 2011: Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer. Gynecologic Oncology 121(1): 224-229

Chen, L.; Su, L.; Li, J.; Zheng, Y.; Yu, B.; Yu, Y.; Yan, M.; Gu, Q.; Zhu, Z.; Liu, B. 2012: Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer. Disease Markers 32(3): 195-202

Lind, G.E.; Ahlquist, T.; Kolberg, M.; Berg, M.; Eknaes, M.; Alonso, M.A.; Kallioniemi, A.; Meling, G.I.; Skotheim, R.I.; Rognum, T.O.; Thiis-Evensen, E.; Lothe, R.A. 2008: Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. Journal of Translational Medicine 6: 13

Sun, J.; Chen, Z.; Zhu, T.; Yu, J.; Ma, K.; Zhang, H.; He, Y.; Luo, X.; Zhu, J. 2009: Hypermethylated SFRP1, but none of other nine genes "informative" for western countries, is valuable for bladder cancer detection in Mainland China. Journal of Cancer Research and Clinical Oncology 135(12): 1717-1727

Wang, D.-R.; Tang, D. 2008: Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World Journal of Gastroenterology 14(4): 524-531

Zamudio, J.R.; Mittra, B.; Campbell, D.A.; Sturm, N.R. 2009: Hypermethylated cap 4 maximizes Trypanosoma brucei translation. Molecular Microbiology 72(5): 1100-1110

Fackler, M.J.; Rivers, A.; Teo, W.W.; Mangat, A.; Taylor, E.; Zhang, Z.; Goodman, S.; Argani, P.; Nayar, R.; Susnik, B.; Sukumar, S.; Khan, S.A. 2009: Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(11): 3802-3811

Boulay, G.; Dubuissez, M.; Van Rechem, C.; Forget, A.; Helin, K.; Ayrault, O.; Leprince, D. 2012: Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. Journal of Biological Chemistry 287(13): 10509-10524

Wurth, L.; Gribling-Burrer, A.-S.; Verheggen, C.él.; Leichter, M.; Takeuchi, A.; Baudrey, S.ép.; Martin, F.; Krol, A.; Bertrand, E.; Allmang, C. 2014: Hypermethylated-capped selenoprotein mRNAs in mammals. Nucleic Acids Research 42(13): 8663-8677

Zhao, C.-H.; Bu, X.-M.; Zhang, N. 2007: Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer. World Journal of Gastroenterology 13(15): 2214-2217

Guo, Y.; Guo, W.; Chen, Z.; Kuang, G.; Yang, Z.; Dong, Z. 2011: Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma. Neoplasma 58(2): 110-117

Bu, X.-M.; Zhao, C.-H.; Zhang, N.; Gao, F.; Lin, S.; Dai, X.-W. 2008: Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer. World Journal of Gastroenterology 14(21): 3421-3424

Chen, H.; Pan, Y.; Cheng, Z.-Y.; Wang, Z.; Liu, Y.; Zhao, Z.-J.; Fan, H. 2013: Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 14(11): 6261-6265

Morenos, L.; Chatterton, Z.; Ng, J.L.; Halemba, M.S.; Parkinson-Bates, M.; Mechinaud, F.; Elwood, N.; Saffery, R.; Wong, N.C. 2014: Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1. Molecular Cancer 13: 123

Xing, C.; Wang, Q.; Tian, H.; Li, B.; Ni, Y.; Yin, S.; Guo, X.; Li, G. 2012: Hypermethylation and downregulation of tumor suppressor gene p16 in benzene poisoning. Wei Sheng Yan Jiu 41(2): 247-250

Lee, J.-Y.; Jeong, W.; Lim, W.; Lim, C.-H.; Bae, S.-M.; Kim, J.; Bazer, F.W.; Song, G. 2013: Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen. Plos one 8(4): E61658

Colombel, M.; Ricci, E.; Picard, A.; Bourrelly, E. 2010: Hypermethylation and prostate cancer. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 20(6): 408-415

Qi, J.; Zhu, Y.-Q.; Luo, J.; Tao, W.-H.; Zhang, J.-M. 2007: Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor. Zhonghua Zhong Liu Za Zhi 29(11): 842-845

Barski, D.; Wolter, M.; Reifenberger, G.; Riemenschneider, M.J. 2010: Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathology 20(3): 623-631

Costanzi, E.; Urbanelli, L.; Bellezza, I.; Magini, A.; Emiliani, C.; Minelli, A. 2014: Hypermethylation contributes to down-regulation of lysosomal β-hexosaminidase α subunit in prostate cancer cells. Biochimie 101: 75-82

Chen, W.; Gao, N.; Shen, Y.; Cen, J.-N. 2010: Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Journal of Gastroenterology and Hepatology 25(4): 823-831

Sánchez-Carbayo, M. 2012: Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 33(2): 347-361

Zhi, Y.F.; Huang, Y.S.; Li, Z.H.; Zhang, R.M.; Wang, S.R. 2007: Hypermethylation in promoter area of LDLR gene in atherosclerosis patients. Fen Zi Xi Bao Sheng Wu Xue Bao 40(6): 419-427

Davies, M.N.; Krause, L.; Bell, J.T.; Gao, F.; Ward, K.J.; Wu, H.; Lu, H.; Liu, Y.; Tsai, P.-C.; Collier, D.A.; Murphy, T.; Dempster, E.; Mill, J.; Battle, A.; Mostafavi, S.; Zhu, X.; Henders, A.; Byrne, E.; Wray, N.R.; Martin, N.G.; Spector, T.D.; Wang, J. 2014: Hypermethylation in the ZBTB20 gene is associated with major depressive disorder. Genome Biology 15(4): R56

He, Y.; Cui, Y.; Xu, B.; Gu, J.; Wang, W.; Luo, X. 2014: Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma. Plos one 9(1): E87994

Fu, X.; Li, J.; Li, K.; Tian, X.; Zhang, Y. 2009: Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. Histopathology 55(5): 554-563

Salskov, A.; Hawes, S.E.; Stern, J.E.; Feng, Q.; Jordan, C.Diana.; Wiens, L.; Rasey, J.; Lu, H.; Kiviat, N.B.; Vesselle, H. 2011: Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung. Journal of Oncology 2011: 950140

Jia, J.-s.; Spicuglia, S. 2013: Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia. Zhonghua Yi Xue Za Zhi 93(48): 3835-3840

Dudziec, E.; Miah, S.; Choudhry, H.M.Z.; Owen, H.C.; Blizard, S.; Glover, M.; Hamdy, F.C.; Catto, J.W.F. 2011: Hypermethylation of CpG islands and shores around specific micro RNAs and mirtrons is associated with the phenotype and presence of bladder cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(6): 1287-1296

Kristensen, L.S.; Asmar, F.; Dimopoulos, K.; Nygaard, M.K.; Aslan, D.; Hansen, J.W.; Ralfkiaer, E.; Grønbæk, K. 2014: Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma. Oncotarget 5(20): 9798-9810

Niu, P-Pan.; Cao, Y.; Gong, T.; Guo, J-Hui.; Zhang, B-Kui.; Jia, S-Jie. 2014: Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients. Journal of Translational Medicine 12: 170

Park, J.H.; Lee, B.I.; Song, E.S.; Whang, S.O.; Lee, W.Y.; Cho, S.J. 2008: Hypermethylation of E-cadherin in endometrial carcinoma. Journal of Gynecologic Oncology 19(4): 241-245

Marsit, C.J.; Posner, M.R.; McClean, M.D.; Kelsey, K.T. 2008: Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer 113(7): 1566-1571

Lin, H-Hui.; Ke, H-Lung.; Wu, W-Jeng.; Lee, Y-Huei.; Chang, L-Li. 2012: Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. Urologic Oncology 30(2): 177-181

Park, S.-H.; Kim, S.-K.; Choe, J.-Y.; Moon, Y.; An, S.; Park, M.J.; Kim, D.S. 2013: Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. Molecules and Cells 35(4): 298-304

Chen, C.; Wang, L.; Liao, Q.; Huang, Y.; Ye, H.; Chen, F.; Xu, L.; Ye, M.; Duan, S. 2013: Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagnostic Pathology 8: 199

Zhao, G.; Qin, Q.; Zhang, J.; Liu, Y.; Deng, S.; Liu, L.; Wang, B.; Tian, K.; Wang, C. 2013: Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer. Annals of Surgical Oncology 20 Suppl. 3: S301-S311

Ye, Q.; Shen, Y.; Wang, X.; Yang, J.; Miao, F.; Shen, C.; Zhang, J. 2010: Hypermethylation of HLA class i gene is associated with HLA class i down-regulation in human gastric cancer. Tissue Antigens 75(1): 30-39

Fambrini, M.; Sorbi, F.; Bussani, C.; Cioni, R.; Sisti, G.; Andersson, K.L. 2013: Hypermethylation of HOXA10 gene in mid-luteal endometrium from women with ovarian endometriomas. Acta Obstetricia et Gynecologica Scandinavica 92(11): 1331-1334

Gao, T.; Nie, Y.; Hu, H.; Liang, Z. 2012: Hypermethylation of IGSF4 gene for noninvasive prenatal diagnosis of thalassemia. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 18(1): Br33-Br40

Ma, J.-x.; Duan, H.-w.; Huang, C.-f.; Yang, H.-j.; Dai, Y.-f.; Niu, Y.; Bin, P.; Liu, Q.; Zheng, Y.-x. 2011: Hypermethylation of O(6)-methylguanine-DNA methyltransferase in human bronchial epithelial cell induced by organic extracts of coke oven emissions. Zhonghua Yu Fang Yi Xue Za Zhi 45(5): 399-403

Huang, S.K.; Fisher, A.S.; Scruggs, A.M.; White, E.S.; Hogaboam, C.M.; Richardson, B.C.; Peters-Golden, M. 2010: Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. American Journal of Pathology 177(5): 2245-2255

Paulíková, S.; Chmelařová, M.; Petera, J.; Palička, V.; Paulík, A. 2013: Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients. Folia Biologica 59(6): 240-245

Miladi-Abdennadher, I.; Abdelmaksoud-Damak, R.; Ayadi, L.; Khabir, A.; Frikha, F.; Kallel, L.; Amouri, A.; Frikha, M.; Sellami-Boudawara, T.; Gargouri, A.; Mokdad-Gargouri, R. 2010: Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 31(5): 503-511

Supic, G.; Kozomara, R.; Jovic, N.; Zeljic, K.; Magic, Z. 2011: Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Diseases 17(8): 794-800

Huang, Y.; Zhang, P.; Zheng, S.; Dong, R. 2014: Hypermethylation of SHH in the pathogenesis of congenital anorectal malformations. Journal of Pediatric Surgery 49(9): 1400-1404

Wong, O.G.-W.; Huo, Z.; Siu, M.K.-Y.; Zhang, H.; Jiang, L.; Wong, E.S.-Y.; Cheung, A.N.-Y. 2010: Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis. Obstetrics and Gynecology International 2010

Li, A.S.M.; Siu, M.K.Y.; Zhang, H.; Wong, E.S.Y.; Chan, K.Y.K.; Ngan, H.Y.S.; Cheung, A.N.Y. 2008: Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma. Reproductive Sciences 15(7): 735-744

Zhang, X.; Yang, R.; Jia, Y.; Cai, D.; Zhou, B.; Qu, X.; Han, H.; Xu, L.; Wang, L.; Yao, Y.; Yang, G. 2014: Hypermethylation of Sp1 binding site suppresses hypothalamic POMC in neonates and may contribute to metabolic disorders in adults: impact of maternal dietary CLAs. Diabetes 63(5): 1475-1487

Wang, Y.-Q.; Li, Y.-M.; Li, X.; Liu, T.; Liu, X.-K.; Zhang, J.-Q.; Guo, J.-W.; Guo, L.-Y.; Qiao, L. 2013: Hypermethylation of TGF-β1 gene promoter in gastric cancer. World Journal of Gastroenterology 19(33): 5557-5564

Bubnov, V.; Moskalev, E.; Petrovskiy, Y.; Bauer, A.; Hoheisel, J.; Zaporozhan, V. 2012: Hypermethylation of TUSC5 genes in breast cancer tissue. Experimental Oncology 34(4): 370-372

Yegin, Z.; Gunes, S.; Buyukalpelli, R. 2013: Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients. Dna and Cell Biology 32(7): 386-392

Galrão, A.L.; Camargo, R.Y.; Friguglietti, C.U.; Moraes, L.; Cerutti, J.M.; Serrano-Nascimento, C.; Suzuki, M.F.; Medeiros-Neto, G.; Rubio, I.G.S. 2014: Hypermethylation of a new Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors. Journal of Clinical Endocrinology and Metabolism 99(6): E944-E952

Lleras, R.A.; Adrien, L.R.; Smith, R.V.; Brown, B.; Jivraj, N.; Keller, C.; Sarta, C.; Schlecht, N.F.; Harris, T.M.; Childs, G.; Prystowsky, M.B.; Belbin, T.J. 2011: Hypermethylation of a cluster of Krüppel-type zinc finger protein genes on chromosome 19q13 in oropharyngeal squamous cell carcinoma. American Journal of Pathology 178(5): 1965-1974

Beta, M.; Chitipothu, S.; Khetan, V.; Biswas, J.; Krishnakumar, S. 2015: Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma. Current Eye Research 40(7): 719-728

Wang, Z.-K.; Liu, J.; Liu, C.; Wang, F.-Y.; Chen, C.-Y.; Zhang, X.-H. 2012: Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas. Journal of Gastroenterology and Hepatology 27(10): 1629-1634

Grau, E.; Martinez, F.; Orellana, C.; Canete, A.; Yañez, Y.; Oltra, S.; Noguera, R.; Hernandez, M.; Bermúdez, J.D.; Castel, V. 2011: Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease. Molecular Carcinogenesis 50(3): 153-162

Sharma, R.; Panda, N.K.; Khullar, M. 2010: Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Diseases 16(7): 668-673

Misawa, K.; Kanazawa, T.; Misawa, Y.; Imai, A.; Endo, S.; Hakamada, K.; Mineta, H. 2011: Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer. Cancer Biomarkers: Section a of Disease Markers 10(3-4): 135-144

Zhi, Y.; Huang, Y.; Li, Z.; Zhang, R. 2008: Hypermethylation of estrogen receptor-alpha gene and high homocysteine in atheromatosis patients. Wei Sheng Yan Jiu 37(3): 314-317

Huang, Y.-S.; Zhi, Y.-F.; Wang, S.-R. 2009: Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology: the Official Journal of the International Society for Pathophysiology 16(4): 259-265

Zhong, X.; Isharwal, S.; Naples, J.M.; Shiff, C.; Veltri, R.W.; Shao, C.; Bosompem, K.M.; Sidransky, D.; Hoque, M.O. 2013: Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. Plos one 8(3): E59089

Vanaja, D.Krishna.; Ehrich, M.; Van den Boom, D.; Cheville, J.C.; Karnes, R.Jeffrey.; Tindall, D.J.; Cantor, C.R.; Young, C.Y.F. 2009: Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Investigation 27(5): 549-560

Katargin, A.N.; Pavlova, L.S.; Kisseljov, F.L.; Kisseljova, N.P. 2009: Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer. Bmc Medical Genomics 2: 30

Na, Y.K.; Lee, S.M.; Hong, H.S.; Kim, J.B.; Park, J.Y.; Kim, D.S. 2010: Hypermethylation of growth arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features. Molecules and Cells 30(1): 89-92

Jiang, M.; Zhang, Y.; Liu, M.; Lan, M.S.; Fei, J.; Fan, W.; Gao, X.; Lu, D. 2011: Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet-induced obese rats. Endocrinology 152(4): 1284-1289

Bromer, J.G.; Wu, J.; Zhou, Y.; Taylor, H.S. 2009: Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150(7): 3376-3382

Huang, Y.-W.; Kuo, C.-T.; Chen, J.-H.; Goodfellow, P.J.; Huang, T.H.-M.; Rader, J.S.; Uyar, D.S. 2014: Hypermethylation of miR-203 in endometrial carcinomas. Gynecologic Oncology 133(2): 340-345

Li, B.; Wang, B.; Niu, L.-J.; Jiang, L.; Qiu, C.-C. 2011: Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma. Epigenetics 6(3): 307-316

Moriyama, T.; Matsumoto, T.; Nakamura, S.; Jo, Y.; Mibu, R.; Yao, T.; Iida, M. 2007: Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Diseases of the Colon and Rectum 50(9): 1384-1392

Krajnović, M.; Jovanović, M.Peruničić.; Mihaljević, B.; Anđelić, Bško.; Tarabar, O.; Knežević-Ušaj, S.; Krtolica, K. 2014: Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease. Clinical and Translational Science 7(5): 384-390

Jabłonowski, Z.; Reszka, E.; Gromadzińska, J.; Wąsowicz, W.; Sosnowski, M. 2011: Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer. Archives of Medical Science: Ams 7(3): 512-516

Fujiwara, S.; Noguchi, T.; Takeno, S.; Kimura, Y.; Fumoto, S.; Kawahara, K. 2008: Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 21(2): 125-131

Cong, D-gang.; Wang, S-fa. 2007: Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof. Zhonghua Yi Xue Za Zhi 87(41): 2932-2934

Löf-Öhlin, Z.M.; Sorbe, B.; Wingren, S.; Nilsson, T.ör.K. 2011: Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients. International Journal of Oncology 39(3): 683-688

Russ, J.; Liu, E.Y.; Wu, K.; Neal, D.; Suh, E.; Irwin, D.J.; McMillan, C.T.; Harms, M.B.; Cairns, N.J.; Wood, E.M.; Xie, S.X.; Elman, L.; McCluskey, L.; Grossman, M.; Van Deerlin, V.M.; Lee, E.B. 2015: Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathologica 129(1): 39-52

Visnovsky, J.; Fiolka, R.; Kudela, E.; Slavik, P.; Krkoska, M.; Lasabová, Z.; Danko, J. 2013: Hypermethylation of selected genes in endometrial carcinogenesis. Neuro Endocrinology Letters 34(7): 675-680

Saelee, P.; Chuensumran, U.; Wongkham, S.; Chariyalertsak, S.; Tiwawech, D.; Petmitr, S. 2012: Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients. Asian Pacific Journal of Cancer Prevention: Apjcp 13(7): 3489-3493

Jin, Z.; Olaru, A.; Yang, J.; Sato, F.; Cheng, Y.; Kan, T.; Mori, Y.; Mantzur, C.; Paun, B.; Hamilton, J.P.; Ito, T.; Wang, S.; David, S.; Agarwal, R.; Beer, D.G.; Abraham, J.M.; Meltzer, S.J. 2007: Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(21): 6293-6300

Wang, L.-j.; Bai, Y.; Bao, Z.-s.; Chen, Y.; Yan, Z.-h.; Zhang, W.; Zhang, Q.-g. 2013: Hypermethylation of testis derived transcript gene promoter significantly correlates with worse outcomes in glioblastoma patients. Chinese Medical Journal 126(11): 2062-2066

Kvasha, S.; Gordiyuk, V.; Kondratov, A.; Ugryn, D.; Zgonnyk, Y.M.; Rynditch, A.V.; Vozianov, A.F. 2008: Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas. Cancer Letters 265(2): 250-257

Reed, K.; Hembruff, S.L.; Laberge, M.L.; Villeneuve, D.J.; Côté, G.B.; Parissenti, A.M. 2008: Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells. Epigenetics 3(5): 270-280

Kostin, P.A.; Zakharzhevskaia, N.B.; Generozov, E.V.; Govorun, V.M.; Chernyshov, S.V.; Shchelygin, I.A. 2010: Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer. Voprosy Onkologii 56(2): 162-168

Liau, J.-Y.; Liao, S.-L.; Hsiao, C.-H.; Lin, M.-C.; Chang, H.-C.; Kuo, K.-T. 2014: Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Human Pathology 45(3): 533-539

Jo, H.; Kang, S.; Kim, J.W.; Kang, G.H.; Park, N.H.; Song, Y.S.; Park, S.Y.; Kang, S.B.; Lee, H.P. 2007: Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer. Journal of Obstetrics and Gynaecology Research 33(3): 236-241

Xi, Z.; Rainero, I.; Rubino, E.; Pinessi, L.; Bruni, A.C.; Maletta, R.G.; Nacmias, B.; Sorbi, S.; Galimberti, D.; Surace, E.I.; Zheng, Y.; Moreno, D.; Sato, C.; Liang, Y.; Zhou, Y.; Robertson, J.; Zinman, L.; Tartaglia, M.C.; St George-Hyslop, P.; Rogaeva, E. 2014: Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients. Human Molecular Genetics 23(21): 5630-5637

Bryan, J.N.; Jabbes, M.; Berent, L.M.; Arthur, G.L.; Taylor, K.H.; Rissetto, K.C.; Henry, C.J.; Rahmatpanah, F.; Rankin, W.V.; Villamil, J.A.; Lewis, M.R.; Caldwell, C.W. 2009: Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma. Bmc Genetics 10: 73

Amstutz, U.; Farese, S.; Aebi, S.; Largiadèr, C.R. 2008: Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy. Journal of Experimental and Clinical Cancer Research: Cr 27: 54

Tsujiuchi, T.; Masaoka, T.; Sugata, E.; Onishi, M.; Fujii, H.; Shimizu, K.; Honoki, K. 2007: Hypermethylation of the Dal-1 gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Molecular Carcinogenesis 46(10): 819-823

Hess, C.J.; Ameziane, N.; Schuurhuis, G.J.; Errami, A.; Denkers, F.; Kaspers, G.J.L.; Cloos, J.; Joenje, H.; Reinhardt, D.; Ossenkoppele, G.J.; Zwaan, C.M.; Waisfisz, Q. 2008: Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Cellular Oncology: the Official Journal of the International Society for Cellular Oncology 30(4): 299-306

Kristensen, H.; Haldrup, C.; Strand, S.; Mundbjerg, K.; Mortensen, M.M.; Thorsen, K.; Ostenfeld, M.S.; Wild, P.J.; Arsov, C.; Goering, W.; Visakorpi, T.; Egevad, L.; Lindberg, J.; Grönberg, H.; Høyer, S.ør.; Borre, M.; Ørntoft, T.F.; Sørensen, K.D. 2014: Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(8): 2169-2181

Lasabova, Z.; Tilandyova, P.; Kajo, K.; Zubor, P.; Burjanivova, T.; Danko, J.; Plank, L. 2010: Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters. Neoplasma 57(1): 35-40

Dejeux, E.; Olaso, R.; Dousset, B.; Audebourg, A.; Gut, I.G.; Terris, B.; Tost, Jörg. 2009: Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression. Endocrine-Related Cancer 16(3): 939-952

Wang, R.; An, J.; Ji, F.; Jiao, H.; Sun, H.; Zhou, D. 2008: Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochemical and Biophysical Research Communications 373(1): 151-154

Carrell, D.T. 2013: Hypermethylation of the MTHFR gene is common in sperm from couples with unexplained pregnancy loss. Epigenomics 5(1): 22-23

Long, N.K.; Kato, K.; Yamashita, T.; Makita, H.; Toida, M.; Hatakeyama, D.; Hara, A.; Mori, H.; Shibata, T. 2008: Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncology 44(11): 1052-1058

Kee, S.Kook.; Lee, J.Yun.; Kim, M.Jin.; Lee, S.Man.; Jung, Y.Won.; Kim, Y.Joo.; Park, J.Yong.; Bae, H.Ik.; Hong, H.Sook.; Yun, Y.Kook.; Kim, S.Geol.; Kim, D.Sun. 2007: Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer. Molecules and Cells 24(3): 364-371

Guillaumet-Adkins, A.; Richter, J.; Odero, M.D.; Sandoval, J.; Agirre, X.; Catala, A.; Esteller, M.; Prósper, F.; Calasanz, M.ía.J.é; Buño, I.; Kwon, M.; Court, F.; Siebert, R.; Monk, D. 2014: Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels. Journal of Hematology and Oncology 7: 4

Sato, M.; Mochizuki, H.; Goto-Koshino, Y.; Fujiwara-Igarashi, A.; Takahashi, M.; Fujino, Y.; Ohno, K.; Tsujimoto, H. 2014: Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors. Veterinary Immunology and Immunopathology 161(3-4): 222-231

Wang, Y.; Fang, Y.; Zhang, F.; Xu, M.; Zhang, J.; Yan, J.; Ju, W.; Brown, W.T.; Zhong, N. 2014: Hypermethylation of the enolase gene (ENO2) in autism. European Journal of Pediatrics 173(9): 1233-1244

Diop-Bove, N.K.; Wu, J.; Zhao, R.; Locker, J.; Goldman, I.D. 2009: Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant Hela cell line. Molecular Cancer Therapeutics 8(8): 2424-2431

Sasaki, H.; Hikosaka, Y.; Kawano, O.; Yano, M.; Fujii, Y. 2010: Hypermethylation of the large tumor suppressor genes in Japanese lung cancer. Oncology Letters 1(2): 303-307

Papageorgiou, S.G.; Lambropoulos, S.; Pappa, V.; Economopoulou, C.; Kontsioti, F.; Papageorgiou, E.; Tsirigotis, P.; Dervenoulas, J.; Economopoulos, T. 2007: Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. American Journal of Hematology 82(9): 824-825

Beukers, W.; Hercegovac, A.; Vermeij, M.; Kandimalla, R.; Blok, A.C.; van der Aa, M.M.N.; Zwarthoff, E.C.; Zuiverloon, T.C.M. 2013: Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages. Journal of Urology 190(1): 311-316

Wargon, V.; Fernandez, S.V.; Goin, M.; Giulianelli, S.án.; Russo, J.; Lanari, C. 2011: Hypermethylation of the progesterone receptor a in constitutive antiprogestin-resistant mouse mammary carcinomas. Breast Cancer Research and Treatment 126(2): 319-332

Tamura, G. 2009: Hypermethylation of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. World Journal of Gastrointestinal Oncology 1(1): 41-46

Radpour, R.; Barekati, Z.; Kohler, C.; Lv, Q.; Bürki, N.; Diesch, C.; Bitzer, J.; Zheng, H.; Schmid, S.; Zhong, X.Y. 2011: Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. Plos one 6(1): E16080

Ben Ayed-Guerfali, D.; Benhaj, K.; Khabir, A.; Abid, M.; Bayrouti, M.I.; Sellami-Boudawara, T.; Gargouri, A.; Mokdad-Gargouri, R. 2011: Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance. Journal of Surgical Oncology 103(7): 687-694

Li, Z.-G.; Jiao, Y.; Li, W.-J.; Deng, G.-R.; Cui, L.; Gao, C.; Zhao, X.-X.; Wu, M.-Y.; Jia, H.-T. 2013: Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia. Leukemia Research 37(10): 1287-1293

Franke, J.; Gehlen, J.; Ehrenhofer-Murray, A.E. 2008: Hypermethylation of yeast telomerase RNA by the snRNA and snoRNA methyltransferase Tgs1. Journal of Cell Science 121(Part 21): 3553-3560

Wang, X.; Wang, L.; Guo, S.; Bao, Y.; Ma, Y.; Yan, F.; Xu, K.; Xu, Z.; Jin, L.; Lu, D.; Xu, J.; Wang, J-Cun. 2013: Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(10): 4194-4203

Sobti, R.C.; MalekZadeh, K.; Nikbakht, M.; Sadeghi, I.A.; Shekari, M.; Singh, S.K. 2010: Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 15(2): 167-174